Page last updated: 2024-08-24

triazoles and Mycoses

triazoles has been researched along with Mycoses in 903 studies

Research

Studies (903)

TimeframeStudies, this research(%)All Research%
pre-199036 (3.99)18.7374
1990's33 (3.65)18.2507
2000's346 (38.32)29.6817
2010's453 (50.17)24.3611
2020's35 (3.88)2.80

Authors

AuthorsStudies
Boechat, N; Castelo-Branco, FS; França, RRF; Hoelz, LVB; Menozzi, CAC1
Panagopoulou, P; Roilides, E1
Fang, JP; Wang, J; Zhang, YT; Zhou, DH1
Berastegui, C; Bravo, C; Campany-Herrero, D; Castells, L; Deu, M; Gavaldà, J; Len, O; Los-Arcos, I; Márquez-Algaba, E; Martín-Gómez, MT; Monforte, A; Moreso, F; Nuvials, X; Sacanell, J; Sempere, A1
Ben-Ami, R; Brüggemann, RJ; Busca, A; Cornely, OA; de Jonge, N; Lewis, R; Piechotta, V; Ráčil, Z; Sinkó, J; Skoetz, N; Stemler, J1
Dong, R; Fang, Y; Jin, W; Lin, N; Shan, Q; Shi, C; Wang, L; Xie, Y; Ye, J1
Aram, JA; Cao, G; Cornely, OA; Desai, A; Fayyad, R; Guo, X; Hamed, K; Wu, D; Zhang, J; Zhang, Y1
de Almeida, C; de Greef, R; Fauchet, F; Hasegawa, C; Iwasa, T; Winchell, GA; Wrishko, RE; Yoshitsugu, H1
Barbi, A; Croubels, S; De Baere, S; De Troyer, N; Deknock, A; Goessens, T; Goethals, P; Greener, M; Lens, L; Martel, A; Pasmans, F; Strubbe, D; Van Leeuwenberg, R; Verbrugghe, E1
Kozaki, T; Mizuhata, J; Ose, A; Shirae, S; Tsuruya, Y1
Andes, DR; Cattaneo, D; Christian, R; Davis, MR; Johnson, MD; Lewis, RE; McCreary, EK; Narayanan, N; Watt, KM; Wiederhold, NP1
Albert, ND; Beyda, ND; Kontoyiannis, DP; Lewis, RE; Wurster, S1
Cardozo, C; Chumbita, M; García-Vidal, C; Moreno-García, E; Puerta-Alcalde, P1
Ahlmann, M; Fröhlich, B; Gastine, S; Groll, AH; Herbrüggen, H; Müller, C; Thorer, H; Tragiannidis, A; Vasileiou, E1
Li, R; Sun, L; Wan, Z; Yu, J1
Atanasova, L; Bogáts, G; Büchner, R; Cai, F; Chenthamara, K; Dóczi, I; Druzhinina, IS; Hatvani, L; Homa, M; Kocsubé, S; Kredics, L; Manikandan, P; Mlinaric-Missoni, E; Narendran, V; Revathi, R; Vágvölgyi, C1
Bowolaksono, A; Chen, X; Indriani, CI; Kajiwara, S; Niimi, K; Niimi, M; Utami, ST; Yaguchi, T1
Bivins, CA; Borthakur, G; Bose, P; Daver, N; Estrov, Z; Huang, X; Kadia, TM; Kantarjian, HM; Konopleva, M; Kontoyiannis, DP; Marx, KR; Masarova, L; McCue, D; Naqvi, K; Pemmaraju, N; Pierce, SA; Qiao, W; Rausch, CR; Ravandi, F; Takahashi, K; Wiederhold, NP; Wurster, S; Yilmaz, M1
Baretta, V; Calore, E; Carraro, F; Cesaro, S; Colombini, A; D'Amico, MR; Mauro, M; Muggeo, P; Perruccio, K; Tridello, G; Zama, D1
Candoni, A; Facchin, G; Fanin, R; Lazzarotto, D1
Balfour-Lynn, IM; Bentley, S; Carr, SB; Davies, JC1
Borman, AM; Fraser, M; Hughes, JM; Johnson, EM; Noel, AR; Oliver, D; Sunderland, J1
Grigg, A; Hughes, CFM; Robinson, DH1
Gómez-López, A1
Álvarez Duarte, E; Salas, V1
Chen, SC; Cornely, OA; Hoenigl, M; Jenks, JD; Thompson, GR1
Diana, A; Isabel Cristina, RS; Karen, A1
Abdul-Hamil, NA; Cherchione, C; Martinelli, G; Nagarajan, C; Wong, GC1
Chen, B; Wan, Y; Wang, J; Xu, JY; Zhou, M; Zhou, RF1
Armstrong-James, D; Pagani, N; Reed, A1
Alexander, S; Chen, L; Dang, H; Dvorak, CC; Esbenshade, AJ; Fisher, BT; Nieder, ML; Skeens, M; Steinbach, WJ; Sung, L; Villaluna, D; Zaoutis, TE1
Kong, WF; Lang, Q; Pasheed Chughtai, A; Yan, HY1
Al-Obaidi, M; Badali, H; Cañete-Gibas, C; Patterson, HP; Wiederhold, NP1
Arikan, K; Aytac, S; Büyükcam, A; Cengiz, AB; Cetin, M; Cetinkaya, FD; Ceyhan, M; Kara, A; Ozsurekci, Y1
Del Principe, MI; Marchesi, F; Menna, P; Minotti, G; Pagano, L; Perrone, S; Salvatorelli, E1
Mammen, MD; Rupa, V; Sahni, RD; Varghese, GM1
Brüggemann, RJ; Bury, D; Muilwijk, EW; Tissing, WJE; Wolfs, TFW1
Aleissa, MM; Alshehri, BS; Gonzalez-Bocco, IH; Leblebjian, H; Luskin, MR; Marty, FM; McDonnell, AM1
Carvalhaes, CG; Castanheira, M; Messer, SA; Pfaller, MA; Rhomberg, P1
Carvalhaes, CG; Castanheira, M; Messer, SA; Pfaller, MA; Rhomberg, PR1
Birch, M; Law, D; Wiederhold, NP1
Cornely, OA1
Ai, H; Chen, J; Han, M; Hu, J; Huang, H; Huang, X; Ji, Y; Liang, Y; Ma, J; Meng, F; Tang, Y; Wu, D; Zhang, R; Zhang, X1
Berking, S; Doedens, D; Fiegl, M; Horns, H; Ostermann, H; Rieger, CT1
Aversa, F; Busca, A; Candoni, A; Cattaneo, C; Cesaro, S; De Luca, A; Delia, M; Dragonetti, G; Fanci, R; Guglielmi, G; Lessi, F; Martino, G; Nadali, G; Nosari, A; Pagano, L; Picardi, M; Potenza, L; Tumbarello, M; Verga, L1
Aragón, B; Cámara, R; Gozalbo, I; Grau, S; Jurado, M; Sanz, J1
Dong, WH; Dong, YL; Li, JX; Wang, TT; Wang, Y; Zhang, GZ1
Cao, YB; Gao, YH; Li, SW; Li, XH; Wang, HT; Wang, L; Wu, XX; Wu, YM; Xu, LX; Yan, B; Zhang, TT; Zhang, YQ1
Gong, BF; Gong, XY; Gu, RX; Li, Y; Lin, D; Liu, BC; Liu, KQ; Liu, YT; Mi, YC; Qiu, SW; Wang, JX; Wang, Y; Wei, H; Wei, SN; Zhang, GJ; Zhao, XL; Zhou, CL1
Ho, CL; Lee, CH; Lin, C; Lin, JC; Sun, M; Yen, WT1
Ahmadi, B; Alshahni, MM; Ansari, S; Badali, H; Makimura, K; Mirhendi, H; Rezaei-Matehkolaei, A; Shokoohi, GR; Vaezi, A1
Chen, L; Dong, W; Dong, Y; Li, Y; Meng, T; Wang, Y; Xie, J; Xing, Y1
Benamu, E; Fernandez-Pol, S; Ho, DY; Liu, AY; Xie, L; Yu, AT1
Cases Viedma, E; García-Robles, AA; Jordá, C; Mancheño, N; Pemán, J; Poveda-Andrés, JL; Reig Mezquida, JP; Solé, A1
Bernier, B; Bondue, B; Etienne, I; Jacob, F; Knoop, C; Lecomte, S; Montesinos, I; Taton, O1
Patterson, TF; Thompson, GR1
Ertem, M; İleri, T; İnce, E; Pekpak, E; Uysal, Z1
Berger, M; Calore, E; Carraro, F; Cesaro, S; Decembrino, N; Molinaro, M; Perruccio, K; Putti, MC; Rossin, S; Tridello, G; Vicenzi, EB1
Chen, C; Cornely, OA; Croos-Dabrera, R; Engelhardt, M; Heep, M; Lademacher, C; Maher, R; Marty, FM; Mullane, KM; Ostrosky-Zeichner, L; Perfect, JR1
Chen, L; Dong, Y; Hao, R; Li, Y; Liu, L; Meng, T; Wang, Y; Zhang, T1
Castanheira, M; Pfaller, MA; Rhomberg, PR1
Berman, E; Epstein, DJ; Frattini, MG; Huang, YT; Klimek, VM; Papanicolaou, GA; Park, JH; Seo, SK; Tallman, MS1
Costanzo, CM; Oliveri, S; Palermo, CI; Scalia, G; Trovato, L1
Martínez-Matías, N; Rodríguez-Medina, JR1
Fleming, ME; Gordon, WT; Jessie, EM; Khan, M; Malone, DL; Murray, CK; Potter, BK; Rodriguez, CJ; Shackelford, SA; Tribble, DR1
DiPippo, AJ; Kontoyiannis, DP; Rausch, CR1
Downes, KJ; Ellis, D; Fisher, BT; Lavigne, S; Zaoutis, TE1
Marini, BL; Perissinotti, AJ1
Bandettini, R; Cavanna, C; Esposto, MC; Grancini, A; Lallitto, F; Lo Cascio, G; Mularoni, A; Ossi, C; Prigitano, A; Tejada, M; Tortorano, AM1
Asbury, KL; Delafield, NL; Kenny, G; Lambert, KL; Larsen, BT; Moran, C; Patron, RL1
Bakker, M; C Alffenaar, JW; Märtson, AG; Span, LFR; Touw, DJ; van den Heuvel, ER; van der Werf, TS; Veringa, A1
Athans, V; Brizendine, KD; Hassouna, H1
Cardozo, C; Diago, E; Enzenhofer, M; Fortun, J; Frutos, A; Garcia-Vidal, C; Gioia, F; Gudiol, C; José Castón, J; López, J; Machado, M; Martín-Dávila, P; Muñoz, P; Parody, R; Puerta-Alcalde, P; Ramos, A1
Daly, RC; Kennedy, CC; Pennington, KM; Peters, S; Razonable, RR; Scott, JP; Wylam, M1
Emami, S; Ghobadi, E; Hashemi, SM; Saednia, S1
Kontoyiannis, DP; Li, R; Liu, W; Shi, X; Tan, J; Wan, Z; Zhang, H; Zhou, Y; Zhu, P1
Paiva, JA; Pereira, JM1
McLaren, A; McLemore, R; Pauken, C; Schmidt, K1
Athanasakis, K; Kyriopoulos, J; Petrakis, I1
Gao, Y; Ping, B; Wu, B; Yue, C; Zhu, Y1
Barreto, JN; Beach, CL; Hogan, WJ; Litzow, MR; Merten, JA; Tosh, PK; Wilson, JW; Wolf, RC1
Al-Badriyeh, D; Bajel, A; Grigg, A; Heng, SC; Kirsa, S; Kong, DC; Nation, RL; Seymour, JF; Slavin, MA; Thursky, K1
Agarwal, K; Chowdhary, A; Gaur, SN; Kathuria, S; Meis, JF; Randhawa, HS; Roy, P; Singh, PK1
Charles, JI; Jeanbourquin, D; Mostofi, K1
Bulacio, L; Escovich, L; López, C; Pairoba, C; Paz, M; Ramadán, S; Ramos, L; Sortino, M1
Kong, DC; Kotsimbos, T; Levvey, B; Morrissey, CO; Neoh, CF; Slavin, MA; Snell, GI; Stewart, K1
Itälä-Remes, M; Remes, K; Salmenniemi, U1
Berry, A; Cardeau-Desangles, I; Cassaing, S; Cointault, O; Esposito, L; Fabre, A; Guitard, J; Iriart, X; Kamar, N; Valentin, A1
Celik, IH; Demirel, G; Dilmen, U; Erdeve, O; Oguz, SS; Uras, N1
Arıkan Akdağlı, S; Aydeniz Ozansoy, F; Dursunoğlu, N; Ergin, C; Kutlu, M; Sarı, I; Sarıbaş, Z1
Huenecke, S; Klingebiel, T; Koehl, U; Latgé, JP; Lehrnbecher, T; Roeger, F; Schmidt, S; Schubert, R; Tramsen, L1
Blennow, O; Kalin, M1
Dolton, MJ; McLachlan, AJ2
Acharya, NR; Krishnan, T; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Porco, TC; Prajna, L; Prajna, NV; Raghavan, A; Rajaraman, R; Ray, KJ; Srinivasan, M; Zegans, ME1
Ostermann, H; Ostermann, J; Peterson, L; Rieger, CT; Rieger, H1
Castanheira, M; Jones, RN; Messer, SA; Pfaller, MA; Woosley, LN1
Gao, X; Ji, X; Marks, DI; Schlamm, HT; Stephens, JM; Tarallo, M1
Goto, T; Hashinaga, K; Hiramatsu, K; Itoh, H; Kadota, J; Kawasaki, K; Sato, Y; Suzuki, Y; Tokimatsu, I1
Cornely, OA; Glossmann, J; Hallek, M; Heimann, SM; Kochanek, M; Kreuzer, KA; Vehreschild, JJ; Vehreschild, MJ1
Byrnes, E; Datta, K; Garcia-Effron, G; Marr, KA; Perlin, DS; Rhee, P; Staab, JF1
Hino, M; Iino, M; Kanamaru, A; Koh, H; Masaoka, T; Ohta, K; Ohyashiki, K; Tamura, K; Tanimoto, M; Urabe, A; Urase, F; Usui, N; Yamaguchi, M; Yamanouchi, J; Yoshida, M1
Heng, SC; Keating, D; Kong, DC; Levvey, B; Morrissey, O; Nation, RL; Slavin, MA; Snell, GI; Westall, GP; Whitford, H; Williams, TJ1
Biswas, C; Chen, SC; Djordjevic, JT; Jolliffe, KA; Sorrell, TC; Zuo, X1
Engelhardt, M; Gross, BN; Ihorst, G; Jung, M; Wäsch, R1
Einsele, H; Grau, A; Heinz, WJ; Helle-Beyersdorf, A; Klinker, H; Lenker, U; Schirmer, D; Zirkel, J1
Alffenaar, JW; Greijdanus, B; Kosterink, JG; Span, LF; Uges, DR; van der Elst, KC; van der Werf, TS; van Hateren, K; Vermeulen, KM1
Campoli, P; Filler, SG; Kristof, AS; Perlin, DS; Sheppard, DC; White, TC1
Cho, BS; Choi, JH; Choi, SM; Kim, HJ; Kim, SH; Kwon, JC; Lee, DG; Lee, HJ; Lee, JW; Lee, S; Min, CK; Min, WS; Park, SH; Yoo, JH1
Chen, FP; Chen, XQ; Hu, JD; Huang, XJ; Jin, J; Li, Y; Liang, YM; Liu, T; Shen, Y; Shen, ZX; Wang, JX; Wang, SJ; Wu, DP; Yu, K; Yu, L1
Baden, LR; Bolaños-Meade, J; Brown, JM; Chirila, C; Gersten, ID; Graham, J; Horowitz, MH; Kurtzberg, J; Leather, H; Marr, KA; Mauskopf, J; Maziarz, RT; Walsh, TJ; Wingard, JR1
Bertz, H; Drognitz, K; Lübbert, M1
Calzada, JI; Diaz, RI; Randolph, JC; Sigler, EJ1
Aline-Fardin, A; Buot, G; Dannaoui, E; Degulys, A; Guitard, J; Hennequin, C; Lapusan, S; Marie, JP; Rio, B1
Böhme, A; Buchheidt, D; Cornely, OA; Egerer, G; Heinz, W; Krüger, W; Link, H; Maschmeyer, G; Mousset, S; Neumann, S; Ostermann, H; Panse, J; Penack, O; Rieger, C; Ruhnke, M; Schmidt-Hieber, M; Silling, G; Südhoff, T; Ullmann, AJ; Wolf, HH1
Boongird, A; Chongtrakool, P; Jirasiritham, S; Larbcharoensub, N; Sumethkul, V; Watcharananan, SP; Wirojtananugoon, C1
Candoni, A; Cojutti, P; Fanin, R; Franceschi, L; Pea, F; Simeone, E1
Allione, B; Audisio, E; Aydin, S; Barbui, AM; Busca, A; D'Ardia, S; De Rosa, FG; Dellacasa, CM; Falda, M; Frairia, C; Manetta, S; Marmont, F; Pecoraro, C; Vitolo, U1
Capilla, J; Fernández-Silva, F; Guarro, J; Hernández, P; Mayayo, E; Sutton, DA1
Leroux, S; Ullmann, AJ1
Bierings, MB; Boelens, JJ; Gerhardt, CE; Hol, JA; Lindemans, CA; Versluys, AB; Wildt de, A; Wolfs, TF1
Mikamo, H; Nishiyama, Y; Ohki, E; Satoh, K; Terada, M; Uchida, K; Yamagishi, Y; Yamaguchi, H1
Goletz, G; Groll, AH; Jürgens, H; Kolve, H; Pieper, S; Yunus, S1
Park, SW; Patel, RV1
Gomes, MZ; Jiang, Y; Kontoyiannis, DP; Lewis, RE; Mulanovich, VE1
Al-Badriyeh, D; Dinleyici, EC; Kara, A; Kong, DC; Senol, E; Turner, SJ1
Dorazilova, Z; Maly, J; Netuka, I; Pirk, J; Szarszoi, O1
Geng, RX; Peng, XM; Rasheed, S; Yan, CY; Yin, BT; Zhang, SL; Zhou, CH1
Caira, M; Pagano, L1
Chan, RC; Larsen, SR; van Hal, SJ1
Kim, DY; Lee, YJ; Park, HJ1
Ascioglu, S; Chan, KA1
Acharya, NR; Cevallos, V; Geetha, M; Karpagam, R; Lalitha, P; Lietman, TM; McLeod, SD; O'Brien, KS; Prajna, NV; Sun, CQ1
Mitra, AK; Pal, D; Patel, M; Paturi, DK; Vadlapatla, RK1
Dalbøge, CS; Gøtzsche, PC; Johansen, HK; Jørgensen, KJ1
Drew, RH; Johnson, MD; Kung, HC; Perfect, JR; Saha-Chaudhuri, P1
Campoli, P; Duarte, RF; Sheppard, DC1
Caceres, M; Cornely, OA; Heinz, WJ; Kartsonis, N; Krishna, G; Maertens, J; Patino, H; Robertson, MN; Ullmann, AJ; Waskin, H1
Bangard, C; Cornely, OA; Shimabukuro-Vornhagen, A; Tran, L; Vehreschild, JJ; Vehreschild, MJ; von Bergwelt-Baildon, M; Wisplinghoff, H1
Li, BJ; Liu, XH; Shi, YX; Sun, GX; Sun, ZH; Wu, HK; Yang, MY; Zhang, YG1
Åkerborg, Ö; Björkholm, M; Höglund, M; Lundberg, J1
Duarte, M; Foppa, M; Goldani, L; Jeffman, M; Rohde, LE; Sprinz, E; Torres, FS1
Kauffman, CA; Kerr, L; Malani, AN; Obear, J; Singal, B1
Arnoldner, MA; Durand, ML; Hamrah, P; Jakobiec, FA; Kheirkhah, A1
Azoulay, E; Bergeron, A; Bretagne, S; Lafaurie, M; Lerolle, N; Molina, JM; Porcher, R; Raffoux, E; Sauvageon, H; Socie, G; Touratier, S1
Blennow, O; El-Serafi, I; Eliasson, E; Hassan, M; Mattsson, J; Pettersson, T; Pohanka, A; Ringdén, O; Szakos, A1
Fung, HC; Peksa, GD; Schultz, K1
Capilla, J; Fothergill, AW; Guarro, J; Mayayo, E; Paredes, K; Sutton, DA1
Aversa, F; Ballanti, S; Busca, A; Caira, M; Candoni, A; Castagnola, C; Cattaneo, C; Fanci, R; Lessi, F; Martino, B; Mitra, ME; Nadali, G; Nosari, A; Pagano, L; Picardi, M; Salutari, P; Tumbarello, M; Verga, L1
Choudhury, S; Marte, RL1
Fernández-Silva, F; Guarro, J; Lackner, M; Lass-Flörl, C1
Bourdelin, M; Daguindau, E; Deconinck, E; Desbrosses, Y; Dubut, J; Grenouillet, F; Larosa, F; Limat, S; Muret, P1
Morris, AM1
Chandrasekar, P; Connelly, N; Cornely, OA; Duarte, RF; Haider, S; Helfgott, D; Kartsonis, N; Langston, A; Laverdiere, M; López-Jiménez, J; Ma, L; Perfect, J; van Iersel, ML; Waskin, H1
Frauenfelder, T; Gerber, B; Köppel, J; Manz, MG; Nair, G; Nguyen-Kim, TD; Paul, M; Schanz, U1
Duettmann, W; Hoenigl, M; Huber-Krassnitzer, B; Krause, R; Prattes, J; Prueller, F; Raggam, RB; Seeber, K; Theiler, G; Wagner, J; Wölfler, A; Zollner-Schwetz, I1
Kim, JH; Williams, K1
Castanheira, M; Farrell, DJ; Jones, RN; Messer, SA; Pfaller, MA1
Choi, SJ; Kang, DY; Oh, SY; Ryu, CK1
Jung, DS; Kontoyiannis, DP; Tverdek, FP1
Boekhout, T; Doroftei, B; Flonta, MM; Kolecka, A; Lupse, M; Man, A; Marangoci, N; Mares, M; Marincu, I; Minea, B; Moraru, RF; Nastasa, V; Pinteala, M; Toma, F1
Chen, J; Hu, J; Huang, H; Huang, X; Jin, J; Li, J; Li, Y; Liang, Y; Ma, J; Sun, Y; Wang, C; Wang, J; Wu, D; Xiao, Y; Yu, K1
Andes, DR; Lepak, AJ1
Al-Hatmi, AM; Bonifaz, A; de Hoog, GS; Garcia-Carmona, K; Meis, JF; van Diepeningen, AD; Vazquez-Maya, L1
Chang, FY; Chang, PY; Chao, TY; Chen, YC; Dai, MS; Ho, CL; Kan, LP; Kao, WY; Lin, HA; Lin, JC; Lin, TY; Wang, CH; Wang, NC; Wu, YY1
Cassumbhoy, M; Chau, MM; Cooper, CM; Kong, DC; Marriott, DJ; Roberts, JA; Trubiano, JA; Urbancic, K; van Hal, SJ; Wilkes, J; Worth, LJ1
Mouton, JW; Seyedmousavi, S; Verweij, PE1
Fan, H; Wang, JF; Xue, Y; Zhu, XB1
Marcella, SW; Sung, AH; Xie, Y1
Ain, Q; Pandey, OP; Pandey, SK; Sengupta, SK1
McKeage, K1
Böhme, A; Cornely, OA; Schmitt-Hoffmann, A; Ullmann, AJ1
Guarascio, AJ; Slain, D1
Cabanillas Stanchi, KM; Döring, M; Ebinger, M; Eikemeier, M; Handgretinger, R; Hartmann, U; Müller, I; Schulz, A; Schwarze, CP1
Hochhaus, A; Schnetzke, U; Scholl, S; Schrenk, KG; Stegemann, K; von Lilienfeld-Toal, M1
Traynor, K1
Han, M; Huang, H; Huang, X; Ji, Y; Meng, F; Ren, H; Shen, Z; Sun, Y; Wang, C; Wu, D; Yu, L; Zhang, X1
Marr, K; Ostrander, D; Shoham, S1
Björkholm, M; Blennow, O; Cederlund, K; Dahlén, T; Kalin, M; Ljungman, P; Nordlander, A1
Healy, JR; Kraft, WK; Moore, JN1
Bagatell, R; Bosse, KR; Fisher, BT; Martino, J1
Castanheira, M; Jones, RN; Messer, SA; Pfaller, MA; Rhomberg, PR1
Caddell, R; Craig, M; Cumpston, A; Hamadani, M; Kanate, AS; Lu, X; Shillingburg, A; Wen, S1
Ananda-Rajah, MR; Kontoyiannis, D1
Li, R; Wan, Z; Yao, L; Yu, J1
Chitasombat, MN; Kontoyiannis, DP1
Couriel, DR; Kauffman, CA; Miceli, MH; Perissinotti, AJ1
Béraud, G; Cabié, A; Coyo, C; Desbois, N; Quist, D; Rozé, B; Savorit, L1
Abdul Halim, NA; Tan, BH; Wong, GC1
Pagano, L; Tumbarello, M1
Borthakur, G; Brown, Y; Cortes, J; Jabbour, E; Kantarjian, H; Konopleva, M; Mattiuzzi, G; Pierce, S; Yilmaz, M1
Back, H; Cho, SY; Choi, JH; Choi, JK; Choi, SM; Kang, S; Kim, HJ; Kim, SH; Kim, YJ; Lee, DG; Lee, EK; Lee, HJ; Min, WS; Park, SH; Yoo, JH1
Arechavala, A; Carrillo-Muñoz, AJ; Eraso, E; Giusiano, G; Jauregizar, N; Negroni, R; Quindós, G; Tur-Tur, C1
Cho, SY; Choi, JH; Choi, JK; Choi, SM; Kim, HJ; Kim, SH; Kim, YJ; Lee, DG; Lee, HJ; Min, WS; Park, SH; Yoo, JH1
Berger, L; Brannelly, LA; Skerratt, LF1
Arilla, MJ; Boluda, B; Calvillo, P; Cano, I; Carpio, N; Jarque, I; Lancharro, A; López-Chuliá, F; Lorenzo, I; Martínez, J; Martínez-Cuadrón, D; Montesinos, P; Navarro, I; Pemán, J; Rodríguez-Veiga, R; Salavert, M; Sanz, GF; Sanz, J; Sanz, MA1
Cha, K; Chae, H; Cho, SY; Kim, HJ; Kim, M; Kim, Y; Kim, YJ; Lee, DG; Lee, S; Yu, H1
Chan, TS; Gill, H; Hwang, YY; Kwong, YL; Marcella, SW1
Badali, H; Chowdhary, A; de Hoog, GS; Fakhim, H; Khodavaisy, S; Meis, JF1
Capilla, J; Guarro, J; Mayayo, E; Thomson, P1
Clark, NM; Grim, SA; Lynch, JP1
Abd El-Mawgoude, HK; Hemdan, MM1
Blume, O; Cabanillas Stanchi, KM; Döring, M; Feucht, J; Feuchtinger, T; Handgretinger, R; Hartmann, U; Heinz, WJ; Klinker, H; Lang, P1
Chai, LY; Khoo, AL; Lim, BP; Ong, B; Tan, BH; Tan, G; Tee, C; Teng, M; Zhao, YJ1
Annaert, P; Augustijns, P; Bica, AM; Colita, A; Mols, R; Peersman, N; Spriet, I; Vanstraelen, K; Vermeersch, P1
Alffenaar, JW; Brouwers, CH; Kosterink, JG; Span, LF; Uges, DR; van den Heuvel, ER; van der Elst, KC; van der Werf, TS; van Wanrooy, MJ1
Aguilar-Zapata, D; Petraitiene, R; Petraitis, V1
Hall, RG; Payne, KD1
Slavin, MA; Thursky, KA1
Aoun, M; Baddley, JW; Bow, EJ; Cornely, OA; Giladi, M; Heinz, WJ; Herbrecht, R; Hope, W; Karthaus, M; Kontoyiannis, DP; Lee, DG; Lee, M; Lortholary, O; Maertens, JA; Maher, RM; Marr, KA; Morrison, VA; Neofytos, D; Oren, I; Patterson, TF; Raad, II; Rahav, G; Schmitt-Hoffmann, AH; Selleslag, D; Shoham, S; Thompson, GR; Ullmann, AJ; Zeiher, B1
Delarze, E; Sanglard, D1
Azzopardi, M; Chambers, D; Chau, C; Hopkins, P; Robinson, CL; Yerkovich, ST1
Capilla, J; Guarro, J; Mayayo, E; Paredes, K1
Gallagher, S; Hashemzadeh, M; Peyton, LR1
Annino, L; Arcioni, F; Bertaina, A; Carotti, A; Caselli, D; Cassetta, MI; Cerchiara, E; Chierichini, A; Cupelli, L; Del Principe, MI; Di Gioia, M; Fallani, S; Fanci, R; Girmenia, C; Mariotti, B; Mengarelli, A; Minotti, C; Novelli, A; Perriello, V; Piedimonte, M; Proia, A; Ribersani, M; Spadea, A; Torelli, GF1
Díaz-Torres, E; Fuentes-Benítes, A; González-Calderón, D; González-Romero, C; Jauregui-Rodríguez, B; Mejía-Dionicio, MG; Morales-Reza, MA; Morales-Rodríguez, M; Ramírez-Villalva, A1
Li, H; Li, S; Ma, X; Tang, B; Tang, P; Wu, D; Xu, K1
Temesgen, Z; Walker, RC; Zeuli, JD1
Azie, N; Franks, B; Goff, D; Horn, D; Khandelwal, N; Shi, F; Shorr, AF; Spalding, J1
Lanternier, FL; Lortholary, O; Pilmis, B1
Antypenko, LM; Fedyunina, NS; Karpenko, OV; Katsev, AM; Kovalenko, SI; Novikov, VP1
Annaert, P; Augustijns, P; Hoenigl, M; Lagrou, K; Maertens, J; Mols, R; Peersman, N; Prattes, J; Schoemans, H; Spriet, I; Theunissen, K; Vanstraelen, K; Vermeersch, P1
Ceesay, MM; Couchman, L; Flanagan, RJ; Pagliuca, A; Smith, M; Wade, J1
Azie, N; Cornely, OA; Engelhardt, M; Kovanda, L; Lee, M; Maher, R; Ostrosky-Zeichner, L; Perfect, JR; Queiroz-Telles, F; Rendon, A; Ribeiro Dos Santos, R; Thompson, GR; Vazquez, JA1
Bang, SM; Cho, JY; Choe, PG; Kim, EJ; Kim, ES; Kim, HB; Kim, I; Kim, NJ; Koh, Y; Lee, JO; Oh, MD; Park, SI; Park, WB; Song, KH; Song, SH; Yoon, S; Yoon, SH; Yu, KS1
Augustynowicz-Kopeć, E; Garczewska, B; Jarzynka, S; Kuś, J; Skorupa, W1
Duettmann, W; Hoenigl, M; Prattes, J1
Buchan, BW; Cockerham, L; Feldman, R; Huang, AM; Lu, Z1
Ananda-Rajah, MR; Bajel, A; Chen, SC; Grigg, A; Haywood, P; Jeong, W; Kong, DC; Lindsay, J; Peleg, AY; Ritchie, D; Seymour, JF; Shanmuganathan, N; Slavin, MA; Urbancic, K1
Bond, SE; Lindsay, PJ; Marriott, DJ; Miyakis, S; Norris, R1
Bubalo, JS; Lewis, JS; Pham, AN1
Blaeschke, F; Cabanillas Stanchi, KM; Döring, M; Ebinger, M; Eikemeier, M; Feucht, J; Feuchtinger, T; Handgretinger, R; Heinz, WJ; Klinker, H; Schwarze, CP1
Arnan, M; Ayats, J; Cuenca-Estrella, M; Duarte, RF; Patiño, B; Sánchez-Ortega, I; Sureda, A1
Chang, YL; Chen, YL; Heitman, J; Wellington, M; Yu, SJ1
Coignard-Biehler, H; Jullien, V; Lanternier, F; Lortholary, O; Pilmis, B; Rouzaud, C1
Freeman, AF; Hallahan, CW; Holland, SM; Jancel, T; Kim, T; Penzak, SR; Shaw, PA1
Abu Saleh, O; Mahmood, M; Sohail, MR1
Bourassa, L; O'Brien, KD; Rakita, RM1
Blaeschke, F; Cabanillas Stanchi, KM; Döring, M; Feucht, J; Feuchtinger, T; Handgretinger, R; Heinz, WJ; Lang, P; Müller, I; Queudeville, M; Schlegel, P1
Fujimoto, Y; Ikawa, K; Kanbayashi, Y; Nomura, K; Taniwaki, M1
Barcia, M; De-Domingo-Barón, B; Pardo-Sánchez, F; Rodríguez-Ares, T; Romero-Jung, P; Touriño-Peralba, R1
Fille, M; Hausdorfer, J; Hinterberger, G; Lass-Flörl, C; Mayr, A; Perkhofer, S; Speth, C1
Rachwalski, EJ; Scheetz, MH; Wieczorkiewicz, JT1
Fleck, R; Hof, H1
Groll, AH; Lehrnbecher, T1
Hoppe-Tichy, T; Lichtenstern, C; Störzinger, D; Swoboda, S; Weigand, MA1
Balasubramaniam, B; Dick, A; Johnson, E; Mayer, E; Narendran, N1
Jansen, JP; Janssen, JJ; Lugtenburg, E; O'Sullivan, AK; Rijnders, B; Span, LF; Stam, WB1
Geria, AN; Scheinfeld, NS1
Espinel-Ingroff, A; Hockey, H; Johnson, E; Szekely, A; Troke, P1
Alexander, BD; Daly, JS; Graybill, JR; Hardalo, CJ; Patino, H; Perfect, JR; Restrepo, A; Tobón, AM1
Alves, AF; Anjos, J; de Hoog, GS; Estevão, H; Faria, E; Gonçalves, T; Hipolito, E; Morais, PV1
AbuTarif, M; Angulo, D; Cornely, OA; Krishna, G; Martinho, M; Xuan, F1
Buchta, V; Vale-Silva, LA; Vejsova, M1
Imai, K; Kobayashi, D; Kogawa, K; Nonoyama, S; Nozaki, M; Sugita, T; Tokimatsu, I; Tsuji, Y1
KLIGMAN, AM; ROSENSWEIG, W1
Cornely, OA; Farowski, F; Kohl, V; Müller, C1
Billaud, EM; Denning, DW; Hope, WW; Lestner, J1
Cleveland, KO; Lacasse, A1
Al-Badriyeh, D; Kong, DC; Liew, D; Stewart, K1
Bijie, H; Diekema, DJ; Dzierzanowska, D; Gibbs, DL; Klimko, NN; Letscher-Bru, V; Lisalova, M; Muehlethaler, K; Newell, VA; Pfaller, MA; Rennison, C; Zaidi, M1
Alastruey-Izquierdo, A; Cuenca-Estrella, M; Hazar, V; Ogunc, D; Ongut, G; Ozhak-Baysan, B; Rodriguez-Tudela, JL; Tezcan, G; Yildiran, ST1
Chang, BP; Chen, YC; Huang, FY; Lee, MD; Lin, CC; Sheu, JC; Sun, PL; Tsai, JD; Tsai, TC1
Collins, CD; Ellis, JJ; Kaul, DR1
Filioti, I; Iosifidis, E; Roilides, E1
Guarro, J; Pastor, FJ; Rodríguez, MM; Serena, C2
Maesaki, S; Tarumoto, N1
Niki, Y2
Fujii, Y; Inase, N; Yoshizawa, Y1
Alastruey-Izquierdo, A; Araujo Ribeiro, M; Cuenca-Estrella, M; Gomez-Lopez, A; Rodriguez-Tudela, JL1
Bouza, E; Guinea, J1
Guarro, J; Mariné, M; Pastor, FJ1
Almirante, B; Pemán, J1
González, GM1
Fothergill, AW; Rinaldi, MG; Sutton, DA1
Anaissie, E; Chang, C; Fishman, J; Horn, D; Marr, K; Neofytos, D; Olyaei, A; Pfaller, M; Steinbach, W; Webster, K1
De Sarro, A; Fera, MT; La Camera, E2
Azuma, E; Hosoki, K; Iwamoto, S; Komada, Y; Kumamoto, T1
Aralikatti, A; Dean, S; Mitra, A; Savant, V; Shah, S1
Morris, MI1
Guarro, J; Mariné, M; Rodríguez, MM; Ruíz-Cendoya, M1
Arsenis, G; Kafetzis, D; Lebessi, E; Pasparakis, D; Stripeli, F; Tsolia, M; Velegraki, A1
Baird, K; Cowen, EW; Gea-Banacloche, J; Mitchell, S; Patel, AR; Pavletic, SZ; Turner, ML; Wise, B1
Alaggio, R; Alessia, B; Cesaro, S; Gamba, P; Marinello, S; Putti, MC; Rossi, L; Toffolutti, T1
Adams, AI; Bergold, AM; Meneghini, LZ; Morimoto, LN1
Naeger-Murphy, N; Pile, JC1
Mehta, J; Pennick, G; Pi, J; Scheetz, MH; Trifilio, SM; Yarnold, PR1
Drew, RH; Perfect, JR; Smith, WJ1
Dorsey, SA; Lewis, JS; Patterson, TF; Pennick, G; Rinaldi, MG; Thompson, GR1
Maertens, J; Meersseman, W; Van Bleyenbergh, P1
Amrein, C; Batisse, A; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Dannaoui, E; Guillemain, R; Lillo-Le Louet, A; Loriot, MA; Pham, MH1
Drew, RH; Perfect, JR; Wilson, DT1
Bellemore, MC; Ellis, DH; Kesson, AM; O'Mara, TJ; Sorrell, TC1
Hangaishi, A; Imai, Y; Kumano, K; Kurokawa, M; Nannya, Y; Takahashi, T; Ueda, K1
Cociglio, M; Eiden, C; Hansel-Esteller, S; Hillaire-Buys, D; Margueritte, G; Palenzuela, G; Peyriere, H1
Amrein, C; Benammar, M; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Guillemain, R; Lefeuvre, S1
Araujo, R; Costa-de-Oliveira, S; Coutinho, I; Pina-Vaz, C; Rodrigues, AG1
Bluemel, A; Ghebremedhin, B; Koenig, B; Koenig, W; Neumann, KH1
Maschmeyer, G1
Fothergill, A; Patterson, TF; Sutton, DA; Thompson, GR; Wiederhold, NP1
Castel, V; Gonzalez-Esteban, J; Madero, L; Sanchez de Toledo, J; Sanz-Rodriguez, C; Sevilla, J1
Hasegawa, A; Imaji, M; Kano, R; Maruyama, H; Murakami, Y; Okabayashi, K; Osumi, T; Watanabe, T1
Ayats, J; Cabellos, C; Fernandez-Viladrich, P; Ferran, E; Font, F; Garcia-Vidal, C1
Engel, P; Herbrecht, R; Levêque, D; Nivoix, Y; Ubeaud-Sequier, G1
Dinc, BM; Kalkanci, A; Kekilli, M; Kurt, M; Odemis, B; Oztas, E; Parlak, E; Sasmaz, N1
Autthateinchai, R; Ikeda, R; Mekha, N; Nishikawa, A; Poonwan, N; Sawanpanyalert, P; Sugita, T1
Furlanut, M; Pea, F; Viale, P1
Aggermann, T; Binder, S; Haas, P; Hochwarter, A; Krepler, K1
Angel, LF; Brady, R; Cadena, J; Levine, DJ; Levine, SM; Maxwell, PR; Michalek, JE; Restrepo, MI; Sanchez, JF1
Acharya, NR; Hong, K; Lee, S; Loh, AR; Mannis, M1
Lass-Flörl, C; Perkhofer, S1
Fothergill, AW; Hickey, PW; Rinaldi, MG; Schmidt, HJ; Sutton, DA; Walsh, TJ; Wickes, BL1
Delaere, L; Lagrou, K; Maertens, J; Peetermans, WE; Spriet, I; Willems, L1
Anasetti, C; Field, T; Gergis, U; Greene, J; Huang, Y; Kharfan-Dabaja, M; Markey, K; Perkins, J; Schell, MJ; Wetzstein, G1
Frueh, BE; Goldblum, D; Muehlethaler, K; Theoulakis, P; Zimmerli, S1
Bougnoux, ME; Buzyn, A; Elie, C; Jullien, V; Lanternier, F; Lebeaux, D; Lecuit, M; Lortholary, O; Suarez, F; Viard, JP1
Amábile-Cuevas, CF; Arredondo-García, JL1
Abderrahim, E; Ben Abdallah, T; Ben Hamida, F; Ben Maïz, H; Bezzine, H; Hedri, H; Khaled, S; Kheder, A; Ounissi, M; Trabelsi, S1
Damon, L; Guglielmo, BJ; Hwang, J; Kaplan, L; Linker, C; Martin, T; O'Malley, R; Sharma, M; Working, M1
Besterman, JM; Diekema, DJ; Georgopapadakou, N; Martell, LA; Messer, SA; Pfaller, MA1
Carreras, E; Casado, MA; de la Cámara, R; Grau, S; Jarque, I; Sabater, FJ; Sanz, MA2
Marriott, D; Miyakis, S; Ray, J; van Hal, SJ1
Abduljalil, K; Cornely, OA; Fuhr, U; Hallek, M; Kohl, V; Müller, C; Rüping, MJ; Scheid, C; Vehreschild, JJ1
Hansel-Esteller, S; Selvy, N; Villiet, M1
Capote, M; Gómez, P; Martín, C; Martín, V; Martínez, F; Molina, JR; Rojas, R; Sánchez-García, J; Serrano, J; Tabares, S; Torres, A1
Böhme, A; Cornely, OA; Drzisga, I; Frommolt, P; Hallek, M; Harnischmacher, U; Mousset, S; Müller, C; Rüping, MJ; Vehreschild, JJ; Wassmer, G1
Akin, M; Ay, Y; Balkan, C; Karapinar, B; Kavakli, K; Yilmaz, D1
Blijlevens, NM; Brüggemann, RJ; Burger, DM; Donnelly, JP; Franke, B; Troke, PF1
Lewis, JS; Thompson, GR1
Drusano, GL1
Hoffman, J; Jelliffe, R; Kovacs, A; Neely, M; Rushing, T1
Alvarado, G; Blamble, D; Cortes, J; Faderl, S; Hernandez, M; Kantarjian, H; Koller, C; Mattiuzzi, GN; Pierce, S; Verstovsek, S; Xiao, L1
Alagöz, N; Bozkurt, E; Cakir, M; Cekiç, O; Imamoğlu, S; Oksüz, L; Yilmaz, OF1
Ethier, MC; Maloney, AM; Mitchell, D; Sung, L; Zaoutis, T1
AbuTarif, MA; Krishna, G; Statkevich, P1
Guarro, J; Madrid, H; Pastor, J; Ruíz-Cendoya, M1
Calvo, E; Guarro, J; Mayayo, E; Pastor, FJ; Rodríguez, MM; Salas, V1
Cornely, OA; Rüping, MJ; Vehreschild, JJ1
Nehls, S; Ogawa, GS; Pariseau, B; Romanelli, AM; Sutton, DA; Wickes, BL1
Chandrasekar, PH; Cronin, S1
Bocanegra, R; Graybill, JR; Najvar, LK; Patterson, TF; Wiederhold, NP1
Celik, U; Clancy, CJ; Crespo, M; Kwak, EJ; Mitsani, D; Nguyen, MH; Nguyen, ML; Pilewski, J; Silveira, FP; Toyoda, Y; Vadnerkar, A; Yousem, SA1
Hsiao, CH; Lai, CH; Ma, DH; Tan, HY; Wu, PC1
Goldani, LZ; Pasqualotto, AC; Thiele, KO1
Collins, CD; DePestel, DD; Mackler, ER; Nemerovski, CW; Stevenson, JG; Welch, KS1
Miharu, M; Osumi, T; Shima, H; Shimada, H; Takahashi, T1
Li, H; Lu, Q; Wan, Z; Zhang, J1
Basara, N; Bierbach, U; Frenzel, K; Lange, T; Mauz-Körholz, C; Michael, C; Niederwieser, D; Preiss, R2
Buzina, W; Horré, R; Lackner, M; Tintelnot, K1
Al-Badriyeh, D; Bajel, A; Downey, M; Grigg, A; Kong, DC; Liew, D; Slavin, M; Stewart, K; Thursky, K1
FISHER, JK; HOPKINS, JG1
Agoglia, L; Alves, J; Araujo, A; Balbi, E; Carius, L; Covelo, M; Enne, M; Gonzalez, AC; Guedes, C; Halpern, M; Martinho, JM; Pacheco, L; Roma, J1
Ailani, H; Cohen, EJ; Eagle, RC; Hammersmith, KM; Rapuano, CJ; Yildiz, EH1
Babatz, J; Ehninger, G; Illmer, T; Pursche, S; Schaich, M; Schuler, U; Stölzel, F1
Baert, K; Beernaert, L; de Backer, P; Haesebrouck, F; Hellebuyck, T; Martel, A; Pasmans, F; van Rooij, P; Van Waeyenberghe, L1
Burhenne, J; Burkhardt, O; Kielstein, JT; Thon, S; Welte, T1
Bangard, C; Cornely, OA; Farowski, F; Hallek, M; Kreuzer, KA; Rüping, MJ; Sims, R; Steinbach, A; Stollorz, A; Vehreschild, JJ; Wisplinghoff, H1
Greiner, RA; Imhof, A; Meier, Y; O'Sullivan, AK; Papadopoulos, G1
Corey, M1
Cooperstock, MS; Griffard, EA; Guajardo, JR; Scoville, CL1
Frick, MA; Guarner, ME; Martín Nalda, A; Nadal, CF; Soler-Palacín, P1
Ito, E; Kamio, T; Kudo, K; Sasaki, S; Sato, T; Terui, K1
Bartoni, K; Schiller, GJ; Territo, MC; Winston, DJ1
Clancy, CJ; Derendorf, H; Li, Y; Nguyen, MH; Theuretzbacher, U1
Elston, DM1
Calvo, E; Guarro, J; Pastor, FJ1
Odio, CM1
Attarbaschi, A; Duerken, M; Garbino, J; Groll, AH; Gruhn, B; Kontny, U; Lehrnbecher, T; Lüer, S; Phillips, R; Scholz, J; Wagner, HJ; Wiesel, T1
Colangelo, PM; Gobburu, JV; Jang, SH1
Borman, AM; Houbraken, J; Rijs, AJ; Samson, RA; Verweij, PE1
Kagoshima, Y; Kamai, Y; Kobayashi, N; Konosu, T; Kubota, M; Mori, M; Shibayama, T; Suzuki, E1
Thompson, GR; Wiederhold, NP1
Arron, ST; Ibrahim, SF; Singer, JP1
Bertz, H; Engelhardt, M; Hieke, S; Jung, M; König, A; Kümmerer, K; Neubauer, WC1
Acharya, NR; Hong, KC; Krishnan, T; Lee, SM; Lietman, TM; Mascarenhas, J; McLeod, SD; Porco, TC; Prajna, L; Prajna, NV; Reddy, PR; Srinivasan, M; Vaitilingam, CM; Zegans, ME1
Kondori, N; Mattsby-Baltzer, I; Svensson, E1
Bermudez, C; Clancy, CJ; Crespo, M; Kwak, EJ; Mitsani, D; Nguyen, MH; Pilewski, J; Silveira, FP; Toyoda, Y; Vadnerkar, A1
Lazzaro, C1
Falzone, E; Guarneri, L; Gugliara, C; Maffeo, F; Pasqua, P; Pulvirenti, F1
Hou, Z; Li, C; Liu, G; Liu, Z; Lu, M; Sha, X; Tan, D; Xie, J; Xie, Y1
Bienvenu, AL; Biswas, P; Caillot, D; Chachaty, E; Cornet, M; Greene, J; Grenouillet, F; Herbrecht, R; Lacroix, C; Lortholary, O; Obenga, G; Raad, I; Sitbon, K; Troke, P1
Biassoni, C; Borghi, E; Cuna, T; Iatta, R; Montagna, MT; Morace, G; Sciota, R1
Abecasis, M; Bilger, K; Bofarull, RM; Cordonnier, C; Cornely, OA; de la Cámara, R; Einsele, H; Faucher, C; Heussel, CP; Liakopoulou, E; Ljungman, P; Maertens, J; Olavarria, E; Pigneux, A; Pineau, M; Rovira, M; Ullmann, AJ; Weisser, M1
Arrieta, AC; Driscoll, T; Groll, AH; Jafri, H; Klein, NJ; Lutsar, I; Milligan, PA; Schlamm, H; Walsh, TJ; Wood, ND1
Cordonnier, C; Cornely, OA; Flückiger, U; Frêre, P; Gachot, B; Heinz, WJ; Herbrecht, R; Lass-Flörl, C; Maertens, J; Marchetti, O; Ribaud, P; Thiebaut, A1
Arisawa, M; Fujii, T; Inagaki, Y; Kobayashi, K; Ohwada, J; Page, MG; Shimma, N; Tsukazaki, M; Umeda, I; Yamazaki, T1
Chai, X; Guan, Z; Hu, H; Sun, Q; Wu, Q; Yan, Y; Yu, S; Zou, Y1
Arnan, M; Duarte, RF; Encuentra, M; Fernández de Sevilla, A; Gudiol, C; Parody, R; Patiño, B; Peralta, T; Sánchez-Ortega, I1
Wan, K; Wang, XL; Zhou, CH1
Baert, K; Debacker, P; Ducatelle, R; Garner, TW; Haesebrouck, F; Martel, A; Pasmans, F; Van Rooij, P; Van Waeyenberghe, L; Vercauteren, G; Woeltjes, T1
Fisher, C; Jones, RL; Judson, IR; Ratnayake, G; Scurr, M; Thway, K1
Díaz-Llopis, M; Garcia-Delpech, S; Salom, D; Udaondo, P1
Bleyzac, N; Goutelle, S; Larcher, R; Mialou, V; Padoin, C1
Anandbabu, K; Basu, G; Devasia, A; Sundaram, M; Tamilarasi, V1
Cárdenes, D; Carrillo-Muñoz, AJ; Eraso, E; Estivill, D; Giusiano, G; Guardia, C; Hernández-Molina, JM; Marcos-Arias, C; Ortiz-Maestro, O; Quindós, G; Santos, P; Tur-Tur, C1
Guarro, J; Pastor, J; Ruíz-Cendoya, M1
Accoceberry, I; Gabriel, F; Noel, T1
Dranitsaris, G; Khoury, H1
Esterly, JS; Fotis, M; Gorski, E; Postelnick, M; Scheetz, MH; Trifilio, S1
Auffarth, GU; Dithmar, S; Thomas, BC; Völcker, HE; Zimmermann, S1
DUGGAN, TL; MOONEY, JJ1
Langston, AA; Mehta, AK1
Cecil, JA; Wenzel, RP1
Balestrazzi, A; Ciompi, L; Franceschini, R; Martone, G; Moramarco, A; Pichierri, P; Tosi, GM1
Arora, R; Goyal, J; Gupta, D; Kaur, R1
Balasingham, A; Balasingham, S; Chalkias, S; Saul, Z; Sutton, DA; Wickes, BL1
Baker, K; Klepser, ME; Valente, C; Zoller, E1
Aversa, F; Cesaro, S; Milano, GM1
Egerer, G; Geist, MJ1
Andreesen, R; Hahn, J; Holler, E; Reichle, A; Stifel, F1
Lipp, HP2
Hoppe-Tichy, T; Lichtenstern, C; Störzinger, D; Weigand, MA1
Brüggemann, RJ; Burger, DM; van der Linden, JW; Verweij, PE; Warris, A1
Castanheira, M; Jones, RN; Messer, SA; Moet, GJ; Pfaller, MA1
Bryan, J; Maertens, J1
Al-Badriyeh, D; Heng, SC; Kong, DC; Neoh, CF; Slavin, M; Stewart, K1
Böhme, A; Heinz, WJ; Silling, G1
Charles, JF; Daikh, DI; Eberle, C; Rooney, T1
Ciecko, SC; Scher, R1
Berger, P; Caillot, D; Dupont, B; Gangneux, JP; Herbrecht, R; Lafuma, A; Michallet, M; Moreau, P; O'Sullivan, AK; Ribaud, P1
Sheng, C; Zhang, W1
Cuenca-Estrella, M1
Askari, E; Cáceres Agra, JJ; Jarque, I; Nicolás Franco, S1
Bloomer, MM; Fintelmann, RE; Gilmer, W; Jeng, BH1
Chiba, S; Hara, A; Homma, M; Kohda, Y; Momo, K; Okoshi, Y; Wada, T; Watanabe, M1
Bryant, AM; Craig, M; Cumpston, A; Slain, D1
Blanche, S; Bougnoux, ME; Catherinot, E; Coignard, H; Debourgogne, A; Garcia-Hermoso, D; Hassouni, N; Lecuit, M; Lortholary, O; Machouart, M; Rivier, A; Salmon, A1
Bose, P; Greenfield, RA; Holter, JL; Parekh, HD1
Cornely, OA; Ullmann, AJ2
Benjamin, DK; Cohen-Wolkowiez, M; Watt, K1
Cordonnier, C; Cornely, OA; Einsele, H; Ljungman, P; Maertens, J; Rovira, M1
Chang, FY; Ho, SJ; Lin, JC; Shang, ST; Wang, NC; Yang, YS1
Deuel, T; Folkerth, R; Jiang, JX; Kesari, S; Lechpammer, M; Marty, FM; Milner, DA; Rosow, L; Zamani, AA1
Davis, JL; Goldstein, SC; Lombardi, LR; Miano, TA; Mitra, N; Morgan, SC; Vardhanabhuti, S; Vozniak, JM1
Sheng, CQ; Wang, SZ; Zhang, WN1
Ananda-Rajah, MR; Cheng, A; Dooley, M; Morrissey, CO; Neville, AM; Slavin, M; Spelman, T1
Cheah, FK; Chlebicka, NL; Goh, YT; Kurup, A; Lin, RT; Low, JG; Tan, BH; Wong, GC1
Garnacho-Montero, J; Jiménez Parrilla, F1
Jarque, I; Salavert, M2
Huang, CY; Sun, PL; Tseng, HK1
Daneshgar, F; Khodabande, A; Siatiri, H; Siatiri, N1
Katragkou, A; Roilides, E1
Askari, E; Fernandez Guerrero, ML; Gadea, I; Prieto, E; Román, A1
Barnes, A; Barr, FJ; Hotston-Moore, A; Malik, R; Murphy, KF; Pearson, GR1
He, L; Ji, WB; Liang, YR; Lu, F; Lü, SC; Luo, Y; Shi, XJ; Zhao, ZM1
Garcia-Hermoso, D; Gay-Andrieu, F; Haloun, A; Le Pape, P; Leclair, F; Lepoivre, T; Miegeville, M; Miossec, C; Morio, F; Treilhaud, M1
Alvarez, MA; Gómez, P; Martín, C; Martín, V; Martínez, F; Molina, JR; Rodríguez, G; Rodríguez-Villa, A; Rojas, R; Sánchez-García, J; Serrano, J; Tallón, D; Torres, A1
Blyth, CC1
Jullien, V1
Ceballos, P; Cociglio, M; Eiden, C; Eymard-Duvernay, S; Fegueux, N; Hillaire-Buys, D; Le Falher, G; Meniane, JC; Peyrière, H; Reynes, J1
Green, MR; Woolery, JE2
Delaunay, J; Fraissinet, F; Gastinne, T; Gibas, CF; Le Pape, P; Miegeville, M; Morio, F; Sigler, L1
Debourgogne, A; Gérard, A; Lévy, B; Machouart, M; Perny, J; Rivier, A; Thivillier, C1
Chvojka, J; Karvunidis, T; Krouzecky, A; Matejovic, M; Novak, I; Radej, J; Stehlik, P; Sykora, R1
Kharb, R; Sharma, PC; Yar, MS1
Alivanis, P; Aperis, G1
Chavala, SH; Ehlers, JP; Postel, EA; Woodward, JA1
Williams, D1
Chen, W; Li, YX; Li, ZM; Liu, TW; Mao, MZ; Wang, SH; Yu, SJ; Zhou, YY1
Blanche, S; Bougnoux, ME; Elie, C; Gerin, M; Jullien, V; Lanternier, F; Lortholary, O; Mahlaoui, N1
Hockey, HP; Hope, WW; Troke, PF1
Lingegowda, PB; Tan, AL; Tan, BH; Tan, CK1
Banerjee, R; Dhiman, N; Henry, NK; Huskins, WC; Joshi, AY; Santillan Salas, CF; Wengenack, NL1
Dickmeyer, NJ; Kiel, PJ1
Atta, KF1
Cook, G; Glasmacher, A; Heussel, CP; Kantecki, M; Kibbler, CC; Marks, DI; Miller, PJ; Pagliuca, A; Ribaud, P; Schlamm, HT; Solano, C1
Aneja, DK; Aneja, KR; Arora, S; Hussain, K; Lohan, P; Prakash, O; Ranjan, P; Sharma, C1
Al Abdallah, Q; Campoli, P; Fielhaber, JA; Filler, SG; Kristof, AS; Laverdiere, M; Robitaille, R; Sheppard, DC; Solis, NV1
Haagsma, CJ; Hendrix, R; Ruinemans, GM1
Gubbins, PO1
de Hoog, GS; Hell, M; Lackner, M; Neureiter, J; Presterl, E; Willinger, B; Wojna, A1
Cui, Y; Jin, C; Li, X; Wu, N1
Caira, M; Leone, G; Pagano, L; Trecarichi, EM; Tumbarello, M1
Pandey, OP; Sengupta, SK; Singh, AK1
Bakhshi, S; Kabra, SK; Mandhaniya, S; Swaroop, C; Thulkar, S; Vishnubhatla, S; Xess, I1
Blanche, S; Chosidow, O; Epaulard, O; Leccia, MT; Lortholary, O; Mamzer-Bruneel, MF; Ravaud, P; Thiebaut, A; Villier, C1
Labbé, AC; Laverdière, M; Levallois, J; Nadeau-Fredette, AC; Ouimet, D; Vallée, M1
Ananda-Rajah, MR; Bajel, A; Cheng, A; Downey, MT; Grigg, A; Slavin, MA; Spelman, T; Thursky, KT; Vincent, J1
Cendejas-Bueno, E; Cuenca-Estrella, M; Cuesta, I; García Rodríguez, J; Gómez-López, A; Gutiérrez-Altés, A; Rodríguez-Tudela, JL1
Alimena, G; Breccia, M; Capria, S; Cartoni, C; Foà, R; Frustaci, AM; Gentile, G; Girmenia, C; Latagliata, R; Loglisci, G; Matturro, A; Meloni, G; Micozzi, A; Minotti, C; Trisolini, SM1
Muralikrishna, A; Padmaja, A; Padmavathi, V; Rajasekhar, C1
Lass-Flörl, C1
Chiche, L; Dicostanzo, MP; Durand, JM; Eldin, C; Harle, JR; Ranque, S; Thomas, G1
de Heredia, CD; Figueras, C; Frick, MA; Lanaspa, M; Martín-Nalda, A; Pou, L; Roselló, E; Soler-Palacín, P1
Kontoyiannis, DP1
Chan, C; Chen, J; Colantonio, D; Seto, W1
Feng, AM; Wei, JY; Yu, WJ1
Felton, TW; Gomez-Lopez, A; Hope, WW; Howard, SJ1
Hamada, Y; Kuroyama, M; Seto, Y; Yago, K1
Lombardi, LR; Marr, KA; Neofytos, D; Nguyen, MH; Ostrander, D; Shields, RK; Thompson, CB; Warren, L1
Cornely, OA; Farowski, F; Fuhr, U; Hallek, M; Kohl, V; Kreuzer, KA; Müller, C; Vehreschild, JJ; Vehreschild, MJ1
Cornely, OA; Heinz, W; Helfgott, D; Huyck, S; Krishna, G; Langston, A; Ma, L; McCarthy, MC; Vehreschild, JJ; Vehreschild, MJ1
Fortún, J1
Almajan, GL; Bancescu, G; Barbuceanu, F; Barbuceanu, SF; Draghici, C; Saramet, G1
Ahmad, S; Al-Ghimlas, F; Al-Mutairi, S; Chandy, R; Guarro, J; Joseph, L; Khan, Z; Sutton, DA1
Chen, F; Chen, Y; Hu, J; Huang, X; Jie, J; Liang, Y; Liu, T; Shen, Z; Wang, F; Wang, J; Wang, S; Yu, K; Yu, L1
Bermudez, C; Bhama, JK; Clancy, CJ; Crespo, MM; Kwak, EJ; Mitsani, D; Nguyen, MH; Pilewski, JM; Shields, RK; Silveira, FP; Toyoda, Y1
Acharya, NR; Krishnan, T; Lalitha, P; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Porco, TC; Prajna, NV; Srinivasan, M; Vaitilingam, CM; Zegans, ME1
Shen, YF; Sun, HL; Zhou, X1
Mossad, SB1
Dolton, MJ; Marriott, D; McLachlan, AJ; Ray, JE1
Newton, EJ1
Deering, KM; Dunn, JL; Field, CL; Frasca, S; Gilbert-Marcheterre, K; Meegan, J; Nyaoke, A; Risatti, G; Romano, TA; Sidor, IF; Spoon, T; Tuttle, AD1
Blyth, CC; Cole, C; Gottardo, NG; Hansford, JR1
Hoenigl, M; Krause, R; Raggam, RB; Salzer, HJ; Seeber, K; Sill, H; Strohmeier, AT; Valentin, A; Valentin, T; Wölfler, A; Zollner-Schwetz, I1
Arron, ST; Binstock, M; Boettger, R; Boker, A; Glidden, DV; Golden, JA; Metchnikoff, C; Singer, JP1
Campbell, WN; Fothergill, AW; Keshtkar-Jahromi, M; McTighe, AH; Segalman, KA1
Eberhard, R; Fleischhauer, J; Kocher, C; Trachsler, S1
Aebi, C; Ammann, RA; Bernhard, S; Diepold, M; Kernland Lang, K; Leibundgut, K; Lüer, S1
Cao, Y; Chai, X; Jiang, Y; Sun, Q; Wu, Q; Yang, G; Yu, S; Zhang, D; Zhang, J; Zou, Y1
Drogari-Apiranthitou, M; Grammatikou, M; Kanioura, L; Mantopoulou, FD; Mitroussia-Ziouva, A; Petrikkos, G; Skiada, A; Tsakris, A; Vrioni, G1
Carroll, KC; Illei, PB; Lederman, HM; Marr, KA; Meriden, Z; Riedel, S; Villa, K; Zhang, SX1
Chen, SC; Lawrence, C; Lemos, BD; Marshall Lyon, G; Spratt, M; Veledar, E; Zwald, FO1
Chakrabarty, A; Gupta, A; Gupta, N; Parchand, S; Ram, J1
Bijleveld, YA; Brüggemann, RJ; Crombag, MR; Huisman, C; Kemper, EM1
Antin, JH; Armand, P; Baden, LR; Hammond, SP; Koo, S; Kubiak, DW; Marty, FM1
Kuo, CH; Kuo, HP; Lin, SC; Lin, SW; Liu, HY; Wu, UI; Yao, M1
Andes, D; Lepak, A1
Bille, J; Bolay, S; Buclin, T; Calandra, T; Csajka, C; Marchetti, O; Pascual, A1
Best, L; Champlin, RE; Georgiadou, SP; Kontoyiannis, DP; Lewis, RE; Torres, HA1
Aigner, M; Auberger, J; Clausen, J; Gastl, G; Lass-Flörl, C; Nachbaur, D1
Abdi, RF; Al-Tawfiq, JA; Tarazi, AE1
Fukushima, K; Goto, H; Miharu, M; Mori, M; Shoji, S; Yoshida, M1
Feng, G; Li, J; Liu, W; Pang, X; Shang, W; Sun, R; Wang, X; Wang, Y; Zhang, S; Zhang, W1
Chen, SC; Dolton, MJ; McLachlan, AJ; Ng, K; Pont, LG; Ray, JE1
Das, S; Gupta, N; Jain, S; Malik, JN1
Baden, LR; Boukedes, S; Camp, PC; Dietzek, A; Fuhlbrigge, AL; Goldberg, HJ; Issa, NC; Koo, S; Kubiak, DW; Marty, FM1
Caira, M; Cuenca-Estrella, M; Pagano, L1
Campo, M; Chaftari, AM; Hachem, RY; Jiang, Y; Kassis, C; Prince, RA; Raad, II; Ramos, E; Wang, W1
Graham, ML; Matthias, KR; Nix, DE; Peloquin, CA1
Damu, GL; Geng, RX; Lv, JS; Wang, Y; Yang, DC; Zhou, CH1
Alsamad, IA; Botterel, F; Coste, A; Papon, JF; Pruliere-Escabasse, V; Toussain, G; Zerah-Lancner, F1
Chen, SC; Dolton, MJ; McLachlan, AJ; Ng, K; Pont, L; Ray, JE1
Girmenia, C; Iori, AP1
Atkinson, G; Lee, GA; McLintock, CA1
Benjamin, DK; Boano, E; Cohen-Wolkowiez, M; Jacqz-Aigrain, E; Manzoni, P; Rizzollo, S; Watt, K1
Aversa, F; Busca, A; Caira, M; Candoni, A; Caramatti, C; Castagnola, C; Cattaneo, C; De Paolis, MR; Delia, M; Di Blasi, R; Di Caprio, L; Fanci, R; Garzia, M; Martino, B; Melillo, L; Mitra, ME; Nadali, G; Nosari, A; Pagano, L; Picardi, M; Potenza, L; Salutari, P; Trecarichi, EM; Tumbarello, M; Verga, L; Vianelli, N1
Falcone, EL; Holland, SM1
Hashimoto, N; Hattori, Y; Kato, J; Koda, Y; Mori, T; Okamoto, S; Sadahira, K; Shimizu, T; Tsukada, Y; Yamane, A; Yokoyama, K1
Chohan, ZH; Sumrra, SH1
Arnan, M; Bermúdez, A; Caballero, T; Duarte, RF; Montes, C; Patiño, B; Sánchez-Ortega, I; Vázquez, L; Yáñez, L1
Chen, SC; Chu, YZ; Fan, H; Hu, TS; Hu, ZD; Kong, F; Liao, K; Lu, J; Ni, YX; Shao, HF; Sun, ZY; Wang, H; Xiao, M; Xu, YC; Yan, Y; Zou, GL1
Aversa, F; Busca, A; Candoni, A; Cesaro, S; Girmenia, C; Luppi, M; Nosari, AM; Pagano, L; Rossi, G; Venditti, A1
Lu, HZ; Shen, YZ; Wang, ZY1
Bryant, AM; Craig, M; Cumpston, A; Hamadani, M; Ross, AL; Slain, D1
Berzins, IK; Naples, LM; Poll, CP1
Döring, M; Erbacher, A; Handgretinger, R; Johann, PD; Kimmig, A; Lang, P; Müller, C; Müller, I; Schwarze, CP1
Ananda-Rajah, MR; Grigg, A; Slavin, MA1
Chen, J; Liang, L; Liu, D1
Buer, J; Dittmer, S; Hamprecht, A; Lackner, M; Rath, PM; Schemuth, H; Sedlacek, L; Steinmann, E; Steinmann, J1
Aversa, F; Cesaro, S; de Rosa, FG; Girmenia, C; Micozzi, A; Mikulska, M; Novelli, A; Sanguinetti, M; Viscoli, C1
Ding, Y; Diong, CP; Hsu, LY; Jin, J; Lim, ZY; Low, CY; Ong, WC; Wong, E1
Estes, LL; Wilson, JW; Zeuli, JD1
Hunt, S; Papadopoulos, G; Prasad, M1
Cornely, OA; Heinz, WJ; Hertenstein, B; Horst, HA; Löffler, J; Maschmeyer, G; Requadt, C; Ruhnke, M; Wagner, T1
Ahmed, R; Akdal, G; Ananda, A; Chan, R; Chiu, AL; Crompton, JL; Francis, I; Ghabrial, R; Gibson, J; Goold, LA; Halmagyi, GM; Madge, SN; McCluskey, PJ; Rodriguez, M; Selva, D; Thompson, EO; Thurtell, MJ1
Barberán, J; Carreras, E; Jarque, I; Mensa, J; Serrano, D; Vázquez, L1
Allen, PB; Baer, MR; Kleinberg, ME; Koka, R1
Lilly, CM; Luke, DR; Mayer, T; Meisner, J; Ranauro, P; Welch, VL1
Yoshida, M1
Gibas, CF; Malejczyk, K; Sigler, L; Smith, SW1
Koparir, M; Koparir, P; Orek, C; Sarac, K1
Chandrasekar, P; Jacinto, PL1
Stevens, DA1
Banerjee, D; Khetan, A; Mandal, SM; Saha, S; Sengupta, J1
Golden, JA; Kukreja, J; Leard, LE; Sayah, DM; Schwartz, BS; Singer, JP1
Greenberg, RN; Martin, CA; Roberts, S1
Garbino, J; Hirschel, B1
Baglivo, E; Baligvo, E; Bouchuiguir-Wafa, K; Garbino, J; Lew, D; Ondrusova, A; Rohner, P1
Cornely, OA; Karthaus, M; Ullmann, AJ1
Deplus, S; Dombret, H; Feuillhade, M; Fournier, S; Molina, JM; Pavageau, W; Verola, O; Zagdanski, AM1
Falk, R; Polacheck, I; Shapiro, M; Wolf, DG1
De Hoog, GS; Hatemi, G; Kantarcioğlu, AS; Mandel, NM; Yücel, A1
Adderson, EE; Andreansky, M; Luján-Zilbermann, J; Rodriguez, CA; Woodard, P1
Chapman, SW; Cleary, JD; Pearson, MM; Rogers, PD1
Chan, J1
Kontoyiannis, DP; Mantadakis, E; Samonis, G1
Holzgrabe, U; Schäfer-Korting, M1
Bocanegra, R; Gonzalez, GM; Graybill, JR; Hernandez, S; Najvar, LK1
Gea-Banacloche, JC; Glasmacher, A; Groll, AH; Just-Nuebling, G; Maschmeyer, G; Walsh, TJ1
Sutton, DA1
Alvarez, ME; Fortún, J; Martín-Dávila, P; Moreno, S; Pintado, V; Sánchez, MA; Sánchez-Sousa, A1
Choquet, S; Chosidow, O; Consigny, S; Datry, A; Dhedin, N; Leblond, V1
Girmenia, C; Martino, P1
Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA1
Lutsar, I; Roffey, S; Troke, P1
Schäfer-Korting, M1
Gupta, AK; Tomas, E1
Giles, SS; Kurtzberg, J; Perfect, JR; Schell, WA; Steinbach, WJ; Trinh, JV1
KADEN, R1
LEQUES, B; PAGES, F; VESVAL, P1
GOLDMAN, L1
Andes, D1
Jacobs, RF; Maples, HD; Saccente, SL; Stowe, CD1
Capilla, J; Guarro, J; Ortoneda, M; Pastor, FJ; Serena, C1
Ehlert, K; Groll, AH; Kolve, H; Paulussen, M; Vormoor, J1
Martin, PL; Miller, JL; Perfect, JR; Schell, WA; Steinbach, WJ1
Baden, LR; DelVecchio, A; Doran, M; Fishman, JA; Katz, JT; Koziol, C; Rubin, RH1
Arechavala, A; Bianchi, MH; Helou, SH; Negroni, R; Petri, N; Robles, AM1
VANBREUSEGHEM, R1
Baden, LR; Cosimi, LA; Marty, FM1
Gothard, P; Rogers, TR1
Rubin, ZA; Somani, J1
Alfonso, EC; Giaconi, JA; Marangon, FB; Miller, D2
Ausin, I; Badia, X; Carreras, E; Herrera, L; Roset, M1
Bocanegra, R; Graybill, JR; Johnson, E; Loebenberg, D; Najvar, LK1
Alaggio, R; Calore, E; Cesaro, S; Cusinato, R; Messina, C; Pillon, M; Toffolutti, T; Zanesco, L1
Cordonnier, C1
Anderson, KL; Mitra, S; Pham, TA; Salouti, R; Taylor, HR1
Aoun, M1
Alexopoulos, EC; Gaitanis, G; Kritikou, S; Velegraki, A1
Herbrecht, R2
Bigley, VH; Duarte, RF; Gosling, RD; Kibbler, CC; Potter, M; Seaton, S1
Kuijper, EJ; Kullberg, BJ; van 't Wout, JW; Verweij, PE1
Klastersky, J1
Alkan, Y; Burhenne, J; Haefeli, WE; Shalit, I; Stein, J; Yaniv, I1
Wingard, JR1
Comair, Y; Kanafani, ZA; Kanj, SS1
Mastromarino, A; Polizzi, A; Saccà, SC; Siniscalchi, C1
Agrawal, AK; Sherman, LK1
Perfect, JR2
Marr, K1
Bareau, B; Camus, C; Tattevin, P1
Danaher, PJ1
Lowry, CM; Marty, FM1
Balwierz, W1
Al-Abdely, HM; Al-Tawfiq, JA; Alkhunaizi, AM; Hassounah, M; Rinaldi, MG; Sutton, DA1
Chen, A; Sobel, JD1
Björkholm, M; Cherif, H; Chryssanthou, E; Kalin, M; Petrini, B1
Ausma, J; Backx, LJ; Borgers, M; Corens, D; De Groot, A; Heeres, J; Marichal, PJ; Meerpoel, L; Odds, FC; Oris, M; Van Breda, A; Van der Veken, LJ; van Dorsselaer, P; Van Gerven, F; Vanden Bossche, HF; Vermuyten, KJ; Willemsens, GH; Woestenborghs, FA1
Cudillo, L; de Fabritiis, P; Dentamaro, T; Girmenia, C; Picardi, A; Santilli, S; Tendas, A1
Garbino, J; Lew, D; Rohner, P; Uckay, I; Van Delden, C1
Batra, R; Gupta, AK; Kohli, Y1
Mohammedi, I; Padoin, C; Piens, MA; Robert, D1
Antachopoulos, C; Bibashi, E; Dotis, J; Koliouskas, D; Papakonstantinou, E; Roilides, E; Tamiolaki, M1
Eggink, CA; Klont, RR; Rijs, AJ; Verweij, PE; Wesseling, P1
Böhme, A; Haas, A; Maschmeyer, G1
Berthou, C; Eveillard, JR; Ianoto, JC; Karam, A; Le Flohic, AM; Le Roy, JP; Misery, L; Quinio, D1
Boisseau-Garsaud, AM; Calès-Quist, D; Desbois, N; Diedhou, A; Dutriaux, C; Saint-Cyr, I1
Steinbach, WJ1
Kofla, G; Ruhnke, M1
Auvrignon, A; Boccon-Gibod, L; Landman-Parker, J; Leverger, G; Moissenet, D; Petit, A; Tabone, MD1
Keady, S; Thacker, M1
Fothergill, AW; González, GM; Loebenberg, D; Rinaldi, MG; Sutton, DA1
Keating, GM1
Morace, G; Polonelli, L1
Benjamin, DK; Steinbach, WJ; Zaoutis, TE1
Jiménez-Cabello, T; Morera-López, Y; Torres-Rodríguez, JM1
Groll, AH; Walsh, TJ2
Alexander, BD; Dodds Ashley, ES1
Fohrer, C; Herbrecht, R; Letscher-Bru, V; Natarajan-Amé, S; Nivoix, Y1
Aguado, JM; Cisneros, JM; Díaz Pedroche, C; Lumbreras, C1
Azar, DT; D'Amico, DJ; Durand, ML; Kieval, SJ; Kim, IK; Loewenstein, JI; Lujan, BJ; Martin, SS; Miller, FS; Miller, JW; Tobin, EH1
Bagg, J; Brailsford, S; Davies, AN; Jackson, MS; Sweeney, MP1
Bauer, M; Graninger, W; Joukhadar, C; Kulemann, V1
Chan-Tack, KM1
Baker, CJ; Pannaraj, PS; Walsh, TJ1
Barak, A; Bash, E; Loewenstein, A; Neudorfer, M; Siegman-Igra, Y; Zayit-Soudry, S1
Colombo, GL; Morlotti, L; Serra, G1
Bertz, H; Finke, J; Kern, WV; Sander, A; Wagner, D1
Chamilos, G; Kontoyiannis, DP1
Chemaly, RF; Hachem, RY; Kontoyiannis, DP; Raad, II; Torres, HA1
Chamilos, G; Kontoyiannis, DP; Lewis, RE1
Burchardt, A; Corcoran, G; Cornely, OA; Courtney, R; Hachem, R; Kontoyiannis, DP; Krishna, G; Martinho, M; Raad, I; Töpelt, K; Ullmann, AJ; Wexler, D1
Gøtzsche, PC; Johansen, HK; Jørgensen, KJ1
Ellis, D; Harkness, J; Kwong, T; Marriott, D1
Magalhaes, EP; Nehemy, MB; Torqueti-Costa, L; Vasconcelos-Santos, DV1
Baccari, P; Fumagalli, L; Lazzarin, A; Magnani, P; Prigitano, A; Sagnelli, C1
Carde, A; Faure, P; Papy, E; Ribaud, P; Touratier, S1
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL1
Delikou, S; Kitra, V; Miyakis, S; Papadakis, V; Papadatos, I; Parcharidou, A; Polychronopoulou, S; Velegraki, A1
Al-Attar, A; Redett, RJ; Williams, CG1
de Marie, S; den Hollander, JG; Levin, MD; Lugtenburg, PJ; Rijnders, BJ; van Arkel, C1
Agostinelli, C; Arpinati, M; Baccarani, M; Bandini, G; Bonifazi, F; Giannini, B; Paolini, S; Ricci, P; Stanzani, M; Vianelli, N1
Corcoran, G; Graybill, JR; Hachem, RY; Hare, R; Herbrecht, R; Kontoyiannis, DP; Raad, II1
Antin, JH; Baden, LR; Campbell, BJ; Cutler, CS; Fiumara, K; Lowry, CM; Marty, FM1
Crum-Cianflone, N; Dull, M; Teneza-Mora, N1
Amorosa, V; Bridges, CR; Isidro, AM; Pentz, WH; Rutenberg, HL; Stopyra, GA1
Afif, C; Bustamante, AB; Cornely, OA; Gaona-Flores, V; Graham, DR; Graybill, JR; Greenberg, RN; Hadley, S; Langston, A; Negroni, R; Pedicone, L; Perfect, JR; Pitisuttithum, P; Raad, II; Restrepo, A; Schiller, G; Ullmann, AJ1
Black, TA; Hare, R; Loebenberg, D; Mann, PA; McNicholas, PM; Mendrick, CA; Norris, CC; Patel, R; Sabatelli, F1
Gilgado, F; Guarro, J; Mariné, M; Pastor, FJ; Serena, C1
Craven, DE; Gorman, SR; Magiorakos, AP; Zimmerman, SK1
Derendorf, H; Ihle, F; Theuretzbacher, U1
Almyroudis, NG; Bhatti, Z; Segal, BH; Shaukat, A1
Asada, N; Komatsu, M; Koseki, M; Matsue, K; Takeuchi, M; Uryu, H1
Pemán, J; Zaragoza, R1
Arechavala, A; Bianchi, MH; López Daneri, G; Negroni, R; Robles, AM; Santiso, G1
Björkholm, M; Cherif, H; Kalin, M1
Colpaert, C; De Decker, K; Ieven, M; Jorens, PG; Van Poucke, S; Vogelaers, D; Wojciechowski, M1
Kauffman, CA1
Rokicka, M1
Arndt, M; Cornely, OA; Müller, C; Queckenberg, C; Theisohn, M1
Cornely, OA; Karthaus, M1
Behringer, K; Cornely, OA; Krüger, K; Kurzai, O; Töx, U; Vehreschild, JJ; Wickenhauser, C1
Chusid, MJ; Destino, L; Havens, PL; Helon, AL; Sutton, DA; Thometz, JG; Willoughby, RE1
Aperis, G; Mylonakis, E; Spanakis, EK1
Akiyama, H; Honma, M; Ito, T; Muramatsu, T; Negishi, K; Ohashi, K; Sakai, M; Sakamaki, H; Shitara, M; Suzuki, T; Ueki, T; Yamashita, T1
Georgopoulos, A; Graninger, W; Kratzer, C; Schmoll, M; Tobudic, S1
Beck, R; Kaben, U; Tintelnot, K1
Proia, LA; Trenholme, GM1
Gopal, L; Sen, P; Sen, PR1
Burhenne, J; Haefeli, WE; Kaufmann, C; Thiel, MA; Zinkernagel, AS1
Crespo, M; Husain, S; Johnson, B; Kwak, EJ; McCurry, KR; Pakstis, DL; Paterson, DL; Pilewski, J; Shutt, K; Studer, S; Zaldonis, D; Zeevi, A1
Barrao, ME; García-Gil, FA; Jiménez, B; Larraga, J; Luque, P; Serrano, MT; Tomé-Zelaya, E1
Galluzzo, ML; Holland, SM; Piontelli, E; Rosenzweig, SD; Santos, PE; Shea, YR; Zelazko, ME1
Boggild, AK; Mohan, S; Ostrowski, MA; Poutanen, SM1
Belousov, DIu; Veselov, AV1
Ayres, BD; Bunya, VY; Cohen, EJ; Hammersmith, KM; Rapuano, CJ1
Kantesaria, B; Krishna, G; Martinho, M; Pedicone, L; Sansone-Parsons, A1
Campbell, C; Johnson, E; Lamagni, TL; Pezzoli, L1
Boparai, N; Chandrasekar, P; Durrant, S; Greinix, H; Langston, A; Lipton, JH; Morais de Azevedo, W; Patino, H; Pedicone, L; Reddy, V; Tarantolo, SR; Ullmann, AJ; Vesole, DH1
Angulo-Gonzalez, D; Cornely, OA; Goh, YT; Hardalo, C; Helfgott, D; Holowiecki, J; Maertens, J; Perfect, J; Petrini, M; Stockelberg, D; Suresh, R; Ullmann, AJ; Walsh, TJ; Winston, DJ1
De Pauw, BE; Donnelly, JP1
Beatty, RF; Edward, D; Levy, J; McCartney, DL; Springer, KL; Tu, EY1
Paugam, A1
Boyken, LB; Diekema, DJ; Hollis, RJ; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S1
Scott, LJ; Simpson, D1
Maesaki, S2
Evens, A; Frankfurt, O; Golf, M; Gordon, L; Kaniecki, K; Mehta, J; Pennick, G; Pi, J; Singhal, S; Tallman, M; Trifilio, S; Williams, S; Winter, J; Zook, J1
Alvárez-Espejo, T; Cobo, M; Fernández, I; Muñez, E; Muñoz, M; Ramos, A; Toquero, J1
Guarro, J; Mariné, M; Pastor, FJ; Rodríguez, MM; Serena, C1
Kalnicky, C; Klein, J; Mullane, K; Rodriguez, T; Stiff, P; Toor, AA1
Almyroudis, NG; Ball, D; Bambach, BJ; Battiwalla, M; Gupta, S; Kwon-Chung, J; McCarthy, PL; Paplham, P; Proefrock, AD; Segal, BH; Varma, A1
Jhanji, V; Mannan, R; Sharma, N; Titiyal, JS; Vajpayee, RB1
Ho, DY; Lee, JD; Montoya, JG; Rosso, F1
Alonso, N; Bajo, R; Casado, MS; de la Llana, FG; Fajardo, M; Garcia-Dominguez, M; Sanz-Rodriguez, C; Vagace, JM; Zarallo, L1
Kwon, DS; Mylonakis, E1
Bellmann, R; Weiler, S1
Petrikkos, G; Skiada, A1
van Dissel, JT; van Nieuwkoop, C1
Kontoyiannis, DP; Lewis, RE1
Krause, DS1
Arisaka, O; Fujisawa, M; Fukushima, K; Hagisawa, S; Kurosawa, H; Matsunaga, T; Nakajima, D; Sugita, K1
Dannaoui, E; Datry, A; Dromer, F; Hoinard, D; Lacroix, C; Lortholary, O; Paugam, A; Poirot, JL; Raoux, D1
Barnett, CJ; Beck, JJ; Edwards, SG; Glynn, NC; Hare, MC; Parry, DW; Ray, R1
Evens, A; Frankfurt, O; Gordon, L; Mehta, J; Pi, J; Singhal, S; Tallman, M; Trifilio, S; Williams, S; Winter, J1
Braverman, RM; Davis, CM; Dishop, MK; Noroski, LM; Paul, ME; Rosenblatt, HM; Sutton, DA1
Freifeld, A; Iwen, PC; Kalil, A; Lesiak, B; Sutton, DA; Van Schooneveld, T1
Choe, L; Guglielmo, BJ; Inciardi, J; Martin, T; Riedel, A; Yuen, C1
Hall, GS; Jeng, BH; Meisler, DM; Schoenfield, L1
Esmore, DS; Griffiths, AP; Levvey, BJ; Oto, T; Rowland, M; Snell, GI; Williams, TJ1
Drees, M; Gupta, M; Hadley, S; Wickes, BL1
Cornely, OA; Farowski, F; Vehreschild, JJ1
Schlamm, HT; Supparatpinyo, K1
Geiger, S; Herold, T; Nickenig, C; Ostermann, H; Rieger, C1
Park, AJ; Tu, EY1
Kauffman, CA; Malani, AN1
Ferhanoglu, B; Mert, A; Sili, U; Yilmaz, M1
Arenz, D; Böhme, A; Buchheidt, D; Cornely, OA; Drzisga, I; Frommolt, P; Harnischmacher, U; Heussel, CP; Hummel, M; Mousset, S; Ullmann, AJ; Vehreschild, JJ; Wassmer, G1
Fuhrmann, V; Holzinger, U; Jaeger, W; Kitzberger, R; Kneidinger, N; Miksits, M; Schenk, P; Thalhammer, F; Warszawska, J1
Del Palacio, A; Pontón, J; Quindós, G1
Cantón, E; Carrillo-Muñoz, AJ; Eraso, E; Pemán, J; Quindós, G1
Alvarez Lerma, F1
Jarque, I; Sanz, MA1
Salavert, M; Solé, A1
Guarro, J; Pastor, FJ1
Beckius, ML; Borra, H; Griffith, ME; Hawley, JS; Hospenthal, DR; McCall, S; Moon, JE; Murray, CK; Ressner, RA; Rivard, RG1
Chen, SC; Sorrell, TC1
Cetinkaya, Z; Ermis, SS; Inan, UU; Kiraz, N; Küsbeci, T; Oztürk, F; Yavas, GF1
Almirante, B; Rodríguez, D1
Hsueh, PR; Huang, LM; Shao, PL1
Chodakewitz, JA; Sable, CA; Strohmaier, KM1
Anten, S; Heddema, ER; Visser, O; Zweegman, AS1
Fung, HB; Schiller, DS1
Chandrasekar, P; Krishna, G; Martinho, M; Patino, H; Ullmann, AJ1
Dunand, J; Paugam, A1
Denning, DW; Pasqualotto, AC1
Conti, S; Drago, M; Fanti, F; Morace, G; Polonelli, L; Scaltrito, MM1
Erwin, GE; Fitzgerald, JE1
Buadi, FK; McClune, B; Przepiorka, D1
Bille, J; Bolay, S; Buclin, T; Calandra, T; Marchetti, O; Pascual, A1
Chamilos, G; Kontoyiannis, DP; Lamaris, GA; Lewis, RE1
Deresinski, S; Nagappan, V1
Fozza, C; La Nasa, G; Longinotti, M; Nieddu, R; Paglietti, B; Podda, L; Sanna, S; Vacca, A1
Hogan, H; Howell, A; Lewis, R; Safdar, A1
Bouza, E; Guinea, J; Peláez, T; Recio, S; Torres-Narbona, M1
Nailor, MD; Revankar, SG; Sobel, JD1
Boot, B; Danho, C; Huynh, A; Mejdoubi, M1
Conlon, JD; Dauenhauer, M; Drolet, BA; Fairley, JA; Margolis, D; Talano, J; Tonkovic-Capin, V1
Arenz, D; Böhme, A; Cornely, OA; Kiehl, MG; Kochanek, M; Pankraz, K; Reichert, D; Ullmann, AJ; Vehreschild, JJ1
Almyroudis, NG; Gonzalez, AV; Segal, BH; Ullmann, AJ1
Anaissie, E; Buvé, K; Maertens, J1
Ali, S; Whittle, AM1
Bahari, IS; Deris, ZZ; Harun, A; Ravichandran, M; Roziawati, Y; Shareef, BT1
Chandler, A; Greene, JN; Houston, SH; Silapunt, S; Sriaroon, C; Vincent, AL1
Bou, G; Fernández, A; Lueiro, F; Velasco, D1
Bennett, JE; Zonios, DI1
Andes, D; Smith, J1
Azor, M; Cano, J; Fothergill, AW; Gené, J; Guarro, J; Rinaldi, MG; Sutton, DA1
Barale, PO; Chaumeil, C; Errera, MH; Guez, A; Nourry, H; Sahel, JA; Warnet, JM; Zamfir, O1
Aragane, N; Fukuno, Y; Fukuoka, M; Hayashi, S; Kawaura, F; Kobayashi, H; Matsuishi, E; Sano, A; Tanaka, M1
Alanio, A; Baruchel, A; Brethon, B; de Kerviler, E; Feuilhade de Chauvin, M; Lacroix, C; Leblanc, T; Menotti, J1
Guarro, J; Mariné, M; Ruíz-Cendoya, M1
Polak, A2
Plempel, M1
Arai, T1
Del Palacio-Hernanz, A; Rodriquez-Noriega, A; Sanz-Sanz, F1
Ehninger, G; Mölle, M; Schuler, U1
Anaissie, EJ; Uzun, O1
Anaissie, EJ; Dignani, MC; Hachem, R; Karyotakis, NC1
Anaissie, EJ; Dignani, MC; Gokaslan, A; Hachem, R; Karyotakis, NC; Stephens, LC; Tin-U, CK1
Björkholm, M1
Anaissie, EJ; Andersson, BS; Bodey, GP; Champlin, RE; Giralt, SA; Kantarjian, HM; Karl, C; Kontoyiannis, DP; O'Brien, S; Vartivarian, S1
Mochizuki, H; Murakami, K; Ohashi, M; Tsuda, T; Watanabe, T; Yamada, H1
Chanock, SJ; Walsh, TJ1
Martínez-Suárez, JV; Rodríguez-Tudela, JL1
Johnson, EM; Radford, SA; Warnock, DW1
Carver, PL; Kauffman, CA1
Bouza, E; Muñoz, P1
Aristizabal, BH; Stevens, DA1
Groll, AH; Piscitelli, SC; Walsh, TJ1
Espinel-Ingroff, A2
Andriole, VT1
Baquero, F1
Anaissie, E; Caillot, D; de Marie, S; Graybill, JR; Viviani, MA; Yamaguchi, H1
Anaissie, EJ; Arikan, S; Loebenberg, D; Lozano-Chiu, M; Paetznick, VL; Rex, JH1
Johnson, EM; Szekely, A; Warnock, DW1
Jones, RN; Marco, F; Messer, SA; Pfaller, MA1
de Pauw, BE; Kullberg, BJ1
Arikan, S; Lozano-Chiu, M; Nangia, S; Paetznick, V; Rex, JH1
Al-Abdely, HM; Bocanegra, R; Fothergill, A; Graybill, JR; Loebenberg, D; Najvar, L; Rinaldi, MG1
Chiou, CC; Groll, AH; Walsh, TJ1
Arnadóttir, M; Asmundsson, P; Bödvarsson, M; Hilmarsdóttir, I; Thorsteinsson, SB1
McDougal, EC; Nesky, MA; Peacock, JE1
Helwick, C1
Arikan, S; Kocagöz, S; Sancak, B; Unal, S; Uzun, O1
Ernst, EJ; Hoffman, HL; Klepser, ME1
Arathoon, E; Chiou, C; Ghannoum, M; Groll, AH; Odds, FC; Viviani, MA; Walsh, TJ1
Uchida, K; Yamaguchi, H; Yokota, N1
Gigliotti, F; Wellington, M1
Fukuoka, T; Harasaki, T; Kamai, Y; Kuwahara, S; Ohya, S; Uchida, K; Yamaguchi, H1
Anaissie, E; Arndt, C; Donowitz, G; Finberg, R; Fioritoni, G; Garber, G; Greenberg, R; Hadley, S; Laverdière, M; Lazarus, HM; Lee, J; Pappas, P; Perfect, J; Petersen, F; Raffalli, J; Reboli, A; Reinhardt, J; Schuster, M; Stiff, P; Walsh, TJ; Wingard, J; Winston, DJ; Yanovich, S1
Marr, KA1
Dixon, CA; Goldberger, MJ; Powers, JH1
Hoffman, HL; Rathbun, RC1
Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA1
Blumer, JL; Lazarus, HM; Romero, A; Schlamm, H; Yanovich, S1
Fothergill, AW; Graybill, JR; McCarthy, DI; Rinaldi, MG; Sun, QN1
Dismukes, WE; Lee, J; Walsh, TJ1
Driscoll, T; Dupont, B; Ghahramani, P; Groll, AH; Hodges, M; Lutsar, I; Perfect, JR; Roden, M; Walsh, TJ1
Johnson, JR1
Cornely, OA; Heussel, CP; Ullmann, AJ1
Ghannoum, MA; Kuhn, DM1
Arikan, S; Rex, JH1
Anaissie, E; Bodey, G; Gokaslan, A; Griffin, G; Hachem, R; Robinson, R; Rubin, R; Sobel, J1
Hughes, CE; Terrell, CL1
Fujishita, M; Kataoka, R; Kobayashi, M; Miyoshi, I1
Graybill, JR; Sharkey, PK1
Mahaney, FX1
Ackerbauer, H; Meingassner, JG; Mieth, H; Petranyi, G; Schaude, M1
Chapman, SW; Cleary, JD; Taylor, JW1
Abelin, J; Gip, L1
Helenglass, G; Jones, A; Milliken, S; Powles, R1
Hino, J; Moriya, O; Nakajima, M; Niki, Y; Soejima, R; Tsukiyama, K; Watanabe, M; Yagi, S1
Adachi, M; Ikeda, H; Kawanishi, M; Matsushima, T; Nakamura, J; Tanabe, J; Tano, Y; Tomizawa, S1
Arai, S; Iguchi, K; Kamiya, H; Sakurai, M1
Goto, H; Goto, M; Mori, H; Nakata, H; Oka, S; Shimada, K; Tokitsu, M1
Hojo, H; Lin, KY; Torii, Y; Toyama, K; Tsuda, A; Yoshikawa, O1
Ebe, T; Hamamoto, T; Hibiya, I; Inagaki, M; Isonuma, H; Kohara, T; Matsumura, M; Mori, T; Takahashi, M; Watanabe, K1
Akahonai, Y; Ikemoto, H; Kasai, M; Kawamura, K; Mikuni, C; Mori, T; Taniuchi, A; Watanabe, K; Yoshida, K; Yoshida, T1
Dupont, B1
Kobayashi, GS; Spitzer, ED1
Graybill, JR2
Colantino, B; Dietlein, J; Fiscella, R; Peyman, GA; Schulman, JA1
Dismukes, WE; Saag, MS1
Walsh, TJ1
Dismukes, WE1
Mattie, H; van Furth, R; Van't Wout, JW1
Pizzo, A; Walsh, TJ1
van 't Wout, JW; van Furth, R1
Meunier, F1
Hermans, PE; Terrell, CL1

Reviews

226 review(s) available for triazoles and Mycoses

ArticleYear
The Medicinal Chemistry of 3-nitro-1,2,4-triazoles: Focus on Infectious Diseases.
    Current topics in medicinal chemistry, 2021, Volume: 21, Issue:23

    Topics: Animals; Chagas Disease; Chemistry, Pharmaceutical; Communicable Diseases; Humans; Leishmaniasis; Mycoses; Triazoles; Trypanosomiasis, African; Tuberculosis

2021
Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association.
    The Lancet. Haematology, 2022, Volume: 9, Issue:5

    Topics: Adult; Antifungal Agents; Hematology; Humans; Leukemia, Myeloid, Acute; Mycoses; Quality of Life; Triazoles

2022
Plain language summary: use of isavuconazole in Chinese patients with an invasive fungal disease.
    Future microbiology, 2022, Volume: 17

    Topics: Antifungal Agents; Aspergillosis; Drug-Related Side Effects and Adverse Reactions; Healthy Volunteers; Humans; Invasive Fungal Infections; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole

2022
Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists: Endorsed by the Mycoses Study Group Education and Research Consortium.
    Pharmacotherapy, 2023, Volume: 43, Issue:10

    Topics: Antifungal Agents; Communicable Diseases; Drug Monitoring; Humans; Mycoses; Pharmacists; Triazoles; Voriconazole

2023
Prophylaxis of mould infections.
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2019, Volume: 32 Suppl 2

    Topics: Antifungal Agents; Hematologic Neoplasms; Humans; Immunocompromised Host; Invasive Fungal Infections; Mycoses; Triazoles

2019
Antifungal therapeutic drug monitoring: focus on drugs without a clear recommendation.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020, Volume: 26, Issue:11

    Topics: Antifungal Agents; Drug Monitoring; Echinocandins; Fluconazole; Humans; Mycoses; Nitriles; Polyenes; Practice Guidelines as Topic; Pyridines; Triazoles

2020
Breakthrough invasive fungal infections: Who is at risk?
    Mycoses, 2020, Volume: 63, Issue:10

    Topics: Adrenal Cortex Hormones; Antifungal Agents; Aspergillus; Candida; Central Venous Catheters; Echinocandins; Fluconazole; Fusarium; Genetic Predisposition to Disease; Hematologic Neoplasms; Humans; Immunocompromised Host; Intensive Care Units; Invasive Fungal Infections; Mucorales; Mycoses; Neutropenia; Opportunistic Infections; Organ Transplantation; Penicillium; Risk Factors; Triazoles

2020
Breakthrough Hormographiella aspergillata Infection in a Patient with Acute Myeloid Leukemia Receiving Posaconazole Prophylaxis: A Case Report and Review.
    Mycopathologia, 2020, Volume: 185, Issue:6

    Topics: Agaricales; Antifungal Agents; Humans; Leukemia, Myeloid, Acute; Mycoses; Pneumonia, Necrotizing; Triazoles

2020
Midostaurin in acute myeloid leukemia: current evidence and practical considerations in routine clinical use.
    Minerva medica, 2020, Volume: 111, Issue:5

    Topics: Aniline Compounds; Anthracyclines; Antifungal Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Echinocandins; fms-Like Tyrosine Kinase 3; Forecasting; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Maintenance Chemotherapy; Mutation; Mycoses; Protein Kinase Inhibitors; Pyrazines; Randomized Controlled Trials as Topic; Recurrence; Staurosporine; Triazoles

2020
Comparison of Antifungal Prophylaxis Drugs in Patients With Hematological Disease or Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Review and Network Meta-analysis.
    JAMA network open, 2020, 10-01, Volume: 3, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Pre-Exposure Prophylaxis; Triazoles; Voriconazole

2020
Pulmonary infection secondary to Blastobotrys raffinosifermentans in a cystic fibrosis patient: Review of the literature.
    Mycoses, 2021, Volume: 64, Issue:6

    Topics: Adult; Amphotericin B; Antifungal Agents; Cystic Fibrosis; Female; Fluconazole; Genes, Fungal; Humans; Immunosuppression Therapy; Microbial Sensitivity Tests; Mycoses; Nitriles; Phylogeny; Pneumonia; Pyridines; Saccharomycetales; Triazoles

2021
Clinical Pharmacokinetics of Triazoles in Pediatric Patients.
    Clinical pharmacokinetics, 2021, Volume: 60, Issue:9

    Topics: Adult; Antifungal Agents; Child; Fluconazole; Humans; Itraconazole; Mycoses; Triazoles; Voriconazole

2021
Efficacy and safety of micafungin versus extensive azoles in the prevention and treatment of invasive fungal infections for neutropenia patients with hematological malignancies: A meta-analysis of randomized controlled trials.
    PloS one, 2017, Volume: 12, Issue:7

    Topics: Adolescent; Adult; Antifungal Agents; Child; Echinocandins; Female; Humans; Leukemia; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Neutropenia; Randomized Controlled Trials as Topic; Triazoles

2017
Scedosporium apiospermum infection of the urinary system with a review of treatment options and cases in the literature.
    Transplant infectious disease : an official journal of the Transplantation Society, 2018, Volume: 20, Issue:1

    Topics: Adult; Antifungal Agents; Bone Marrow Transplantation; Female; Humans; Immunocompromised Host; Itraconazole; Male; Mycoses; Pyrimidines; Scedosporium; Triazoles; Urinary Tract Infections; Voriconazole

2018
Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial.
    Mycoses, 2018, Volume: 61, Issue:7

    Topics: Adult; Antifungal Agents; Fungi; Humans; Immunocompromised Host; Invasive Fungal Infections; Invasive Pulmonary Aspergillosis; Middle Aged; Mucormycosis; Mycoses; Nitriles; Pyridines; Randomized Controlled Trials as Topic; Rare Diseases; Renal Insufficiency; Triazoles

2018
Utility of posaconazole therapeutic drug monitoring and assessment of plasma concentration threshold for effective prophylaxis of invasive fungal infections: a meta-analysis with trial sequential analysis.
    BMC infectious diseases, 2018, 04-02, Volume: 18, Issue:1

    Topics: Antifungal Agents; Blood Chemical Analysis; Chemoprevention; Drug Monitoring; Humans; Invasive Fungal Infections; Mycoses; Predictive Value of Tests; Reproducibility of Results; Treatment Outcome; Triazoles

2018
Fundamental Concepts of Azole Compounds and Triazole Antifungals: A Beginner's Review.
    Puerto Rico health sciences journal, 2018, Volume: 37, Issue:3

    Topics: Antifungal Agents; Azoles; Drug Interactions; Drug Resistance, Fungal; Fungi; Humans; Mycoses; Triazoles

2018
Current advances of triazole alcohols derived from fluconazole: Design, in vitro and in silico studies.
    European journal of medicinal chemistry, 2019, May-15, Volume: 170

    Topics: Animals; Antifungal Agents; Candida; Candidiasis; Drug Design; Drug Discovery; Fluconazole; Fungi; Humans; Models, Molecular; Mycoses; Triazoles

2019
New antifungal antibiotics.
    Current opinion in infectious diseases, 2013, Volume: 26, Issue:2

    Topics: Antifungal Agents; Echinocandins; Humans; Lung Diseases, Fungal; Mycoses; Triazoles

2013
Second- versus first-generation azoles for antifungal prophylaxis in hematology patients: a systematic review and meta-analysis.
    Annals of hematology, 2013, Volume: 92, Issue:6

    Topics: Antifungal Agents; Antineoplastic Agents; Aspergillosis; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Multicenter Studies as Topic; Mycoses; Neutropenia; Odds Ratio; Patient Dropouts; Prospective Studies; Randomized Controlled Trials as Topic; Transplantation Conditioning; Treatment Outcome; Triazoles

2013
Cervical spondylitis due to Phaeoacremonium venezuelense in an immunocompetent patient. A first case report.
    Journal de mycologie medicale, 2012, Volume: 22, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Cervical Vertebrae; Epidural Abscess; Humans; Immunocompetence; Kidney Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Mycoses; Pyrimidines; Species Specificity; Spondylitis; Tomography, X-Ray Computed; Triazoles; Voriconazole

2012
Posaconazole therapeutic drug monitoring in the real-life setting: a single-center experience and review of the literature.
    Pharmacotherapy, 2013, Volume: 33, Issue:10

    Topics: Academic Medical Centers; Administration, Oral; Adult; Age Factors; Aged; Antifungal Agents; Drug Monitoring; Female; Hematologic Diseases; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Mycoses; Prospective Studies; Risk Factors; Triazoles; Young Adult

2013
Management and diagnostic guidelines for fungal diseases in infectious diseases and clinical microbiology: critical appraisal.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2013, Volume: 19, Issue:12

    Topics: Antifungal Agents; Aspergillosis; Candidiasis, Invasive; Evidence-Based Medicine; Humans; Mucormycosis; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole

2013
Fungal infections associated with long-term mechanical circulatory support-diagnosis and management.
    Journal of cardiac surgery, 2014, Volume: 29, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Heart Failure; Heart-Assist Devices; Humans; Incidence; Mycoses; Pyrimidines; Risk Factors; Time Factors; Triazoles; Voriconazole

2014
The role of primary antifungal prophylaxis in patients with haematological malignancies.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2014, Volume: 20 Suppl 6

    Topics: Administration, Intravenous; Antibiotic Prophylaxis; Antifungal Agents; Hematologic Neoplasms; Humans; Meta-Analysis as Topic; Mycoses; Practice Guidelines as Topic; Triazoles

2014
Clinically relevant drug-drug interactions between antiretrovirals and antifungals.
    Expert opinion on drug metabolism & toxicology, 2014, Volume: 10, Issue:4

    Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-Retroviral Agents; Antifungal Agents; Benzoxazines; Carbamates; Cyclopropanes; Drug Interactions; Drug Monitoring; Echinocandins; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Itraconazole; Mycoses; Organophosphates; Pyrimidines; Ritonavir; Sulfonamides; Triazoles; Voriconazole

2014
Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
    The Cochrane database of systematic reviews, 2014, Feb-24, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2014
Optimizing azole antifungal therapy in the prophylaxis and treatment of fungal infections.
    Current opinion in infectious diseases, 2014, Volume: 27, Issue:6

    Topics: Antibiotic Prophylaxis; Antifungal Agents; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Itraconazole; Mycoses; Population Surveillance; Precision Medicine; Triazoles; Voriconazole

2014
Antifungal pharmacokinetics and pharmacodynamics.
    Cold Spring Harbor perspectives in medicine, 2014, Nov-10, Volume: 5, Issue:5

    Topics: Animals; Antifungal Agents; Disease Models, Animal; Echinocandins; Flucytosine; Humans; Mice; Mycoses; Polyenes; Rabbits; Rats; Triazoles

2014
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014.
    Internal medicine journal, 2014, Volume: 44, Issue:12b

    Topics: Antifungal Agents; Consensus; Drug Administration Schedule; Drug Delivery Systems; Drug Dosage Calculations; Drug Interactions; Drug Monitoring; Hematologic Neoplasms; Humans; Molecular Sequence Data; Mycoses; Opportunistic Infections; Practice Guidelines as Topic; Rehydration Solutions; Triazoles; Voriconazole

2014
Isavuconazole, a broad-spectrum triazole for the treatment of systemic fungal diseases.
    Expert review of anti-infective therapy, 2015, Volume: 13, Issue:1

    Topics: Antifungal Agents; Humans; Mycoses; Nitriles; Pyridines; Triazoles

2015
Efficacy and safety of echinocandins versus triazoles for the prophylaxis and treatment of fungal infections: a meta-analysis of RCTs.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:4

    Topics: Antifungal Agents; Chemoprevention; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Humans; Mycoses; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Triazoles

2015
Posaconazole: a review of the gastro-resistant tablet and intravenous solution in invasive fungal infections.
    Drugs, 2015, Volume: 75, Issue:4

    Topics: Animals; Antifungal Agents; Chemistry, Pharmaceutical; Clinical Trials as Topic; Gastrointestinal Tract; Humans; Infusions, Intravenous; Mycoses; Tablets, Enteric-Coated; Triazoles

2015
Review of the new delayed-release oral tablet and intravenous dosage forms of posaconazole.
    Pharmacotherapy, 2015, Volume: 35, Issue:2

    Topics: Administration, Intravenous; Animals; Antifungal Agents; Biological Availability; Delayed-Action Preparations; Humans; Mycoses; Tablets; Triazoles

2015
Pharmacologic and clinical evaluation of posaconazole.
    Expert review of clinical pharmacology, 2015, Volume: 8, Issue:3

    Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Critical Illness; Delayed-Action Preparations; Humans; Mycoses; Triazoles

2015
The 'cephalosporin era' of triazole therapy: isavuconazole, a welcomed newcomer for the treatment of invasive fungal infections.
    Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:10

    Topics: Animals; Antifungal Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Interactions; Drug Resistance, Fungal; Fungi; Humans; Immunocompromised Host; Mycoses; Nitriles; Pyridines; Triazoles

2015
[Clinical usefulness of triazole derivatives in the management of fungal infections].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2015, Volume: 28, Issue:4

    Topics: 14-alpha Demethylase Inhibitors; Animals; Antifungal Agents; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Fungal; Fungal Proteins; Humans; Kidney Diseases; Mycoses; Squalene Monooxygenase; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles

2015
Posaconazole: Use in the Prophylaxis and Treatment of Fungal Infections.
    Seminars in respiratory and critical care medicine, 2015, Volume: 36, Issue:5

    Topics: Antifungal Agents; Drug Interactions; Drug Resistance, Fungal; Humans; Immunocompromised Host; Mycoses; Salvage Therapy; Transplant Recipients; Triazoles; United States; United States Food and Drug Administration

2015
Network Meta-analysis and Pharmacoeconomic Evaluation of Fluconazole, Itraconazole, Posaconazole, and Voriconazole in Invasive Fungal Infection Prophylaxis.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Adult; Antifungal Agents; Aspergillus; Candida; Cost-Benefit Analysis; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Economic; Mycoses; Singapore; Survival Analysis; Triazoles; Voriconazole

2016
Echinocandins: The Expanding Antifungal Armamentarium.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Dec-01, Volume: 61 Suppl 6

    Topics: Animals; Antifungal Agents; Aspergillus; Candida; Candidiasis, Invasive; Drug Therapy, Combination; Echinocandins; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles

2015
Dosing of antifungal agents in obese people.
    Expert review of anti-infective therapy, 2016, Volume: 14, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candidiasis, Invasive; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Mycoses; Nitriles; Obesity; Pyridines; Triazoles

2016
Defining the frontiers between antifungal resistance, tolerance and the concept of persistence.
    Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2015, Volume: 23

    Topics: Amphotericin B; Antifungal Agents; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Drug Tolerance; Echinocandins; Flucytosine; Fungi; Host-Pathogen Interactions; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles

2015
Triazole antifungals: a review.
    Drugs of today (Barcelona, Spain : 1998), 2015, Volume: 51, Issue:12

    Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Humans; Mycoses; Triazoles

2015
Isavuconazonium sulfate for the treatment of fungal infection.
    Drugs of today (Barcelona, Spain : 1998), 2016, Volume: 52, Issue:1

    Topics: Antifungal Agents; Clinical Trials as Topic; Drug Interactions; Humans; Mycoses; Nitriles; Pyridines; Triazoles

2016
Isavuconazonium sulfate (Cresemba)--a new antifungal.
    The Medical letter on drugs and therapeutics, 2016, Mar-14, Volume: 58, Issue:1490

    Topics: Antifungal Agents; Aspergillosis; Drug Interactions; Female; Fungi; Humans; Male; Mucormycosis; Mycoses; Nitriles; Pregnancy; Pyridines; Triazoles

2016
Treatment of Paecilomyces variotii pneumonia with posaconazole: case report and literature review.
    Mycoses, 2016, Volume: 59, Issue:12

    Topics: Antifungal Agents; Female; Humans; Middle Aged; Mycoses; Paecilomyces; Pneumonia; Triazoles

2016
New facets of antifungal therapy.
    Virulence, 2017, 02-17, Volume: 8, Issue:2

    Topics: Antifungal Agents; Drug Discovery; Drug Synergism; Drug Therapy, Combination; Echinocandins; Humans; Immunocompromised Host; Invasive Fungal Infections; Mycoses; Polyenes; Triazoles

2017
Posaconazole: an oral triazole with an extended spectrum of activity.
    The Annals of pharmacotherapy, 2008, Volume: 42, Issue:10

    Topics: Animals; Antifungal Agents; Clinical Trials as Topic; Drug Monitoring; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Mycoses; Risk Factors; Triazoles

2008
Posaconazole for paediatric patients: status of development and future perspectives.
    Mycoses, 2008, Volume: 51 Suppl 2

    Topics: Adolescent; Adult; Antifungal Agents; Child; Child, Preschool; Humans; Mycoses; Triazoles

2008
Pramiconazole, a triazole compound for the treatment of fungal infections.
    IDrugs : the investigational drugs journal, 2008, Volume: 11, Issue:9

    Topics: Animals; Antifungal Agents; Clinical Trials as Topic; Drug Design; Drug Evaluation, Preclinical; Humans; Imidazoles; Mycoses; Patents as Topic; Triazoles

2008
[Posaconazole: another triazole antifungal of the new generation?].
    Deutsche medizinische Wochenschrift (1946), 2008, Volume: 133, Issue:45

    Topics: Antifungal Agents; Humans; Mycoses; Triazoles

2008
Therapeutic drug monitoring for triazoles.
    Current opinion in infectious diseases, 2008, Volume: 21, Issue:6

    Topics: Antifungal Agents; Drug Monitoring; Humans; Mycoses; Triazoles

2008
Trichosporon mucoides fungemia in a liver transplant recipient: case report and review.
    Transplant infectious disease : an official journal of the Transplantation Society, 2009, Volume: 11, Issue:2

    Topics: Antifungal Agents; Enterococcus faecium; Fatal Outcome; Fungemia; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Mycoses; Peritonitis; Postoperative Complications; Tacrolimus; Triazoles; Trichosporon; Vancomycin; Vancomycin Resistance

2009
Therapeutic strategies for invasive fungal infections in neonatal and pediatric patients.
    Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:18

    Topics: Amphotericin B; Antifungal Agents; Child; Child, Preschool; Drug Resistance, Fungal; Echinocandins; Humans; Infant, Newborn; Mycoses; Triazoles

2008
[Oral antifungal agents].
    Nihon rinsho. Japanese journal of clinical medicine, 2008, Volume: 66, Issue:12

    Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Diabetes Complications; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole

2008
[Trends in development of new antifungal agents in Japan].
    Nihon rinsho. Japanese journal of clinical medicine, 2008, Volume: 66, Issue:12

    Topics: Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Discovery; Echinocandins; Humans; Japan; Lipopeptides; Mycoses; Triazoles

2008
[Clinical efficacies of antifungal injections].
    Nihon rinsho. Japanese journal of clinical medicine, 2008, Volume: 66, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Drug Delivery Systems; Echinocandins; Fluconazole; Humans; Infusions, Intravenous; Injections; Itraconazole; Lipopeptides; Liposomes; Micafungin; Mycoses; Organophosphates; Pyrimidines; Triazoles; Voriconazole

2008
Isavuconazole: a new and promising antifungal triazole for the treatment of invasive fungal infections.
    Future microbiology, 2008, Volume: 3, Issue:6

    Topics: Animals; Antifungal Agents; Aspergillus; Candida; Clinical Trials as Topic; Cryptococcus neoformans; Disease Models, Animal; Mycoses; Nitriles; Pyridines; Triazoles

2008
[Advances in the diagnosis and treatment of yeast infections: role of the new antifungal agents].
    Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 13

    Topics: Amphotericin B; Antibodies, Fungal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Fungal; Candida; Candidiasis; Clinical Trials as Topic; DNA, Fungal; Drug Interactions; Echinocandins; Fungemia; Humans; Mycology; Mycoses; Triazoles; Yeasts

2008
New and investigational triazole agents for the treatment of invasive fungal infections.
    Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:6

    Topics: Antifungal Agents; Drug Resistance, Fungal; Humans; Mycoses; Triazoles

2008
Posaconazole: a new oral antifungal agent with an expanded spectrum of activity.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2009, Feb-01, Volume: 66, Issue:3

    Topics: Antifungal Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles

2009
Clinical indications for newer antifungal agents.
    Journal of hospital medicine, 2009, Volume: 4, Issue:2

    Topics: Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Drug Therapy; Echinocandins; Endemic Diseases; Humans; Mycoses; Neutropenia; Triazoles; Zygomycosis

2009
Posaconazole's impact on prophylaxis and treatment of invasive fungal infections: an update.
    Expert review of anti-infective therapy, 2009, Volume: 7, Issue:2

    Topics: Animals; Antifungal Agents; Disease Models, Animal; Drug Dosage Calculations; Drug Interactions; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles

2009
New therapies for fungal pneumonia.
    Current opinion in infectious diseases, 2009, Volume: 22, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Fungi; Galactose; Humans; Mannans; Mycoses; Pneumonia; Pulmonary Aspergillosis; Pyrimidines; Radiography, Thoracic; Triazoles; Voriconazole

2009
Antifungal therapy for invasive fungal diseases in allogeneic stem cell transplant recipients: an update.
    Mycopathologia, 2009, Volume: 168, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Echinocandins; Humans; Mycoses; Stem Cell Transplantation; Transplantation, Homologous; Triazoles

2009
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Prevention of mould infections.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 63 Suppl 1

    Topics: Antifungal Agents; Chemoprevention; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Mycoses; Neutropenia; Patient Isolation; Pyrimidines; Triazoles; Voriconazole

2009
Fungal postoperative spondylodiscitis due to Scedosporium prolificans.
    The spine journal : official journal of the North American Spine Society, 2009, Volume: 9, Issue:9

    Topics: Anti-Bacterial Agents; Antifungal Agents; Arthrodesis; Debridement; Discitis; Female; Humans; Intervertebral Disc Displacement; Magnetic Resonance Imaging; Middle Aged; Mycoses; Orthopedic Procedures; Postoperative Complications; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2009
Drug-drug interactions of triazole antifungal agents in multimorbid patients and implications for patient care.
    Current drug metabolism, 2009, Volume: 10, Issue:4

    Topics: Antifungal Agents; Biotransformation; Comorbidity; Contraindications; Drug Interactions; Food; Gastric Acid; Guidelines as Topic; Humans; Membrane Transport Proteins; Mycoses; Risk Factors; Triazoles

2009
Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination.
    Expert opinion on investigational drugs, 2009, Volume: 18, Issue:9

    Topics: Anidulafungin; Animals; Antifungal Agents; Clinical Trials, Phase III as Topic; Drug Combinations; Drug Synergism; Echinocandins; Humans; Molecular Structure; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2009
New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
    Expert review of anti-infective therapy, 2009, Volume: 7, Issue:8

    Topics: Antifungal Agents; Drug Resistance, Fungal; Echinocandins; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles

2009
Pharmacology and clinical use of voriconazole.
    Expert opinion on drug metabolism & toxicology, 2010, Volume: 6, Issue:1

    Topics: Animals; Antifungal Agents; Drug Interactions; Drug Monitoring; Drug Resistance, Fungal; Fungi; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2010
Primary antifungal prophylaxis in acute myeloblastic leukemia and myelodysplastic syndrome--still an open question?
    Leukemia & lymphoma, 2010, Volume: 51, Issue:1

    Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Resistance, Fungal; Echinocandins; Fever; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Medical Oncology; Mycoses; Myelodysplastic Syndromes; Triazoles

2010
Safety of triazole antifungal drugs in patients with cancer.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:3

    Topics: Antifungal Agents; Antineoplastic Agents; Drug Interactions; Drug Monitoring; Humans; Mycoses; Neoplasms; Triazoles

2010
Novel triazole antifungal drugs: focus on isavuconazole, ravuconazole and albaconazole.
    Current opinion in investigational drugs (London, England : 2000), 2010, Volume: 11, Issue:2

    Topics: Animals; Antifungal Agents; Clinical Trials as Topic; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Quinazolines; Thiazoles; Triazoles

2010
Modern antifungal therapy for neutropenic fever.
    Current hematologic malignancy reports, 2006, Volume: 1, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fever; Humans; Immunocompromised Host; Kidney Diseases; Lipopeptides; Liposomes; Liver Diseases; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2006
Pharmacokinetic/pharmacodynamic profile of posaconazole.
    Clinical pharmacokinetics, 2010, Volume: 49, Issue:6

    Topics: Animals; Antifungal Agents; Area Under Curve; Biological Availability; Drug Interactions; Drug Resistance, Fungal; Food-Drug Interactions; Fungi; Humans; Mycoses; Triazoles

2010
[Antifungal therapy for infants, children and adolescents with suspected or documented invasive fungal infection].
    Drugs of today (Barcelona, Spain : 1998), 2010, Volume: 46 Suppl C

    Topics: Adolescent; Antifungal Agents; Antineoplastic Agents; Candidiasis; Child; Child, Preschool; Fever; Humans; Infant; Infant, Newborn; Mycoses; Neoplasms; Neutropenia; Triazoles

2010
Isavuconazole: a comprehensive review of spectrum of activity of a new triazole.
    Mycopathologia, 2010, Volume: 170, Issue:5

    Topics: Animals; Antifungal Agents; Clinical Trials as Topic; Disease Models, Animal; Fungi; Humans; Mice; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Triazoles

2010
Use of posaconazole in the treatment of invasive fungal  infections.
    Expert review of hematology, 2009, Volume: 2, Issue:6

    Topics: Animals; Antifungal Agents; Clinical Trials as Topic; Drug Resistance, Fungal; Fungi; Graft vs Host Disease; Humans; Immunocompromised Host; Leukemia, Myeloid; Mice; Mycoses; Myelodysplastic Syndromes; Rabbits; Stem Cell Transplantation; Triazoles; United States

2009
Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections.
    Expert review of hematology, 2009, Volume: 2, Issue:3

    Topics: Antifungal Agents; Drug Resistance, Fungal; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2009
Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections.
    Drug design, development and therapy, 2010, Nov-04, Volume: 4

    Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Fungi; Humans; Mycoses; Risk Factors; Triazoles

2010
Pharmacoeconomics of voriconazole in the management of invasive fungal infections.
    Expert review of pharmacoeconomics & outcomes research, 2010, Volume: 10, Issue:6

    Topics: Antifungal Agents; Cost-Benefit Analysis; Drug Costs; Economics, Pharmaceutical; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2010
New lead structures in antifungal drug discovery.
    Current medicinal chemistry, 2011, Volume: 18, Issue:5

    Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Carbazoles; Drug Discovery; Echinocandins; Enzyme Inhibitors; Glucosyltransferases; Humans; Mycoses; Naphthoquinones; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles

2011
[Antifungal agents in the treatment of systemic infections: Relevance of mechanism of action, activity profile and resistances].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2010, Volume: 23, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Echinocandins; Fungi; Humans; Mycoses; Triazoles

2010
Pharmacokinetics of antifungal agents in children.
    Early human development, 2011, Volume: 87 Suppl 1

    Topics: Adult; Antifungal Agents; Child; Echinocandins; Humans; Immunocompromised Host; Mycoses; Nucleosides; Polyenes; Preventive Medicine; Triazoles

2011
The emerging life-threatening opportunistic fungal pathogen Kodamaea ohmeri: optimal treatment and literature review.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2010, Volume: 43, Issue:3

    Topics: Aged; Antifungal Agents; Diabetes Mellitus, Type 2; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Opportunistic Infections; Pyrimidines; Risk Factors; Saccharomycetales; Treatment Outcome; Triazoles; Voriconazole

2010
[Recent advances in the study of new antifungal lead compounds].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2010, Volume: 45, Issue:8

    Topics: Antifungal Agents; Fungi; Heterocyclic Compounds; Humans; Lipopeptides; Molecular Structure; Mycoses; Nitriles; Plant Extracts; Plants, Medicinal; Pyridines; Quinazolines; Quinones; Structure-Activity Relationship; Thiazoles; Triazoles

2010
[Drug interactions in critically-ill patients. An important factor in the use of micafungin?].
    Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29 Suppl 2

    Topics: Adult; Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Child; Critical Illness; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Therapy, Combination; Echinocandins; Humans; Infant, Newborn; Lipopeptides; Micafungin; Microsomes, Liver; Mycoses; Triazoles

2011
[Is micafungin useful in the prophylaxis of invasive fungal disease in hematological patients?].
    Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29 Suppl 2

    Topics: Adult; Ambulatory Care; Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Clinical Trials as Topic; Dose-Response Relationship, Drug; Echinocandins; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Kidney Diseases; Lipopeptides; Male; Meta-Analysis as Topic; Micafungin; Mycoses; Postoperative Complications; Practice Guidelines as Topic; Triazoles

2011
Best practice in treating infants and children with proven, probable or suspected invasive fungal infections.
    Current opinion in infectious diseases, 2011, Volume: 24, Issue:3

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Child; Echinocandins; Fever of Unknown Origin; Humans; Infant; Mycoses; Pyrimidines; Triazoles; Voriconazole

2011
Emerging infectious endocarditis due to Scedosporium prolificans: a model of therapeutic complexity.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2011, Volume: 30, Issue:11

    Topics: Adult; Amphotericin B; Antifungal Agents; Communicable Diseases, Emerging; Embolectomy; Endocarditis; Fatal Outcome; Female; Femoral Artery; Humans; Immunocompromised Host; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Pyrimidines; Scedosporium; Thrombosis; Tomography, X-Ray Computed; Triazoles; Voriconazole

2011
Antifungal azoles: old and new.
    The Pediatric infectious disease journal, 2011, Volume: 30, Issue:6

    Topics: Antifungal Agents; Drug Interactions; Humans; Mycoses; Triazoles

2011
[Pharmacokinetics and pharmacodynamics of antifungal drugs in children].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2011, Volume: 18 Suppl 1

    Topics: Amphotericin B; Antifungal Agents; Child; Echinocandins; Evidence-Based Medicine; Flucytosine; Humans; Mycoses; Triazoles

2011
New insights into chemistry and anti-infective potential of triazole scaffold.
    Current medicinal chemistry, 2011, Volume: 18, Issue:21

    Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Fungi; Humans; Models, Molecular; Mycoses; Triazoles; Virus Diseases; Viruses

2011
Posaconazole: a new antifungal weapon.
    Reviews on recent clinical trials, 2011, Volume: 6, Issue:3

    Topics: Antifungal Agents; Clinical Trials as Topic; Drug Interactions; Drug Resistance, Fungal; Humans; Immunocompromised Host; Kidney Diseases; Mycoses; Opportunistic Infections; Triazoles

2011
Observational study of the clinical efficacy of voriconazole and its relationship to plasma concentrations in patients.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:10

    Topics: Adult; Antifungal Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Monitoring; Female; Fungi; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2011
Triazole antifungal agents drug-drug interactions involving hepatic cytochrome P450.
    Expert opinion on drug metabolism & toxicology, 2011, Volume: 7, Issue:11

    Topics: Antifungal Agents; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Mycoses; Triazoles

2011
Uncommon yeast infections in hematological patients: from diagnosis to treatment.
    Expert review of anti-infective therapy, 2011, Volume: 9, Issue:11

    Topics: Antifungal Agents; Blastomyces; Cryptococcus; Echinocandins; Hematologic Neoplasms; Humans; Mycological Typing Techniques; Mycoses; Survival Rate; Triazoles; Trichosporon

2011
Phototoxicity and photocarcinogenesis associated with voriconazole.
    Medecine et maladies infectieuses, 2011, Volume: 41, Issue:12

    Topics: Antifungal Agents; Biotransformation; Carcinoma, Squamous Cell; Clinical Trials as Topic; Cocarcinogenesis; Comorbidity; Dermatitis, Phototoxic; Drug Interactions; Humans; Immunocompromised Host; Melanoma; Mycoses; Neoplasms, Radiation-Induced; Photochemistry; Postoperative Complications; Pyrimidines; Retinoids; Retrospective Studies; Skin Neoplasms; Sunlight; Transplantation; Triazoles; Voriconazole

2011
Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2012, Volume: 16, Issue:1

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Mycoses; North America; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole

2012
Triazole antifungal agents in invasive fungal infections: a comparative review.
    Drugs, 2011, Dec-24, Volume: 71, Issue:18

    Topics: Antifungal Agents; Fluconazole; Fungi; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole

2011
Scedosporium apiospermum catheter-related soft-tissue infection: a case report and review of the literature.
    Medical mycology, 2012, Volume: 50, Issue:6

    Topics: Aged; Catheter-Related Infections; DNA, Fungal; Genes, Fungal; Humans; Male; Mycoses; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Scedosporium; Sequence Analysis, DNA; Soft Tissue Infections; Treatment Outcome; Triazoles; Voriconazole

2012
Invasive mycoses: strategies for effective management.
    The American journal of medicine, 2012, Volume: 125, Issue:1 Suppl

    Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Antifungal Agents; Antineoplastic Agents; Aspartate Aminotransferases; Aspergillosis; Bilirubin; Biomarkers; Drug Monitoring; Echinocandins; Female; Flucytosine; Humans; Immunocompromised Host; Leukemia; Liver; Liver Function Tests; Male; Middle Aged; Mucormycosis; Mycoses; Myelodysplastic Syndromes; Opportunistic Infections; Pneumonia; Risk Factors; Triazoles

2012
Therapeutic drug monitoring of voriconazole in children.
    Therapeutic drug monitoring, 2012, Volume: 34, Issue:1

    Topics: Antifungal Agents; Child; Drug Monitoring; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2012
Posaconazole: the case for therapeutic drug monitoring.
    Therapeutic drug monitoring, 2012, Volume: 34, Issue:1

    Topics: Antifungal Agents; Drug Monitoring; Humans; Mycoses; Triazoles

2012
Investigation and threshold of optimum blood concentration of voriconazole: a descriptive statistical meta-analysis.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2012, Volume: 18, Issue:4

    Topics: Age Factors; Antifungal Agents; Drug Monitoring; Female; Humans; Liver Diseases; Male; Mycoses; Odds Ratio; Pyrimidines; Triazoles; Voriconazole

2012
[Antifungal therapy update: new drugs and medical uses].
    Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29 Suppl 5

    Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Early Diagnosis; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Micafungin; Mycoses; Randomized Controlled Trials as Topic; Salvage Therapy; Treatment Outcome; Triazoles

2011
Posaconazole exposure-response relationship: evaluating the utility of therapeutic drug monitoring.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:6

    Topics: Animals; Antifungal Agents; Drug Monitoring; Humans; Mycoses; Triazoles

2012
Unusual case of cutaneous and synovial Paecilomyces lilacinus infection of hand successfully treated with voriconazole and review of published literature.
    Mycopathologia, 2012, Volume: 174, Issue:3

    Topics: Adult; Aged; Antifungal Agents; Bursa, Synovial; Dermatomycoses; Female; Hand; Histocytochemistry; Humans; Male; Microscopy; Middle Aged; Mycoses; Paecilomyces; Pyrimidines; Synovitis; Treatment Outcome; Triazoles; Voriconazole

2012
Ochroconis gallopava infection in a patient with chronic granulomatous disease: case report and review of the literature.
    Medical mycology, 2012, Volume: 50, Issue:8

    Topics: Antifungal Agents; Ascomycota; Granulomatous Disease, Chronic; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2012
Safety and interactions of new antifungals in stem cell transplant recipients.
    Expert opinion on drug safety, 2012, Volume: 11, Issue:5

    Topics: Amphotericin B; Animals; Antifungal Agents; Drug Interactions; Echinocandins; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Mycoses; Opportunistic Infections; Pharmacovigilance; Renal Insufficiency; Stem Cell Transplantation; Triazoles

2012
Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazole.
    Current drug metabolism, 2013, Volume: 14, Issue:2

    Topics: Antifungal Agents; Extracorporeal Membrane Oxygenation; Humans; Infant, Newborn; Mycoses; Triazoles

2013
Invasive fungal infection in chronic granulomatous disease: insights into pathogenesis and management.
    Current opinion in infectious diseases, 2012, Volume: 25, Issue:6

    Topics: Antifungal Agents; Granulomatous Disease, Chronic; Humans; Itraconazole; Mycoses; Surgical Procedures, Operative; Triazoles

2012
Making sense of posaconazole therapeutic drug monitoring: a practical approach.
    Current opinion in infectious diseases, 2012, Volume: 25, Issue:6

    Topics: Antifungal Agents; Drug Monitoring; Humans; Mycoses; Triazoles

2012
Voriconazole in clinical practice.
    Journal of chemotherapy (Florence, Italy), 2012, Volume: 24, Issue:6

    Topics: 14-alpha Demethylase Inhibitors; Animals; Antifungal Agents; Aspergillosis; Candidiasis, Invasive; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Fungal; Evidence-Based Medicine; Fungi; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2012
Neuro-ophthalmology of invasive fungal sinusitis: 14 consecutive patients and a review of the literature.
    Clinical & experimental ophthalmology, 2013, Volume: 41, Issue:6

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Cause of Death; Eye Infections, Fungal; Female; Fungi; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Risk Factors; Sinusitis; Tomography, X-Ray Computed; Triazoles; Voriconazole

2013
Safety of posaconazole.
    Expert opinion on drug safety, 2013, Volume: 12, Issue:2

    Topics: Animals; Antifungal Agents; Chemistry, Pharmaceutical; Drug Interactions; Histamine H2 Antagonists; Humans; Mycoses; Nausea; Proton Pump Inhibitors; Triazoles

2013
Scedosporium prolificans pericarditis and mycotic aortic aneurysm in a lung transplant recipient receiving voriconazole prophylaxis.
    Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:2

    Topics: Aged; Aneurysm, Infected; Antifungal Agents; Aortic Aneurysm; Drug Resistance, Fungal; Female; Humans; Lung Transplantation; Mycoses; Pericarditis; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2013
Successful treatment of Paecilomyces lilacinus endophthalmitis with voriconazole.
    Scandinavian journal of infectious diseases, 2002, Volume: 34, Issue:9

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Endophthalmitis; Female; Humans; Male; Middle Aged; Mycoses; Paecilomyces; Pyrimidines; Triazoles; Voriconazole

2002
Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies.
    Blood, 2003, May-01, Volume: 101, Issue:9

    Topics: Adrenal Cortex Hormones; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Clinical Trials as Topic; Disease Susceptibility; Drug Carriers; Evidence-Based Medicine; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Liposomes; Mycoses; Neutropenia; Recurrence; Risk Factors; Triazoles

2003
Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2002, Volume: 21, Issue:12

    Topics: Antifungal Agents; Humans; Leukemia, Myeloid; Male; Middle Aged; Mycoses; Neutropenia; Pyrimidines; Risk Factors; Triazoles; Trichosporon; Voriconazole

2002
Voriconazole: a new triazole antifungal agent.
    The Annals of pharmacotherapy, 2003, Volume: 37, Issue:3

    Topics: Antifungal Agents; Drug Administration Schedule; Drug Interactions; Formularies as Topic; Humans; Length of Stay; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2003
Systemic mycoses in the immunocompromised host: an update in antifungal therapy.
    The Journal of hospital infection, 2003, Volume: 53, Issue:4

    Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Candidiasis; Deoxycholic Acid; Drug Combinations; Echinocandins; Fungal Proteins; Humans; Immunocompromised Host; Mycoses; Peptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Triazoles

2003
[A silver lining on the horizon: new antimycotics].
    Pharmazie in unserer Zeit, 2003, Volume: 32, Issue:2

    Topics: Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Echinocandins; Fungi; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2003
Clinical pharmacology of antifungal compounds.
    Infectious disease clinics of North America, 2003, Volume: 17, Issue:1

    Topics: Anti-Bacterial Agents; Antifungal Agents; Drug Design; Echinocandins; Flucytosine; Fungal Proteins; Humans; Immunocompromised Host; Molecular Structure; Mycoses; Peptides; Peptides, Cyclic; Polyenes; Triazoles

2003
Laboratory evaluation of new antifungal agents against rare and refractory mycoses.
    Current opinion in infectious diseases, 2002, Volume: 15, Issue:6

    Topics: Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Echinocandins; Fungi; Humans; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole

2002
New antifungal drugs and new clinical trials: interpreting results may be difficult.
    Current opinion in oncology, 2003, Volume: 15, Issue:4

    Topics: Animals; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Data Interpretation, Statistical; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2003
[New systemic antifungal drugs: mechanisms of action, drug interactions and side effects].
    Mycoses, 2003, Volume: 46 Suppl 1

    Topics: Anti-Bacterial Agents; Antifungal Agents; Azoles; Caspofungin; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Fungi; Glucosyltransferases; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2003
New antifungal agents.
    Dermatologic clinics, 2003, Volume: 21, Issue:3

    Topics: Administration, Oral; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Drug Approval; Echinocandins; Humans; Lipopeptides; Macrolides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole

2003
Pharmacokinetics and pharmacodynamics in the development of antifungal compounds.
    Current opinion in investigational drugs (London, England : 2000), 2003, Volume: 4, Issue:8

    Topics: Animals; Antifungal Agents; Area Under Curve; Clinical Trials as Topic; Disease Models, Animal; Drug Design; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles

2003
Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients.
    The Journal of infection, 2004, Volume: 48, Issue:1

    Topics: Antifungal Agents; Caspofungin; Child; Echinocandins; Fatal Outcome; Humans; Immunocompromised Host; Lipopeptides; Male; Mitosporic Fungi; Mycoses; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole

2004
Voriconazole for serious fungal infections.
    International journal of clinical practice, 2004, Volume: 58, Issue:1

    Topics: Antifungal Agents; Aspergillus; Candida; Controlled Clinical Trials as Topic; Drug Interactions; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2004
New options for the treatment of invasive fungal infections.
    Seminars in oncology, 2004, Volume: 31, Issue:2 Suppl 4

    Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Mycetoma; Mycoses; Neoplasms; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2004
[Meta-analysis on safety and efficacy of liposomal amphotericin B in the empirical treatment of febrile neutropenia].
    Medicina clinica, 2004, May-01, Volume: 122, Issue:16

    Topics: Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Fever; Humans; Liposomes; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2004
Fungal infections: current diagnosis and treatment.
    The hematology journal : the official journal of the European Haematology Association, 2004, Volume: 5 Suppl 3

    Topics: Amphotericin B; Antifungal Agents; Fungemia; Humans; Immunocompromised Host; Mycoses; Neoplasms; Neutropenia; Premedication; Randomized Controlled Trials as Topic; Risk Factors; Triazoles

2004
[Voriconazole: a new weapon against invasive fungal infections].
    Revue medicale de Bruxelles, 2004, Volume: 25, Issue:3

    Topics: Antifungal Agents; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Safety; Tissue Distribution; Triazoles; Voriconazole

2004
Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections.
    International journal of clinical practice, 2004, Volume: 58, Issue:6

    Topics: Antifungal Agents; Clinical Trials, Phase III as Topic; Drug Evaluation; Humans; Mycoses; Treatment Outcome; Triazoles

2004
[New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
    Nederlands tijdschrift voor geneeskunde, 2004, Aug-21, Volume: 148, Issue:34

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Carriers; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Species Specificity; Treatment Outcome; Triazoles; Voriconazole

2004
Voriconazole: therapeutic review of a new azole antifungal.
    Expert review of anti-infective therapy, 2004, Volume: 2, Issue:4

    Topics: Animals; Antifungal Agents; Azoles; Clinical Trials as Topic; Drug Interactions; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2004
Pseudallescheria boydii cranial osteomyelitis and subdural empyema successfully treated with voriconazole: a case report and literature review.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2004, Volume: 23, Issue:11

    Topics: Adult; Antifungal Agents; Empyema, Subdural; Female; Humans; Mycoses; Osteomyelitis; Pseudallescheria; Pyrimidines; Triazoles; Voriconazole

2004
Management of invasive mycoses in hematology patients: current approaches.
    Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:13 Suppl 7

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Hematopoietic Stem Cell Transplantation; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Peptides, Cyclic; Randomized Controlled Trials as Topic; Survival Analysis; Triazoles

2004
Use of newer antifungal therapies in clinical practice: what do the data tell us?
    Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:13 Suppl 7

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Liposomes; Mycoses; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis

2004
Combination antifungal therapy: where are we now, and where are we going?
    Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:13 Suppl 7

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Caspofungin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2004
Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole.
    Medical mycology, 2005, Volume: 43, Issue:1

    Topics: Antifungal Agents; Ascomycota; Brain Diseases; Central Nervous System Fungal Infections; Humans; Male; Middle Aged; Mycoses; Treatment Outcome; Triazoles

2005
Emerging azole antifungals.
    Expert opinion on emerging drugs, 2005, Volume: 10, Issue:1

    Topics: Animals; Antifungal Agents; Azoles; Drugs, Investigational; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2005
Fusarium peritonitis concomitant to kidney transplantation successfully managed with voriconazole: case report and review of the literature.
    Transplant international : official journal of the European Society for Organ Transplantation, 2005, Volume: 18, Issue:5

    Topics: Antifungal Agents; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fusarium; Humans; Kidney Transplantation; Middle Aged; Mycoses; Organ Transplantation; Peritonitis; Pyrimidines; Triazoles; Voriconazole

2005
[Update on therapy of invasive mycoses in hematology and oncology].
    Deutsche medizinische Wochenschrift (1946), 2005, Jun-03, Volume: 130, Issue:22

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Drug Combinations; Echinocandins; Hematologic Neoplasms; Humans; Itraconazole; Lipopeptides; Liposomes; Mycoses; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Risk Factors; Stem Cell Transplantation; Triazoles; Voriconazole; Zygomycosis

2005
Antifungal agents in children.
    Pediatric clinics of North America, 2005, Volume: 52, Issue:3

    Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole

2005
Voriconazole: review of a broad spectrum triazole antifungal agent.
    Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:7

    Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Cryptococcosis; Cyclic N-Oxides; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Injections, Intravenous; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2005
Posaconazole.
    Drugs, 2005, Volume: 65, Issue:11

    Topics: Animals; Antifungal Agents; Clinical Trials as Topic; Fungi; Humans; Mycoses; Triazoles

2005
Antifungal treatment in pediatric patients.
    Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2005, Volume: 8, Issue:4

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Azoles; Caspofungin; Child; Child, Preschool; Drug Resistance, Fungal; Echinocandins; Flucytosine; Fungal Proteins; Humans; Infant; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Triazoles

2005
Posaconazole: clinical pharmacology and potential for management of fungal infections.
    Expert review of anti-infective therapy, 2005, Volume: 3, Issue:4

    Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Fungi; Humans; Molecular Structure; Mycoses; Triazoles

2005
Posaconazole.
    Drugs of today (Barcelona, Spain : 1998), 2005, Volume: 41, Issue:6

    Topics: Antifungal Agents; Clinical Trials as Topic; Fungi; Humans; Mycoses; Triazoles

2005
Management of systemic fungal infections: alternatives to itraconazole.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 56 Suppl 1

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Mycoses; Randomized Controlled Trials as Topic; Triazoles

2005
Safety and potential of drug interactions of caspofungin and voriconazole in multimorbid patients.
    Pharmacology, 2005, Volume: 75, Issue:4

    Topics: Anti-Bacterial Agents; Anticonvulsants; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Cross Infection; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Monitoring; Echinocandins; Food-Drug Interactions; Humans; Immunocompromised Host; Intensive Care Units; Lipopeptides; Liver; Mycoses; Peptides, Cyclic; Polypharmacy; Pyrimidines; Reverse Transcriptase Inhibitors; Triazoles; Voriconazole

2005
Posaconazole: a broad-spectrum triazole antifungal.
    The Lancet. Infectious diseases, 2005, Volume: 5, Issue:12

    Topics: Antifungal Agents; Drug Resistance, Fungal; Fungi; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Treatment Outcome; Triazoles

2005
Voriconazole versus amphotericin B in cancer patients with neutropenia.
    The Cochrane database of systematic reviews, 2006, Jan-25, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2006
Invasive Acremonium strictum infection in a bone marrow transplant recipient.
    The Pediatric infectious disease journal, 2006, Volume: 25, Issue:3

    Topics: Acremonium; Antifungal Agents; Bone Marrow Transplantation; Child; Female; Humans; Male; Mycoses; Opportunistic Infections; Osteomyelitis; Pyrimidines; Tibia; Triazoles; Urine; Voriconazole

2006
Fungal prosthetic mitral valve endocarditis caused by Scopulariopsis species: case report and review of the literature.
    The Journal of thoracic and cardiovascular surgery, 2006, Volume: 131, Issue:5

    Topics: Aged; Amphotericin B; Antifungal Agents; Arterial Occlusive Diseases; Cardiac Surgical Procedures; Device Removal; Endarterectomy; Endocarditis; Fatal Outcome; Female; Femoral Artery; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Leg; Mitosporic Fungi; Mitral Valve; Mycoses; Prosthesis-Related Infections; Pyrimidines; Reoperation; Triazoles; Voriconazole

2006
Pharmacokinetic/pharmacodynamic profile of voriconazole.
    Clinical pharmacokinetics, 2006, Volume: 45, Issue:7

    Topics: Animals; Antifungal Agents; Biotransformation; Drug Interactions; Fungi; Half-Life; Humans; Mycoses; Protein Binding; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole

2006
Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients.
    Mycopathologia, 2006, Volume: 162, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Drug Therapy, Combination; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2006
Invasive fungal infections in critically ill patients: different therapeutic options and a uniform strategy.
    Revista iberoamericana de micologia, 2006, Volume: 23, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Critical Illness; Cross Infection; Deoxycholic Acid; Drug Combinations; Fluconazole; Humans; Intensive Care Units; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2006
Clinical efficacy of new antifungal agents.
    Current opinion in microbiology, 2006, Volume: 9, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Diarrhea; Exanthema; Humans; Mycoses; Nausea; Peptides, Cyclic; Triazoles; Vomiting; Zygomycosis

2006
Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections.
    Mycoses, 2006, Volume: 49 Suppl 1

    Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Disease Models, Animal; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mycoses; Rabbits; Rats; Treatment Outcome; Triazoles

2006
Second-line treatment in invasive mould infections.
    Mycoses, 2006, Volume: 49 Suppl 1

    Topics: Antifungal Agents; Aspergillosis; Humans; Mycoses; Salvage Therapy; Treatment Outcome; Triazoles; Zygomycosis

2006
New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Oct-15, Volume: 43, Issue:8

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Cryptococcosis; Echinocandins; Fever; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2006
Disseminated phaeohyphomycosis due to Ochroconis gallopavum in the setting of advanced HIV infection.
    Medical mycology, 2006, Volume: 44, Issue:8

    Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Ascomycota; Biopsy; Fatal Outcome; Histocytochemistry; Humans; Male; Marijuana Abuse; Mycoses; Pyrimidines; Triazoles; Voriconazole

2006
[Voriconazole safety: short review of clinical data].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2006, Volume: 51, Issue:3-4

    Topics: Antifungal Agents; Drug Interactions; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2006
[The latest data on posaconazole].
    Medecine et maladies infectieuses, 2007, Volume: 37, Issue:2

    Topics: Adult; Animals; Antifungal Agents; Central Nervous System Fungal Infections; Chagas Cardiomyopathy; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Humans; Immunocompromised Host; Mice; Mycoses; Premedication; Triazoles; Trypanocidal Agents

2007
Voriconazole : a review of its use in the management of invasive fungal infections.
    Drugs, 2007, Volume: 67, Issue:2

    Topics: Adolescent; Adult; Antifungal Agents; Child; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2007
[The future of antifungal agents].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2007, Volume: 48, Issue:1

    Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole

2007
Aspergillus infection of implantable cardioverter-defibrillators and pacemakers: case report and literature review.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2007, Volume: 26, Issue:5

    Topics: Aged; Antifungal Agents; Aspergillus flavus; Defibrillators, Implantable; Female; Humans; Mycoses; Prosthesis-Related Infections; Pyrimidines; Triazoles; Voriconazole

2007
Treating disseminated fusariosis: amphotericin B, voriconazole or both?
    Mycoses, 2007, Volume: 50, Issue:3

    Topics: Aged; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fever; Fusarium; Humans; Immunocompromised Host; Liposomes; Male; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
Posaconazole: a new broad-spectrum antifungal agent.
    Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:8

    Topics: Animals; Antifungal Agents; Disease Models, Animal; Drug Resistance, Fungal; Fungi; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Mycoses; Salvage Therapy; Triazoles

2007
Recent advances in antifungal chemotherapy.
    International journal of antimicrobial agents, 2007, Volume: 30, Issue:2

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Double-Blind Method; Drug Resistance, Fungal; Drug Therapy, Combination; Humans; Multicenter Studies as Topic; Mycoses; Peptides, Cyclic; Randomized Controlled Trials as Topic; Triazoles

2007
Paecilomyces lilacinus infection in a liver transplant patient: case report and review of the literature.
    Transplant infectious disease : an official journal of the Transplantation Society, 2008, Volume: 10, Issue:2

    Topics: Antifungal Agents; Humans; International Cooperation; Liver Transplantation; Male; Middle Aged; Mycoses; Paecilomyces; Postoperative Complications; Pyrimidines; Triazoles; Voriconazole

2008
Changing epidemiology of rare mould infections: implications for therapy.
    Drugs, 2007, Volume: 67, Issue:13

    Topics: Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Fusarium; Humans; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Zygomycosis

2007
[In vitro antifungal activity of voriconazole: New data after the first years of clinical experience].
    Revista iberoamericana de micologia, 2007, Sep-30, Volume: 24, Issue:3

    Topics: Antifungal Agents; Aspergillus; Biofilms; Candida; Cryptococcus; Drug Resistance, Fungal; Drug Synergism; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts

2007
[Role of voriconazole in critically ill patients with invasive mycoses].
    Revista iberoamericana de micologia, 2007, Sep-30, Volume: 24, Issue:3

    Topics: Antifungal Agents; Comorbidity; Critical Care; Fungemia; Humans; Intensive Care Units; Kidney; Multicenter Studies as Topic; Mycoses; Prospective Studies; Pyrimidines; Spain; Triazoles; Voriconazole

2007
[Current indications for voriconazole in onco-hematological patients].
    Revista iberoamericana de micologia, 2007, Sep-30, Volume: 24, Issue:3

    Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Drug Resistance, Fungal; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Multicenter Studies as Topic; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Salvage Therapy; Spain; Triazoles; Voriconazole; Zygomycosis

2007
[Voriconazole for the therapy of mycoses in recipients of solid organ transplants].
    Revista iberoamericana de micologia, 2007, Sep-30, Volume: 24, Issue:3

    Topics: Antibiotic Prophylaxis; Antifungal Agents; Drug Interactions; Humans; Immunosuppressive Agents; Lung Diseases, Fungal; Lung Transplantation; Mycoses; Organ Transplantation; Postoperative Complications; Pyrimidines; Triazoles; Voriconazole

2007
[The role of voriconazole in the treatment of emerging mycoses].
    Revista iberoamericana de micologia, 2007, Sep-30, Volume: 24, Issue:3

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Communicable Diseases, Emerging; Fusarium; Humans; Mycoses; Opportunistic Infections; Paecilomyces; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2007
Antifungal agents.
    The Medical journal of Australia, 2007, Oct-01, Volume: 187, Issue:7

    Topics: Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Half-Life; Humans; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2007
Antifungal agents in neonates: issues and recommendations.
    Paediatric drugs, 2007, Volume: 9, Issue:5

    Topics: Antifungal Agents; Echinocandins; Humans; Infant, Newborn; Mycoses; Polyenes; Pyrimidines; Triazoles

2007
[New development in the treatment of deep-seated mycoses].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2007, Sep-10, Volume: 96, Issue:9

    Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole

2007
Recent advances and challenges in the treatment of invasive fungal infections.
    International journal of antimicrobial agents, 2007, Volume: 30, Issue:6

    Topics: Antifungal Agents; Aspergillus; Candida; Double-Blind Method; Echinocandins; Fungemia; Fungi; Humans; Mycoses; Randomized Controlled Trials as Topic; Triazoles

2007
Advances in antifungal therapy.
    Annual review of medicine, 2008, Volume: 59

    Topics: Adult; Antifungal Agents; Child; Echinocandins; Humans; Mycoses; Triazoles

2008
Posaconazole: an extended-spectrum triazole antifungal agent.
    Clinical therapeutics, 2007, Volume: 29, Issue:9

    Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Candidiasis; Drug Resistance, Fungal; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Tissue Distribution; Triazoles

2007
New and emerging treatments for fungal infections.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 61 Suppl 1

    Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Mycoses; Quinazolines; Stereoisomerism; Triazoles

2008
Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Dec-15, Volume: 45, Issue:12

    Topics: Animals; Antifungal Agents; Candidiasis; Controlled Clinical Trials as Topic; Disease Models, Animal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles

2007
Use of terbinafine in rare and refractory mycoses.
    Future microbiology, 2008, Volume: 3, Issue:1

    Topics: Animals; Antifungal Agents; Candida; Dermatomycoses; Drug Resistance, Fungal; Humans; Mycoses; Naphthalenes; Terbinafine; Treatment Outcome; Triazoles

2008
Broad-spectrum antifungal prophylaxis in patients with cancer at high risk for invasive mold infections: point.
    Journal of the National Comprehensive Cancer Network : JNCCN, 2008, Volume: 6, Issue:2

    Topics: Antifungal Agents; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Mycoses; Myelodysplastic Syndromes; Neoplasms; Neutropenia; Risk Assessment; Triazoles

2008
Broad-spectrum antifungal prophylaxis in patients with cancer at high risk for invasive mold infections: counterpoint.
    Journal of the National Comprehensive Cancer Network : JNCCN, 2008, Volume: 6, Issue:2

    Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; beta-Glucans; Enzyme-Linked Immunosorbent Assay; Humans; Immunocompromised Host; Mycoses; Neoplasms; Neutropenia; Proteoglycans; Risk Assessment; Tomography, X-Ray Computed; Triazoles

2008
Update on azole antifungals.
    Seminars in respiratory and critical care medicine, 2008, Volume: 29, Issue:2

    Topics: Antifungal Agents; Biological Availability; Clinical Trials as Topic; Drug Interactions; Humans; Mycoses; Triazoles

2008
Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations.
    Therapeutic drug monitoring, 2008, Volume: 30, Issue:2

    Topics: Antifungal Agents; Drug Monitoring; Fluconazole; Flucytosine; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole

2008
Antifungal agents--clinical pharmacokinetics and drug interactions.
    Mycoses, 2008, Volume: 51 Suppl 1

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Echinocandins; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole

2008
[Future of antifungal and antiviral agents. 1. Antifungal agents].
    Nihon rinsho. Japanese journal of clinical medicine, 1984, Volume: 42, Issue:3

    Topics: Allylamine; Antifungal Agents; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Imidazoles; Mycoses; Structure-Activity Relationship; Triazoles

1984
[Prophylaxis and therapy of fungal infections in oncology].
    Mycoses, 1995, Volume: 38 Suppl 1

    Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Incidence; Mycoses; Neoplasms; Triazoles

1995
Antifungal prophylaxis in patients with hematologic malignancies: a reappraisal.
    Blood, 1995, Sep-15, Volume: 86, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Clinical Trials as Topic; Disease Susceptibility; Drug Administration Routes; Hematopoietic Cell Growth Factors; Humans; Immunocompromised Host; Leukocyte Transfusion; Mycoses; Neoplasms; Neutropenia; Triazoles

1995
Chemoprophylaxis of fungal infections in neutropenic patients.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:7

    Topics: Antifungal Agents; Flucytosine; Humans; Imidazoles; Mycoses; Neutropenia; Polyenes; Triazoles

1994
Evolving concepts of prevention and treatment of invasive fungal infections in pediatric bone marrow transplant recipients.
    Bone marrow transplantation, 1996, Volume: 18 Suppl 3

    Topics: Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Child; Clinical Trials as Topic; Fluconazole; Flucytosine; Humans; Imidazoles; Immunocompromised Host; Itraconazole; Mycoses; Neutropenia; Transplantation Conditioning; Triazoles

1996
[Antifungal resistance in opportunistic pathogenic fungi (II). Imidazoles and triazoles].
    Enfermedades infecciosas y microbiologia clinica, 1996, Volume: 14, Issue:8

    Topics: Antifungal Agents; Candida albicans; Cell Membrane; DNA Replication; DNA, Fungal; Drug Resistance, Microbial; Drug Resistance, Multiple; Fungi; Imidazoles; Microbial Sensitivity Tests; Mycoses; Structure-Activity Relationship; Triazoles

1996
Use of azoles for systemic antifungal therapy.
    Advances in pharmacology (San Diego, Calif.), 1997, Volume: 39

    Topics: Antifungal Agents; Drug Interactions; Drug Resistance, Microbial; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles

1997
[Fungal infections in patients undergoing solid organ transplantation].
    Enfermedades infecciosas y microbiologia clinica, 1997, Volume: 15 Suppl 2

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Celiac Artery; Cytomegalovirus Infections; Female; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppression Therapy; Incidence; Liver Transplantation; Male; Middle Aged; Mucormycosis; Mycoses; Postoperative Complications; Risk Factors; Thrombosis; Time Factors; Transplantation; Triazoles

1997
Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development.
    Advances in pharmacology (San Diego, Calif.), 1998, Volume: 44

    Topics: Animals; Antifungal Agents; Fungi; Humans; Mycoses; Triazoles

1998
Current and future therapy of invasive fungal infections.
    Current clinical topics in infectious diseases, 1998, Volume: 18

    Topics: Amphotericin B; Antifungal Agents; Drug Carriers; Flucytosine; Humans; Liposomes; Mycoses; Triazoles

1998
New approaches to antifungal chemotherapy.
    Medical mycology, 1998, Volume: 36 Suppl 1

    Topics: Amphotericin B; Animals; Antifungal Agents; Clinical Trials as Topic; Combined Modality Therapy; Drug Therapy, Combination; Fungi; Humans; Mycoses; Opportunistic Infections; Randomized Controlled Trials as Topic; Triazoles

1998
Therapy of invasive fungal infections.
    The Netherlands journal of medicine, 1999, Volume: 55, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Catheterization, Central Venous; Contraindications; Drug Therapy, Combination; Flucytosine; Fungemia; Granulocyte Colony-Stimulating Factor; Humans; Immunotherapy; Mycoses; Neutropenia; Triazoles

1999
New drugs and novel targets for treatment of invasive fungal infections in patients with cancer.
    The oncologist, 2000, Volume: 5, Issue:2

    Topics: Anidulafungin; Antifungal Agents; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neoplasms; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2000
Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000, Volume: 31, Issue:3

    Topics: Antifungal Agents; Brain Abscess; Central Nervous System; Drainage; Humans; Male; Middle Aged; Mycoses; Pseudallescheria; Pyrimidines; Triazoles; Voriconazole

2000
Novel triazole antifungal agents.
    Expert opinion on investigational drugs, 2000, Volume: 9, Issue:3

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Humans; Immunocompromised Host; Mycoses; Opportunistic Infections; Triazoles

2000
New targets and delivery systems for antifungal therapy.
    Medical mycology, 2000, Volume: 38 Suppl 1

    Topics: Antifungal Agents; Drug Delivery Systems; Drug Design; Fungi; Humans; Mycoses; Triazoles

2000
Update on antifungal agents.
    The Pediatric infectious disease journal, 2001, Volume: 20, Issue:10

    Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Enzyme Inhibitors; Glucosyltransferases; Humans; Membrane Proteins; Mycoses; Pyrimidines; Schizosaccharomyces pombe Proteins; Treatment Outcome; Triazoles; Voriconazole

2001
Review of the safety and efficacy of voriconazole.
    Expert opinion on investigational drugs, 2002, Volume: 11, Issue:3

    Topics: Animals; Antifungal Agents; Humans; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Pyrimidines; Triazoles; Voriconazole

2002
Voriconazole -- better chances for patients with invasive mycoses.
    European journal of medical research, 2002, May-31, Volume: 7, Issue:5

    Topics: Antifungal Agents; Candida; Candidiasis; Drug Interactions; Drug Resistance, Fungal; Drug Tolerance; Humans; Mycoses; Pyrimidines; Safety; Triazoles; Voriconazole

2002
Ravuconazole Eisai/Bristol-Myers Squibb.
    Current opinion in investigational drugs (London, England : 2000), 2002, Volume: 3, Issue:4

    Topics: Administration, Oral; Animals; Antifungal Agents; Clinical Trials as Topic; Humans; Mycoses; Structure-Activity Relationship; Thiazoles; Triazoles

2002
Antifungal agents used for deep-seated mycotic infections.
    Mayo Clinic proceedings, 1992, Volume: 67, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Mycoses; Thromboxane-A Synthase; Triazoles

1992
Fungal infections and their management.
    British journal of clinical practice. Supplement, 1990, Volume: 71

    Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses; Naphthalenes; Terbinafine; Triazoles

1990
Imidazoles and triazoles in antifungal therapy.
    DICP : the annals of pharmacotherapy, 1990, Volume: 24, Issue:2

    Topics: Animals; Humans; Imidazoles; Mycoses; Triazoles

1990
Testing of organisms for susceptibility to triazoles: is it justified?
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1989, Volume: 8, Issue:5

    Topics: Antifungal Agents; Drug Resistance, Microbial; Fluconazole; Fungi; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Triazoles

1989
New antifungal agents.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1989, Volume: 8, Issue:5

    Topics: Aminoglycosides; Anti-Bacterial Agents; Antifungal Agents; Azoles; Echinocandins; Fluconazole; Fungi; Humans; Itraconazole; Ketoconazole; Mycoses; Peptides; Peptides, Cyclic; Triazoles

1989
Azole antifungal agents: emphasis on new triazoles.
    Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:1

    Topics: Animals; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses; Triazoles

1988
Recent advances in the treatment of systemic fungal infections.
    Methods and findings in experimental and clinical pharmacology, 1987, Volume: 9, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles

1987
Azole antifungal drugs: old and new.
    Annals of internal medicine, 1988, Aug-01, Volume: 109, Issue:3

    Topics: Animals; Antifungal Agents; Azoles; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Triazoles

1988
Treatment of systemic fungal infections: recent progress and current problems.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1988, Volume: 7, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles

1988
Systemic fungal infections: diagnosis and treatment. I. Therapeutic agents.
    Infectious disease clinics of North America, 1988, Volume: 2, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Humans; Ketoconazole; Mycoses; Triazoles

1988

Trials

67 trial(s) available for triazoles and Mycoses

ArticleYear
Isavuconazole as Primary Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 Study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 05-18, Volume: 72, Issue:10

    Topics: Adult; Aged; Antifungal Agents; Humans; Leukemia, Myeloid, Acute; Mycoses; Myelodysplastic Syndromes; Nitriles; Prospective Studies; Pyridines; Triazoles

2021
A Randomized Trial of Caspofungin vs Triazoles Prophylaxis for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplant.
    Journal of the Pediatric Infectious Diseases Society, 2021, Apr-30, Volume: 10, Issue:4

    Topics: Adolescent; Adult; Antifungal Agents; Caspofungin; Child; Child, Preschool; Hematopoietic Stem Cell Transplantation; Humans; Infant; Invasive Fungal Infections; Mycoses; Triazoles; Young Adult

2021
[Efficacy and Safety of Posaconazoleon for Primary Antifungal Prophylaxis against Invasive Fungal Disease in Patients with Stem Cell Transplantation].
    Zhongguo shi yan xue ye xue za zhi, 2017, Volume: 25, Issue:3

    Topics: Antifungal Agents; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Mycoses; Stem Cell Transplantation; Triazoles

2017
Micafungin versus posaconazole prophylaxis in acute leukemia or myelodysplastic syndrome: A randomized study.
    The Journal of infection, 2018, Volume: 77, Issue:3

    Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Antifungal Agents; Chemoprevention; Female; Humans; Incidence; Leukemia; Male; Micafungin; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Survival Analysis; Treatment Failure; Triazoles

2018
The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.
    JAMA ophthalmology, 2013, Volume: 131, Issue:4

    Topics: Administration, Topical; Adult; Antifungal Agents; Corneal Perforation; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Pyrimidines; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole; Wound Healing

2013
Empirical voriconazole therapy for febrile neutropenic patients with hematological disorders: a prospective multicenter trial in Japan.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013, Volume: 19, Issue:6

    Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Antigens, Fungal; Febrile Neutropenia; Female; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole; Young Adult

2013
Posaconazole vs. fluconazole as invasive fungal infection prophylaxis in China: a multicenter, randomized, open-label study.
    International journal of clinical pharmacology and therapeutics, 2013, Volume: 51, Issue:9

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Prospective Studies; Triazoles

2013
Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2013, Sep-01, Volume: 70, Issue:17

    Topics: Antifungal Agents; Case-Control Studies; Cohort Studies; Cost-Benefit Analysis; Decision Support Techniques; Double-Blind Method; Fluconazole; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole

2013
No difference between posaconazole and fluconazole antifungal prophylaxis and mycological diagnostics except costs in patients undergoing AML chemotherapy: a 1-year "real-life" evaluation.
    Annals of hematology, 2014, Volume: 93, Issue:1

    Topics: Adult; Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Laboratory Techniques; Female; Fluconazole; Fungemia; Germany; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Prospective Studies; Triazoles; Young Adult

2014
In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial.
    American journal of ophthalmology, 2014, Volume: 157, Issue:2

    Topics: Adult; Antifungal Agents; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Inhibitory Concentration 50; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Natamycin; Pyrimidines; Triazoles; Voriconazole

2014
Clinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology-oncology patients: a retrospective cohort study.
    Cancer medicine, 2014, Volume: 3, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Fluconazole; Hematologic Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mycoses; Retrospective Studies; Treatment Outcome; Triazoles; United States

2014
Phase 1B study of the pharmacokinetics and safety of posaconazole intravenous solution in patients at risk for invasive fungal disease.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:7

    Topics: Adult; Aged; Antifungal Agents; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Injections, Intravenous; Male; Middle Aged; Mycoses; Pharmaceutical Solutions; Triazoles

2014
Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: a 6-yr analysis from the cologne cohort for neutropenic patients.
    European journal of haematology, 2014, Volume: 93, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Antineoplastic Agents; Drug Therapy, Combination; Echinocandins; Female; Follow-Up Studies; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Neutropenia; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Triazoles

2014
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:11

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Data Collection; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Prospective Studies; Treatment Outcome; Triazoles; Young Adult

2014
Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropenia.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:10

    Topics: Antifungal Agents; Female; Humans; Male; Middle Aged; Mycoses; Neutropenia; Tablets; Triazoles

2014
Safety and pharmacokinetics of isavuconazole as antifungal prophylaxis in acute myeloid leukemia patients with neutropenia: results of a phase 2, dose escalation study.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:4

    Topics: Adult; Aged; Antifungal Agents; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Immunosuppression Therapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Neutropenia; Nitriles; Patient Safety; Pyridines; Triazoles

2015
Pharmacokinetics of posaconazole prophylaxis of patients with acute myeloid leukemia.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:9

    Topics: Adult; Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Prospective Studies; Salvage Therapy; Triazoles

2015
Determination of posaconazole concentration with LC-MS/MS in adult patients with hematologic malignancy.
    Clinica chimica acta; international journal of clinical chemistry, 2015, Oct-23, Volume: 450

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Chromatography, Liquid; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Tandem Mass Spectrometry; Triazoles; Young Adult

2015
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
    Lancet (London, England), 2016, Feb-20, Volume: 387, Issue:10020

    Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Aspergillosis; Double-Blind Method; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Male; Middle Aged; Mycoses; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole

2016
Hospital resource use of patients receiving isavuconazole vs voriconazole for invasive mold infections in the phase III SECURE trial.
    Journal of medical economics, 2016, Volume: 19, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Body Mass Index; Double-Blind Method; Female; Glomerular Filtration Rate; Hospital Charges; Humans; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole; Young Adult

2016
Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, 08-01, Volume: 63, Issue:3

    Topics: Adult; Aged; Antifungal Agents; Blastomycosis; Coccidioidomycosis; Cryptococcosis; Female; Histoplasmosis; Humans; Male; Middle Aged; Mycoses; Nitriles; Paracoccidioidomycosis; Pyridines; Triazoles; Young Adult

2016
Posaconazole Tablet Formulation at 400 Milligrams Daily Achieves Desired Minimum Serum Concentrations in Adult Patients with a Hematologic Malignancy or Stem Cell Transplant.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:11

    Topics: Adult; Aged; Antifungal Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Tablets; Treatment Outcome; Triazoles

2016
Efficacy, safety and feasibility of antifungal prophylaxis with posaconazole tablet in paediatric patients after haematopoietic stem cell transplantation.
    Journal of cancer research and clinical oncology, 2017, Volume: 143, Issue:7

    Topics: Administration, Oral; Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Mycoses; Tablets; Triazoles

2017
Pharmacokinetics of oral posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome.
    Pharmacotherapy, 2008, Volume: 28, Issue:10

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Antineoplastic Agents; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Prospective Studies; Single-Blind Method; Triazoles; Young Adult

2008
Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:1

    Topics: Amphotericin B; Australia; Cost-Benefit Analysis; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2009
Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia.
    European journal of haematology, 2010, Volume: 84, Issue:3

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Middle Aged; Mycoses; Neutropenia; Prospective Studies; Pyrimidines; Transplantation Conditioning; Triazoles; Voriconazole; Young Adult

2010
Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2011, Volume: 19, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Bilirubin; Drug Monitoring; Female; Humans; Infusions, Intravenous; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2011
Population pharmacokinetics of posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome.
    Current medical research and opinion, 2010, Volume: 26, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Population; Single-Blind Method; Triazoles; Young Adult

2010
Efficacy, safety, and breakthrough infections associated with standard long-term posaconazole antifungal prophylaxis in allogeneic stem cell transplantation recipients.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2011, Volume: 17, Issue:4

    Topics: Adolescent; Adult; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Stem Cell Transplantation; Time Factors; Transplantation, Homologous; Triazoles; Young Adult

2011
Exposure-response of posaconazole used for prophylaxis against invasive fungal infections: evaluating the need to adjust doses based on drug concentrations in plasma.
    Clinical pharmacology and therapeutics, 2010, Volume: 88, Issue:1

    Topics: Antifungal Agents; Antineoplastic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Graft vs Host Disease; Humans; Mycoses; Neutropenia; Stem Cell Transplantation; Treatment Outcome; Triazoles

2010
Voriconazole pharmacokinetics and safety in immunocompromised children compared to adult patients.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:8

    Topics: Adult; Antifungal Agents; Area Under Curve; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Immunocompromised Host; Injections, Intravenous; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2010
Comparison of natamycin and voriconazole for the treatment of fungal keratitis.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2010, Volume: 128, Issue:6

    Topics: Administration, Topical; Anti-Infective Agents, Local; Antifungal Agents; Cornea; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Male; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Pyrimidines; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole

2010
[Economic evaluation of posaconazole in prophylaxis of invasive fungal infections in Italian neutropenic patients with acute myeloid leukaemia or myelodysplastic syndrome].
    Le infezioni in medicina, 2010, Volume: 18, Issue:2

    Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit Analysis; Deoxycholic Acid; Drug Combinations; Drug Costs; Equipment and Supplies; Fluconazole; Follow-Up Studies; Hospital Costs; Humans; Immunocompromised Host; Infusions, Intravenous; Italy; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Myelodysplastic Syndromes; Neutropenia; Oncology Nursing; Treatment Outcome; Triazoles

2010
Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study.
    Haematologica, 2010, Volume: 95, Issue:10

    Topics: Adult; Aged; Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Leukemia; Male; Middle Aged; Mycoses; Pyrimidines; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2010
Pharmacokinetics, safety, and tolerability of voriconazole in immunocompromised children.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:10

    Topics: Antifungal Agents; Child; Child, Preschool; Female; Humans; Immunocompromised Host; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2010
Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.
    Clinical & experimental ophthalmology, 2011, Volume: 39, Issue:5

    Topics: Administration, Topical; Adult; Antifungal Agents; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Male; Microbiological Techniques; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Pilot Projects; Prospective Studies; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole

2011
Utilisation, efficacy and safety of voriconazole: prospective, non-interventional study on treatment of IFIs in clinical practice.
    Current medical research and opinion, 2011, Volume: 27, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; Critical Illness; Female; Humans; Infant; Injections, Intravenous; Male; Middle Aged; Mycoses; Professional Practice; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2011
Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2011, Volume: 15, Issue:5

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Fever; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Prospective Studies; Pyrimidines; Radiography, Thoracic; Risk Factors; Singapore; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2011
Voriconazole as primary antifungal prophylaxis in children undergoing allo-SCT.
    Bone marrow transplantation, 2012, Volume: 47, Issue:4

    Topics: Acute Disease; Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Male; Mycoses; Pyrimidines; Stem Cell Transplantation; Time Factors; Triazoles; Voriconazole

2012
Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration.
    Therapeutic drug monitoring, 2011, Volume: 33, Issue:4

    Topics: Anti-Infective Agents; Area Under Curve; Critical Illness; Drug Monitoring; Half-Life; Hemofiltration; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2011
Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation.
    British journal of haematology, 2011, Volume: 155, Issue:3

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Female; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Male; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult

2011
Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized, clinical study.
    Journal of pediatric hematology/oncology, 2011, Volume: 33, Issue:8

    Topics: Administration, Oral; Adolescent; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Child; Child, Preschool; Female; Humans; Infant; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Mycoses; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2011
Pharmacokinetics of different dosing strategies of oral posaconazole in patients with compromised gastrointestinal function and who are at high risk for invasive fungal infection.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5

    Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Area Under Curve; Biological Availability; Diet, High-Fat; Dietary Supplements; Drug Administration Schedule; Drug Dosage Calculations; Female; Gastrointestinal Tract; Humans; Immunocompromised Host; Intestinal Absorption; Male; Middle Aged; Mycoses; Risk; Triazoles

2012
A multicenter, open-label study of posaconazole oral suspension in the treatment of invasive fungal infections in patients refractory to or intolerant of first-line therapy.
    Future microbiology, 2012, Volume: 7, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Aspergillus; Candida; Drug Tolerance; Female; Fusarium; Humans; Male; Middle Aged; Mycoses; Salvage Therapy; Triazoles; Young Adult

2012
Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial.
    Cornea, 2012, Volume: 31, Issue:6

    Topics: Antifungal Agents; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Natamycin; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole

2012
Voriconazole for fungal corneal ulcers.
    Ophthalmology, 2012, Volume: 119, Issue:5

    Topics: Acremonium; Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Ascomycota; Aspergillus flavus; Aspergillus niger; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Humans; Itraconazole; Middle Aged; Mycoses; Natamycin; Prospective Studies; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2012
Comparison of micafungin and voriconazole in the treatment of invasive fungal infections in kidney transplant recipients.
    Journal of clinical pharmacy and therapeutics, 2012, Volume: 37, Issue:6

    Topics: Adult; Aged; Antifungal Agents; China; Echinocandins; Female; Humans; Kidney Transplantation; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Survival Rate; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2012
Comparison of posaconazole versus weekly amphotericin B lipid complex for the prevention of invasive fungal infections in hematopoietic stem-cell transplantation.
    Transplantation, 2012, Aug-15, Volume: 94, Issue:3

    Topics: Administration, Oral; Adult; Aged; Amphotericin B; Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Leukemia; Lipids; Lymphoma; Male; Middle Aged; Mycoses; Prospective Studies; Risk; Tacrolimus; Time Factors; Transplantation, Homologous; Triazoles

2012
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55, Issue:11

    Topics: Aged; Antifungal Agents; Female; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Triazoles

2012
Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2013, Volume: 32, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Double-Blind Method; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Middle Aged; Mycoses; Neutropenia; Placebos; Pyrimidines; Triazoles; Voriconazole

2013
Plasma levels of voriconazole administered via a nasogastric tube to critically ill patients.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2005, Volume: 24, Issue:5

    Topics: Aged; Antifungal Agents; Critical Illness; Female; Humans; Intubation, Gastrointestinal; Male; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2005
Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:2

    Topics: Adult; Aged; Antifungal Agents; Bone Marrow Transplantation; Female; Fever; Humans; Male; Middle Aged; Mycoses; Neutropenia; Triazoles

2006
Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, May-15, Volume: 42, Issue:10

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Female; Fusarium; Humans; Leukemia; Male; Middle Aged; Mycoses; Retrospective Studies; Salvage Therapy; Treatment Outcome; Triazoles

2006
Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Jun-15, Volume: 42, Issue:12

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Mycoses; Triazoles

2006
Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1

    Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Aqueous Humor; Aspergillus fumigatus; Candida albicans; Humans; Keratitis; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
Posaconazole plasma concentrations in juvenile patients with invasive fungal infection.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3

    Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Body Surface Area; Body Weight; Child; Female; Humans; Male; Mycoses; Treatment Outcome; Triazoles

2007
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.
    The New England journal of medicine, 2007, Jan-25, Volume: 356, Issue:4

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Double-Blind Method; Female; Fluconazole; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mycoses; Opportunistic Infections; Risk Factors; Triazoles

2007
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
    The New England journal of medicine, 2007, Jan-25, Volume: 356, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Female; Fluconazole; Humans; Itraconazole; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Opportunistic Infections; Single-Blind Method; Treatment Outcome; Triazoles

2007
A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
    The Journal of infection, 2007, Volume: 55, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Humans; Incidence; Length of Stay; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Middle Aged; Mycoses; Placebos; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2007
Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease.
    Pharmacotherapy, 2007, Volume: 27, Issue:12

    Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Antifungal Agents; Body Weight; Chronic Disease; Diarrhea; Double-Blind Method; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Opportunistic Infections; Racial Groups; Sex Factors; Transplantation, Homologous; Triazoles

2007
Double-blind investigation of R-42470 (terconazole cream 0.4%) and clotrimazole (cream 1%) for the topical treatment of mycotic vaginitis.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1984, Volume: 3, Issue:3

    Topics: Administration, Topical; Adolescent; Adult; Antifungal Agents; Clotrimazole; Double-Blind Method; Female; Humans; Imidazoles; Middle Aged; Mycoses; Ointments; Pregnancy; Pregnancy Complications, Infectious; Triazoles; Vaginitis

1984
Effectiveness of an oral triazole for opportunistic mold infections in patients with cancer: experience with SCH 39304.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 17, Issue:6

    Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Female; Humans; Leukemia; Male; Middle Aged; Mycoses; Neoplasms; Opportunistic Infections; Prospective Studies; Triazoles

1993
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
    The New England journal of medicine, 2002, Jan-24, Volume: 346, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Chronic Disease; Female; Fever; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Neoplasms; Neutropenia; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2002
Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study.
    Journal of clinical pharmacology, 2002, Volume: 42, Issue:4

    Topics: Administration, Oral; Adult; Antifungal Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Graft Rejection; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Neoplasms; Pyrimidines; Risk Factors; Triazoles; Voriconazole

2002
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.
    The Pediatric infectious disease journal, 2002, Volume: 21, Issue:3

    Topics: Adolescent; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Administration Schedule; Female; Granulomatous Disease, Chronic; Hematologic Neoplasms; Humans; Infant; Male; Mycoses; Pyrimidines; Treatment Failure; Triazoles; Voriconazole

2002
[Clinical study of fluconazole on deep-seated fungal infections].
    The Japanese journal of antibiotics, 1989, Volume: 42, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Candidiasis; Child; Clinical Trials as Topic; Cryptococcosis; Drug Tolerance; Female; Fluconazole; Humans; Japan; Male; Middle Aged; Multicenter Studies as Topic; Mycoses; Triazoles

1989
A prospective study of the efficacy of fluconazole (UK-49,858) against deep-seated fungal infections.
    The Journal of antimicrobial chemotherapy, 1988, Volume: 21, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Clinical Trials as Topic; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Prospective Studies; Triazoles

1988

Other Studies

610 other study(ies) available for triazoles and Mycoses

ArticleYear
Evaluating posaconazole, its pharmacology, efficacy and safety for the prophylaxis and treatment of fungal infections.
    Expert opinion on pharmacotherapy, 2022, Volume: 23, Issue:2

    Topics: Adolescent; Antifungal Agents; Humans; Immunocompromised Host; Mycoses; Triazoles

2022
[Efficacy of Posaconazole for Primary Prophylaxis in the Induction Therapy of Childhood Acute Lymphoblastic Leukemia].
    Zhongguo shi yan xue ye xue za zhi, 2021, Volume: 29, Issue:6

    Topics: Antifungal Agents; Child; Humans; Induction Chemotherapy; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Primary Prevention; Triazoles

2021
Safety and Effectiveness of Isavuconazole Treatment for Fungal Infections in Solid Organ Transplant Recipients (ISASOT Study).
    Microbiology spectrum, 2022, 02-23, Volume: 10, Issue:1

    Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus; Female; Humans; Male; Middle Aged; Mycoses; Nitriles; Organ Transplantation; Pyridines; Transplant Recipients; Triazoles

2022
Cost-Effectiveness of Posaconazole vs. First-Generation Triazoles for the Prevention of Invasive Fungal Infections Among High-Risk Patients With Hematological Malignancies in China.
    Frontiers in public health, 2022, Volume: 10

    Topics: Antifungal Agents; Cost-Benefit Analysis; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Mycoses; Tablets; Triazoles

2022
Model-Informed Dose Justifications of Posaconazole in Japanese Patients for Prophylaxis and Treatment Against Fungal Infection.
    Journal of clinical pharmacology, 2023, Volume: 63, Issue:4

    Topics: Administration, Oral; Antifungal Agents; East Asian People; Humans; Mycoses; Tablets; Triazoles

2023
Widespread triazole pesticide use affects infection dynamics of a global amphibian pathogen.
    Ecology letters, 2023, Volume: 26, Issue:2

    Topics: Amphibians; Animals; Chytridiomycota; Mycoses; Pesticides; Plant Breeding; Triazoles

2023
Population Pharmacokinetics, Exposure-Safety, and Probability of Target Attainment Analyses for Isavuconazole in Japanese Patients With Deep-Seated Mycoses.
    Journal of clinical pharmacology, 2023, Volume: 63, Issue:6

    Topics: Animals; East Asian People; Humans; Mice; Mycoses; Probability; Triazoles

2023
Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis.
    Diagnostic microbiology and infectious disease, 2019, Volume: 95, Issue:3

    Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Species Specificity; Triazoles

2019
Plasma exposures following posaconazole delayed-release tablets in immunocompromised children and adolescents.
    The Journal of antimicrobial chemotherapy, 2019, 12-01, Volume: 74, Issue:12

    Topics: Administration, Oral; Adolescent; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Delayed-Action Preparations; Female; Humans; Immunocompromised Host; Liver; Liver Function Tests; Male; Mycoses; Plasma; Retrospective Studies; Tablets; Triazoles

2019
    Journal of medical microbiology, 2019, Volume: 68, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Triazoles; Voriconazole

2019
Agricultural systems as potential sources of emerging human mycoses caused by Trichoderma: a successful, common phylotype of Trichoderma longibrachiatum in the frontline.
    FEMS microbiology letters, 2019, 11-01, Volume: 366, Issue:21

    Topics: Agriculture; Antifungal Agents; Environmental Exposure; Environmental Microbiology; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mycological Typing Techniques; Mycoses; Phylogeny; Triazoles; Trichoderma

2019
Identification and functional characterization of
    Bioscience, biotechnology, and biochemistry, 2020, Volume: 84, Issue:7

    Topics: Amino Acid Sequence; Amphotericin B; Antifungal Agents; Asia, Southeastern; ATP Binding Cassette Transporter, Subfamily B; Candida albicans; Drug Resistance, Fungal; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Mycoses; Phylogeny; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Talaromyces; Transcriptome; Triazoles

2020
Posaconazole delayed-release tablets in paediatric haematology-oncology patients.
    Mycoses, 2020, Volume: 63, Issue:6

    Topics: Administration, Oral; Adolescent; Antifungal Agents; Child; Child, Preschool; Delayed-Action Preparations; Female; Hematologic Neoplasms; Humans; Male; Mycoses; Retrospective Studies; Tablets; Triazoles

2020
18F-FDG Positron Emission Tomography (PET) Scan as a Useful Tool to Assess Response to Antimycotic Therapy in Disseminated Invasive Mycosis in Acute Myeloid Leukemia.
    Mycopathologia, 2020, Volume: 185, Issue:3

    Topics: Aged; Anidulafungin; Antifungal Agents; Drug Combinations; Humans; Immunocompromised Host; Invasive Fungal Infections; Kidney; Leukemia, Myeloid, Acute; Liver; Male; Mycoses; Nitriles; Positron-Emission Tomography; Pyridines; Spleen; Treatment Outcome; Triazoles

2020
Combination antifungal therapy for Scedosporium species in cystic fibrosis.
    Pediatric pulmonology, 2020, Volume: 55, Issue:8

    Topics: Adolescent; Antifungal Agents; Ascomycota; Child; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Mycoses; Retrospective Studies; Scedosporium; Terbinafine; Treatment Outcome; Triazoles

2020
Lessons from isavuconazole therapeutic drug monitoring at a United Kingdom Reference Center.
    Medical mycology, 2020, Oct-01, Volume: 58, Issue:7

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Mycoses; Nitriles; Pyridines; Serum; Sex Factors; Triazoles; United Kingdom; Young Adult

2020
Optimal oral cyclosporin dosing with concomitant posaconazole post allogeneic stem cell transplantation.
    Leukemia & lymphoma, 2020, Volume: 61, Issue:10

    Topics: Antifungal Agents; Cyclosporine; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Retrospective Studies; Triazoles

2020
In vitro activity of isavuconazole against clinically isolated yeasts from Chile.
    Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2020, Volume: 51, Issue:4

    Topics: Antifungal Agents; Chile; Humans; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Triazoles; Yeasts

2020
Successful salvage therapy for fungal bronchial anastomotic infection after -lung transplantation with an inhaled triazole anti-fungal PC945.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2020, Volume: 39, Issue:12

    Topics: Administration, Inhalation; Adult; Anastomosis, Surgical; Bronchi; Bronchitis; Dose-Response Relationship, Drug; Female; Fungi; Humans; Lung Transplantation; Male; Middle Aged; Mycoses; Salvage Therapy; Surgical Wound Infection; Triazoles

2020
Case Report: Successful Treatment of Pulmonary Talaromyces marneffei Infection with Posaconazole in a Renal Transplant Recipient.
    The American journal of tropical medicine and hygiene, 2020, 11-23, Volume: 104, Issue:2

    Topics: Adult; Antifungal Agents; Humans; Immunocompromised Host; Kidney Transplantation; Lung; Male; Mycoses; Respiratory Tract Infections; Talaromyces; Tomography, X-Ray Computed; Transplant Recipients; Triazoles

2020
Is Posaconazole Really Effective in Adolescent patients as a Prophylactic Agent: Experience of a Tertiary Care Center.
    Journal of pediatric hematology/oncology, 2021, 07-01, Volume: 43, Issue:5

    Topics: Adolescent; Antifungal Agents; Fanconi Anemia; Female; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Tertiary Care Centers; Triazoles

2021
Choosing Antifungals for the Midostaurin-Treated Patient: Does CYP3A4 Outweigh Recommendations? A Brief Insight from Real Life.
    Chemotherapy, 2021, Volume: 66, Issue:1-2

    Topics: Adult; Aged; Antifungal Agents; Antineoplastic Agents; Cytochrome P-450 CYP3A; Diarrhea; Female; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Mycoses; Staurosporine; Triazoles

2021
Clinical utility of antifungal susceptibility testing in patients with fungal rhinosinusitis.
    Indian journal of medical microbiology, 2021, Volume: 39, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Azoles; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Mycoses; Sinusitis; Triazoles; Voriconazole

2021
Triazole antifungal use for prophylaxis and treatment of invasive fungal diseases for patients receiving gilteritinib.
    Leukemia research, 2021, Volume: 108

    Topics: Adult; Aged; Aged, 80 and over; Aniline Compounds; Antifungal Agents; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Prognosis; Pyrazines; Retrospective Studies; Survival Rate; Triazoles; Young Adult

2021
Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and Western Pacific Region: data from the SENTRY Antifungal Surveillance Program (2011-2019).
    The Journal of antibiotics, 2021, Volume: 74, Issue:8

    Topics: Antifungal Agents; Asia; Aspergillus; Aspergillus fumigatus; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Pacific Islands; Public Health Surveillance; Triazoles

2021
In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years.
    Diagnostic microbiology and infectious disease, 2021, Volume: 101, Issue:3

    Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Europe; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; North America; Opportunistic Infections; Triazoles; Voriconazole

2021
Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans.
    The Journal of antimicrobial chemotherapy, 2017, 07-01, Volume: 72, Issue:7

    Topics: Antifungal Agents; Ascomycota; Caspofungin; Dihydroorotate Dehydrogenase; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Oxidoreductases Acting on CH-CH Group Donors; Scedosporium; Triazoles; Voriconazole

2017
Isavuconazole: is there a need for a new antifungal?
    The Journal of antimicrobial chemotherapy, 2017, 03-01, Volume: 72, Issue:suppl_1

    Topics: Antifungal Agents; Drug Discovery; Humans; Mycoses; Nitriles; Pyridines; Triazoles

2017
Primary fungal prophylaxis in acute leukemia patients with different risk factors: retrospective analysis from the CAESAR study.
    International journal of hematology, 2017, Volume: 106, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Asian People; Central Venous Catheters; Child; Child, Preschool; Consolidation Chemotherapy; Female; Humans; Incidence; Induction Chemotherapy; Infant; Leukemia; Male; Middle Aged; Mycoses; Neutropenia; Retrospective Studies; Risk Factors; Serum Albumin; Sex Factors; Triazoles; Young Adult

2017
Antifungal prophylaxis in newly diagnosed AML patients-Adherence to guidelines and feasibility in a real life setting.
    Mycoses, 2017, Volume: 60, Issue:9

    Topics: Adult; Aged; Antifungal Agents; Female; Fluconazole; Galactose; Guideline Adherence; Guidelines as Topic; Humans; Leukemia, Myeloid, Acute; Male; Mannans; Middle Aged; Mycoses; Pre-Exposure Prophylaxis; Retrospective Studies; Triazoles

2017
SEIFEM 2010-E: economic evaluation of posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia receiving induction chemotherapy.
    Leukemia & lymphoma, 2017, Volume: 58, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit Analysis; Drug Costs; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Monte Carlo Method; Mycoses; Outcome Assessment, Health Care; Triazoles; Young Adult

2017
Cost-effectiveness of posaconazole tablets versus fluconazole as prophylaxis for invasive fungal diseases in patients with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    The European journal of health economics : HEPAC : health economics in prevention and care, 2018, Volume: 19, Issue:4

    Topics: Antifungal Agents; Cost-Benefit Analysis; Female; Fluconazole; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Spain; Tablets; Triazoles

2018
Development of indicators for evaluating the appropriate use of triazoles for invasive fungal disease: A Delphi panel survey.
    Journal of clinical pharmacy and therapeutics, 2017, Volume: 42, Issue:6

    Topics: Adult; Antifungal Agents; Drug Interactions; Female; Humans; Male; Middle Aged; Mycoses; Pharmacists; Surveys and Questionnaires; Triazoles

2017
[Primary antifungal prophylaxis with posaconazole plays a pivotal role during chemotherapy of acute myeloid leukemia].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2017, Jun-14, Volume: 38, Issue:6

    Topics: Antifungal Agents; Humans; Incidence; Induction Chemotherapy; Leukemia, Myeloid, Acute; Mycoses; Remission Induction; Retrospective Studies; Triazoles

2017
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:11

    Topics: Adult; Antifungal Agents; Ascomycota; Child, Preschool; Drug Resistance, Fungal; Female; Humans; Imidazoles; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Triazoles; Yeasts; Young Adult

2017
Fluconazole versus mould-active triazoles for primary antifungal prophylaxis in adult patients with acute lymphoblastic leukemia: clinical outcome and cost-effectiveness analysis.
    International journal of hematology, 2018, Volume: 107, Issue:2

    Topics: Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Cost-Benefit Analysis; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Treatment Outcome; Triazoles; Young Adult

2018
Salvage therapy with topical posaconazole in lung transplant recipients with invasive Scedosporium infection.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2018, Volume: 18, Issue:2

    Topics: Administration, Topical; Adult; Antifungal Agents; Cystic Fibrosis; Emphysema; Female; Humans; Immunocompromised Host; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Prognosis; Salvage Therapy; Scedosporium; Transplant Recipients; Triazoles

2018
Necrotizing Microascus tracheobronchitis in a bilateral lung transplant recipient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2018, Volume: 20, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Bronchi; Bronchitis; Endoscopy; Female; Humans; Immunocompromised Host; Lung Transplantation; Middle Aged; Mycoses; Necrosis; Transplant Recipients; Treatment Outcome; Triazoles

2018
Novel approaches to antifungal therapy.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2018, Volume: 18, Issue:2

    Topics: Humans; Mycoses; Salvage Therapy; Scedosporium; Transplant Recipients; Triazoles

2018
Toxicity of Vincristine Combined With Posaconazole in Children With Acute Lymphoblastic Leukemia.
    Journal of pediatric hematology/oncology, 2018, Volume: 40, Issue:5

    Topics: Abdominal Pain; Adolescent; Constipation; Female; Humans; Hypertension; Muscle Weakness; Mycoses; Neuralgia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Triazoles; Vincristine

2018
Posaconazole oral dose and plasma levels in pediatric hematology-oncology patients.
    European journal of haematology, 2018, Volume: 100, Issue:3

    Topics: Administration, Oral; Adolescent; Anemia, Aplastic; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Drug Administration Schedule; Drug Dosage Calculations; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Deficiency Syndromes; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Mycoses; Remission Induction; Retrospective Studies; Survival Analysis; Transplantation, Homologous; Triazoles

2018
Direct in vitro comparison of the prodrug isavuconazonium sulfate with the isavuconazole active compound against Aspergillus spp. and 2 rare moulds.
    Diagnostic microbiology and infectious disease, 2018, Volume: 92, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Mycoses; Nitriles; Prodrugs; Pyridines; Scedosporium; Triazoles

2018
Evaluation of isavuconazole MIC strips for susceptibility testing of Aspergillus and Scedosporium species.
    Medical mycology, 2019, Jun-01, Volume: 57, Issue:4

    Topics: Antifungal Agents; Aspergillus; Humans; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Scedosporium; Triazoles

2019
Treatment of Suspected Invasive Fungal Infection in War Wounds.
    Military medicine, 2018, 09-01, Volume: 183, Issue:suppl_2

    Topics: Administration, Topical; Afghan Campaign 2001-; Amphotericin B; Antifungal Agents; beta-Cyclodextrins; Debridement; Excipients; Humans; Mycoses; Recurrence; Risk Factors; Tobramycin; Treatment Outcome; Triazoles; Vancomycin; Voriconazole; Wounds and Injuries

2018
Tolerability of isavuconazole after posaconazole toxicity in leukaemia patients.
    Mycoses, 2019, Volume: 62, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Leukemia; Liver Function Tests; Male; Middle Aged; Mycoses; Nitriles; Pyridines; Retrospective Studies; Triazoles; Young Adult

2019
Posaconazole Administration in Hospitalized Children in the United States.
    Journal of the Pediatric Infectious Diseases Society, 2019, Nov-06, Volume: 8, Issue:5

    Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Drug Prescriptions; Female; Hospitalization; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Male; Mycoses; Retrospective Studies; Triazoles; United States

2019
Managing liver dysfunction in haematology patients: Switch antifungals, or use the tincture of time?
    Mycoses, 2019, Volume: 62, Issue:3

    Topics: Adult; Aged; Antifungal Agents; Chemoprevention; Drug Substitution; Female; Humans; Leukemia, Myeloid, Acute; Liver Diseases; Liver Function Tests; Male; Middle Aged; Mycoses; Retrospective Studies; Time Factors; Triazoles; Young Adult

2019
Yeast-like filamentous fungi: Molecular identification and in vitro susceptibility study.
    Medical mycology, 2019, Oct-01, Volume: 57, Issue:7

    Topics: Antifungal Agents; DNA, Fungal; Fluconazole; Fungi; Humans; Italy; Microbial Sensitivity Tests; Mycoses; Triazoles; Voriconazole

2019
A case of Verruconis gallopava infection in a heart transplant recipient successfully treated with posaconazole.
    Transplant infectious disease : an official journal of the Transplantation Society, 2019, Volume: 21, Issue:2

    Topics: Antifungal Agents; Ascomycota; Heart Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses; Thorax; Tomography, X-Ray Computed; Treatment Outcome; Triazoles

2019
Posaconazole trough concentrations are not influenced by inflammation: A prospective study.
    International journal of antimicrobial agents, 2019, Volume: 53, Issue:3

    Topics: Adult; Aged; Antifungal Agents; C-Reactive Protein; Female; Humans; Inflammation; Longitudinal Studies; Male; Middle Aged; Mycoses; Plasma; Prospective Studies; Triazoles; Young Adult

2019
Real-world use-Isavuconazole at a large academic medical center.
    Mycoses, 2019, Volume: 62, Issue:6

    Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemoprevention; Drug Substitution; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Mycoses; Nitriles; Pyridines; Retrospective Studies; Survival Analysis; Treatment Outcome; Triazoles; United States

2019
Posaconazole salvage therapy: The Posifi study.
    Mycoses, 2019, Volume: 62, Issue:6

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Blood Chemical Analysis; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Salvage Therapy; Spain; Tertiary Care Centers; Treatment Outcome; Triazoles; Withholding Treatment

2019
Why do lung transplant patients discontinue triazole prophylaxis?
    Transplant infectious disease : an official journal of the Transplantation Society, 2019, Volume: 21, Issue:3

    Topics: Adult; Aged; Antifungal Agents; Drug Interactions; Female; Humans; Invasive Fungal Infections; Itraconazole; Lung Transplantation; Male; Medication Adherence; Middle Aged; Mycoses; Retrospective Studies; Triazoles; Voriconazole

2019
Screening the in vitro susceptibility of posaconazole in clinical isolates of Candida spp. and Aspergillus spp. and analyzing the sequence of ERG11 or CYP51A in non-wild-type isolates from China.
    Diagnostic microbiology and infectious disease, 2019, Volume: 95, Issue:2

    Topics: Antifungal Agents; Aspergillus; Candida; China; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Fungal Proteins; Humans; Microbial Sensitivity Tests; Mutation; Mycoses; Triazoles

2019
Voriconazole is cytotoxic at locally delivered concentrations: a pilot study.
    Clinical orthopaedics and related research, 2013, Volume: 471, Issue:10

    Topics: Animals; Antifungal Agents; Cell Line; Cell Proliferation; Cell Survival; Fibroblasts; Mice; Mycoses; Osteoblasts; Pilot Projects; Pyrimidines; Triazoles; Voriconazole

2013
Posaconazole vs fluconazole/itraconazole in the prophylaxis of invasive fungal infections in immunocompromised patients: a cost-effectiveness analysis in Greece.
    Journal of medical economics, 2013, Volume: 16, Issue:5

    Topics: Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Greece; Health Expenditures; Humans; Immunocompromised Host; Itraconazole; Models, Economic; Mycoses; Neutropenia; Triazoles

2013
The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole.
    American journal of hematology, 2013, Volume: 88, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus; Female; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Pyrimidines; Recurrence; Remission Induction; Retrospective Studies; Rhizopus; Triazoles; Voriconazole

2013
Pharmacoeconomic evaluation of fluconazole, posaconazole and voriconazole for antifungal prophylaxis in patients with acute myeloid leukaemia undergoing first consolidation chemotherapy.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:7

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Consolidation Chemotherapy; Economics, Pharmaceutical; Female; Fluconazole; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2013
Molecular characterization and in vitro antifungal susceptibility profile of Schizophyllum commune, an emerging basidiomycete in bronchopulmonary mycoses.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Pyrimidines; Schizophyllum; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole

2013
Oral infections caused by yeasts in patients with head and neck cancer undergoing radiotherapy. Identification of the yeasts and evaluation of their antifungal susceptibility.
    Journal de mycologie medicale, 2012, Volume: 22, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Fungal; Head and Neck Neoplasms; Humans; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Nystatin; Opportunistic Infections; Saccharomyces cerevisiae; Species Specificity; Terbinafine; Triazoles

2012
Preemptive treatment with voriconazole in lung transplant recipients.
    Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:4

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillus fumigatus; Cohort Studies; Female; Humans; Incidence; Lung Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2013
Outcome of allogeneic SCT in patients with pre-transplant invasive fungal infection.
    Bone marrow transplantation, 2013, Volume: 48, Issue:9

    Topics: Antibiotic Prophylaxis; Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Mycoses; Triazoles

2013
Disseminated Ochroconis gallopava infection in a heart transplant patient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:3

    Topics: Antifungal Agents; Ascomycota; Brain; Fatal Outcome; Heart Transplantation; Humans; Lung; Male; Middle Aged; Mycoses; Peritoneum; Pyrimidines; Triazoles; Voriconazole

2013
Compassionate use of voriconazole in newborn infants diagnosed with severe invasive fungal sepsis.
    European review for medical and pharmacological sciences, 2013, Volume: 17, Issue:6

    Topics: Antifungal Agents; Compassionate Use Trials; Female; Humans; Infant; Infant, Newborn; Male; Mycoses; Pyrimidines; Sepsis; Triazoles; Voriconazole

2013
[Isolation of Scedosporium apiospermum (teleomorph: Pseudallescheria apiosperma) from an acute myeloid leukemia patient].
    Mikrobiyoloji bulteni, 2013, Volume: 47, Issue:2

    Topics: Antifungal Agents; Bronchoalveolar Lavage Fluid; Caspofungin; Echinocandins; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Lung; Male; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2013
No effect of antifungal compounds on functional properties of human antifungal T-helper type 1 cells.
    Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:4

    Topics: Antifungal Agents; Cells, Cultured; Hematopoietic Stem Cell Transplantation; Humans; Interferon-gamma; Lymphocyte Activation; Mycoses; Th1 Cells; Triazoles; Tumor Necrosis Factor-alpha

2013
What types of Candida infections should be included when evaluating breakthrough infections during posaconazole prophylaxis?
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:6

    Topics: Antifungal Agents; Drug Monitoring; Female; Fungi; Humans; Male; Mycoses; Triazoles

2013
Reply to "What types of Candida infections should be included when evaluating breakthrough infections during posaconazole prophylaxis?".
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:6

    Topics: Antifungal Agents; Drug Monitoring; Female; Fungi; Humans; Male; Mycoses; Triazoles

2013
Posaconazole prophylaxis--impact on incidence of invasive fungal disease and antifungal treatment in haematological patients.
    Mycoses, 2013, Volume: 56, Issue:6

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Incidence; Male; Middle Aged; Mycoses; Retrospective Studies; Triazoles; Young Adult

2013
Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic
    Journal of clinical microbiology, 2013, Volume: 51, Issue:8

    Topics: Antifungal Agents; Echinocandins; Fungi; Global Health; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles; Yeasts

2013
Association between drug tolerability and medical resource use in prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplant.
    Journal of medical economics, 2013, Volume: 16, Issue:8

    Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Child; Female; Health Services; Hematopoietic Stem Cell Transplantation; Hospitalization; Humans; Itraconazole; Male; Middle Aged; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2013
Association of sustained high plasma trough concentration of voriconazole with the incidence of hepatotoxicity.
    Clinica chimica acta; international journal of clinical chemistry, 2013, Sep-23, Volume: 424

    Topics: Adolescent; Aged; Aged, 80 and over; Antifungal Agents; Child; Drug Dosage Calculations; Drug Monitoring; Female; Humans; Liver; Liver Function Tests; Logistic Models; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2013
Treatment cost development of patients undergoing remission induction chemotherapy: a pharmacoeconomic analysis before and after introduction of posaconazole prophylaxis.
    Mycoses, 2014, Volume: 57, Issue:2

    Topics: Adolescent; Adult; Antifungal Agents; Chemoprevention; Cost-Benefit Analysis; Economics, Pharmaceutical; Female; Health Care Costs; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Remission Induction; Retrospective Studies; Triazoles; Young Adult

2014
Isavuconazole activity against Aspergillus lentulus, Neosartorya udagawae, and Cryptococcus gattii, emerging fungal pathogens with reduced azole susceptibility.
    Journal of clinical microbiology, 2013, Volume: 51, Issue:9

    Topics: Antifungal Agents; Aspergillus; Azoles; Communicable Diseases, Emerging; Cryptococcus gattii; Humans; Microbial Sensitivity Tests; Mycoses; Neosartorya; Nitriles; North America; Pyridines; Triazoles

2013
Relationship between trough plasma and epithelial lining fluid concentrations of voriconazole in lung transplant recipients.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:9

    Topics: Adult; Antifungal Agents; Bronchoalveolar Lavage Fluid; Female; Humans; Lung; Lung Transplantation; Male; Middle Aged; Mycoses; Pilot Projects; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2013
In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:12

    Topics: Antifungal Agents; Drug Synergism; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Phosphorylcholine; Pyrimidines; Triazoles; Voriconazole

2013
Posaconazole concentrations after allogeneic hematopoietic stem cell transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:5

    Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Triazoles; Young Adult

2013
Dried blood spot analysis suitable for therapeutic drug monitoring of voriconazole, fluconazole, and posaconazole.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:10

    Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Dried Blood Spot Testing; Drug Monitoring; Fluconazole; Humans; Middle Aged; Mucormycosis; Mycoses; Triazoles; Young Adult

2013
Pharmacokinetics of posaconazole within epithelial cells and fungi: insights into potential mechanisms of action during treatment and prophylaxis.
    The Journal of infectious diseases, 2013, Nov-15, Volume: 208, Issue:10

    Topics: Antibiotic Prophylaxis; Antifungal Agents; Aspergillus fumigatus; Biological Transport; Cell Line; Cell Membrane; Epithelial Cells; Fungi; Humans; Mycoses; Protein Binding; Spores, Fungal; Triazoles

2013
Posaconazole treatment in Korea: single-center experience over 5 years.
    Yonsei medical journal, 2013, Volume: 54, Issue:5

    Topics: Adult; Aged; Antifungal Agents; Female; Humans; Immunocompromised Host; Male; Middle Aged; Mucormycosis; Mycoses; Republic of Korea; Salvage Therapy; Triazoles

2013
Subacute exogenous Rhizoctonia solani endophthalmitis following cataract extraction with intraocular lens implantation.
    Journal of cataract and refractive surgery, 2013, Volume: 39, Issue:10

    Topics: Acute Disease; Antifungal Agents; Cataract Extraction; Combined Modality Therapy; Device Removal; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Lens Implantation, Intraocular; Male; Middle Aged; Mycoses; Postoperative Complications; Pyrimidines; Rhizoctonia; Triazoles; Vitrectomy; Voriconazole

2013
Acremonium sclerotigenum-Acremonium egyptiacum: a multi-resistant fungal pathogen complicating the course of aplastic anaemia.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2014, Volume: 20, Issue:1

    Topics: Acremonium; Adult; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Male; Mycoses; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2014
Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
    Annals of hematology, 2014, Volume: 93, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candidiasis, Invasive; Catheter-Related Infections; Chemotherapy-Induced Febrile Neutropenia; Clinical Trials as Topic; Combined Modality Therapy; Drug Monitoring; Drug Therapy, Combination; Echinocandins; Fungemia; Humans; Immunocompromised Host; Immunotherapy; Invasive Pulmonary Aspergillosis; Mycoses; Neoplasms; Salvage Therapy; Triazoles

2014
Treatment of a brain abscess caused by Scedosporium apiospermum and Phaeoacremonium parasiticum in a renal transplant recipient.
    The Southeast Asian journal of tropical medicine and public health, 2013, Volume: 44, Issue:3

    Topics: Antifungal Agents; Brain Abscess; Cerebral Phaeohyphomycosis; Coinfection; Humans; Immunocompromised Host; Kidney Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2013
Antifungal prophylaxis with posaconazole in patients with acute myeloid leukemia: dose intensification coupled with avoidance of proton pump inhibitors is beneficial in shortening time to effective concentrations.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12

    Topics: Adult; Aged; Antifungal Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Proton Pump Inhibitors; Retrospective Studies; Triazoles

2013
Prevention of invasive fungal infections in patients with acute myeloid leukaemia: results of a single centre retrospective observational study with the use of posaconazole versus conventional mould-active azoles.
    Journal of chemotherapy (Florence, Italy), 2014, Volume: 26, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Cohort Studies; Female; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Retrospective Studies; Triazoles; Young Adult

2014
Evaluation of the efficacies of Amphotericin B, Posaconazole, Voriconazole, and Anidulafungin in a murine disseminated infection by the emerging opportunistic Fungus Sarocladium (Acremonium) kiliense.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12

    Topics: Acremonium; Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Echinocandins; Male; Mice; Mycoses; Pyrimidines; Triazoles; Voriconazole

2013
Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients.
    Bone marrow transplantation, 2014, Volume: 49, Issue:1

    Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fusariosis; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lipopeptides; Logistic Models; Male; Mycoses; Neutrophils; Prospective Studies; Pyrimidines; Retrospective Studies; Risk; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2014
Fungal peritonitis associated with Curvularia geniculata and Pithomyces species in a patient with vulvar cancer who was successfully treated with oral voriconazole.
    The Journal of antibiotics, 2014, Volume: 67, Issue:2

    Topics: Antifungal Agents; Antineoplastic Agents; Ascomycota; Diabetic Nephropathies; Female; Humans; Immunocompromised Host; Medroxyprogesterone; Middle Aged; Mycoses; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole; Vulvar Neoplasms

2014
Azole-based chemoprophylaxis of invasive fungal infections in paediatric patients with acute leukaemia: an internal audit.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:3

    Topics: Adolescent; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Cohort Studies; Female; Humans; Infant; Leukemia; Male; Mycoses; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2014
Access to a new class of biologically active quinoline based 1,2,4-triazoles.
    European journal of medicinal chemistry, 2014, Volume: 71

    Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Quinolines; Structure-Activity Relationship; Triazoles

2014
Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pyrimidines; Remission Induction; Retrospective Studies; Secondary Prevention; Tertiary Care Centers; Triazoles; Voriconazole

2014
Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey.
    BMC infectious diseases, 2013, Nov-26, Volume: 13

    Topics: Amphotericin B; Antifungal Agents; Cost-Benefit Analysis; Economics, Pharmaceutical; Humans; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Turkey; Voriconazole

2013
Synthesis and biological evaluation of α-triazolyl chalcones as a new type of potential antimicrobial agents and their interaction with calf thymus DNA and human serum albumin.
    European journal of medicinal chemistry, 2014, Volume: 71

    Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Cattle; Chalcones; DNA; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Serum Albumin; Triazoles

2014
Is there still a place for itraconazole prophylaxis in high-risk hematology patients?
    Annals of hematology, 2014, Volume: 93, Issue:9

    Topics: Antifungal Agents; Hematologic Neoplasms; Humans; Mycoses; Triazoles

2014
Factors affecting voriconazole plasma concentrations in patients with invasive fungal infections.
    International journal of clinical pharmacology and therapeutics, 2014, Volume: 52, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Female; Humans; Male; Middle Aged; Mycoses; Polymorphism, Genetic; Pyrimidines; Triazoles; Voriconazole

2014
Utilization and comparative effectiveness of caspofungin and voriconazole early after market approval in the U.S.
    PloS one, 2014, Volume: 9, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Caspofungin; Child; Drug Approval; Echinocandins; Female; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Off-Label Use; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; United States; Voriconazole; Young Adult

2014
Understanding antifungal prophylaxis with posaconazole in hematology patients: an evolving bedside to bench story.
    Haematologica, 2014, Volume: 99, Issue:4

    Topics: Antifungal Agents; Chemoprevention; Hematologic Diseases; Humans; Mycoses; Triazoles

2014
Microwave assistant synthesis, antifungal activity and DFT theoretical study of some novel 1,2,4-triazole derivatives containing pyridine moiety.
    International journal of molecular sciences, 2014, May-08, Volume: 15, Issue:5

    Topics: Antifungal Agents; Chemistry Techniques, Synthetic; Fungi; Humans; Microwaves; Models, Molecular; Mycoses; Pyridines; Triazoles

2014
Economic evaluation of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infection in high-risk neutropenic patients in Sweden.
    Clinical drug investigation, 2014, Volume: 34, Issue:7

    Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Life Expectancy; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Quality of Life; Quality-Adjusted Life Years; Sweden; Triazoles

2014
Tumorlike cardiac fungal mycetoma caused by Scedosporium apiospermum presenting as symptomatic ventricular tachycardia.
    Circulation, 2014, May-13, Volume: 129, Issue:19

    Topics: Adult; Antifungal Agents; Heart; Hemodynamics; Humans; Male; Mycetoma; Mycoses; Pyrimidines; Scedosporium; Tachycardia, Ventricular; Treatment Outcome; Triazoles; Voriconazole

2014
Alopecia and nail changes associated with voriconazole therapy.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Aug-01, Volume: 59, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Antifungal Agents; Cross-Sectional Studies; Disease Outbreaks; Female; Humans; Male; Methylprednisolone; Michigan; Middle Aged; Mycoses; Nails; Prevalence; Triazoles; Voriconazole

2014
Successful treatment of Paecilomyces lilacinus keratitis with oral posaconazole.
    Cornea, 2014, Volume: 33, Issue:7

    Topics: Administration, Oral; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Male; Middle Aged; Mycoses; Paecilomyces; Triazoles

2014
Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2014, Volume: 20, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemoprevention; Drug Resistance, Fungal; Female; France; Humans; Immunocompromised Host; Incidence; Male; Middle Aged; Mycoses; Retrospective Studies; Triazoles; Young Adult

2014
Posaconazole concentrations in human tissues after allogeneic stem cell transplantation.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:8

    Topics: Antifungal Agents; Autopsy; Brain Chemistry; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Kidney; Liver; Lung; Mycoses; Myocardium; Transplantation, Homologous; Triazoles

2014
Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2015, Volume: 21, Issue:6

    Topics: Adult; Aged; Algorithms; Antifungal Agents; Azoles; Drug Dosage Calculations; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycoses; Retrospective Studies; Sirolimus; Tacrolimus; Triazoles; Voriconazole; Young Adult

2015
Experimental treatment of Curvularia infection.
    Diagnostic microbiology and infectious disease, 2014, Volume: 79, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Disease Models, Animal; Immunocompromised Host; Male; Mice; Mycoses; Treatment Outcome; Triazoles; Voriconazole

2014
Malassezia pachydermatis fungaemia in an adult on posaconazole prophylaxis for acute myeloid leukaemia.
    Pathology, 2014, Volume: 46, Issue:5

    Topics: Aged; Antifungal Agents; Fungemia; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Malassezia; Male; Mycoses; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Superinfection; Triazoles

2014
Assessing micafungin/triazole combinations for the treatment of invasive scedosporiosis due to Scedosporium apiospermum and Scedosporium boydii.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:11

    Topics: Animals; Antifungal Agents; Drug Therapy, Combination; Echinocandins; Lipopeptides; Male; Micafungin; Mice; Microbial Sensitivity Tests; Mycoses; Random Allocation; Scedosporium; Triazoles

2014
Posaconazole prophylaxis in neutropenic patients with hematological malignancies: limits in clinical practice.
    Medical mycology, 2014, Volume: 52, Issue:7

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Child; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Neoplasms; Humans; Incidence; Male; Middle Aged; Mycoses; Plasma; Prospective Studies; Treatment Outcome; Triazoles; Withholding Treatment; Young Adult

2014
Review: voriconazole for prevention or treatment of invasive fungal infections in cancer with neutropenia.
    Annals of internal medicine, 2014, Jul-15, Volume: 161, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Humans; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Triazoles

2014
Efficacy of anti-fungal but not anti-bacterial prophylaxis in intensive primary AML therapy: a real-world, retrospective comparative single-centre study.
    Swiss medical weekly, 2014, Volume: 144

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Bacteremia; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Mycoses; Retrospective Studies; Survival Rate; Triazoles

2014
Impact of structured personal on-site patient education on low posaconazole plasma concentrations in patients with haematological malignancies.
    International journal of antimicrobial agents, 2014, Volume: 44, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Austria; Chemoprevention; Cohort Studies; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Male; Medication Adherence; Middle Aged; Mycoses; Patient Education as Topic; Plasma; Triazoles; Young Adult

2014
Posaconazole salvage treatment for invasive fungal infection.
    Mycopathologia, 2014, Volume: 178, Issue:3-4

    Topics: Adult; Aged; Antifungal Agents; Byssochlamys; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Mucor; Mycoses; Retrospective Studies; Salvage Therapy; Survival Analysis; Time Factors; Treatment Outcome; Triazoles; Withholding Treatment

2014
Activity of echinocandins and triazoles against a contemporary (2012) worldwide collection of yeast and moulds collected from invasive infections.
    International journal of antimicrobial agents, 2014, Volume: 44, Issue:4

    Topics: Antifungal Agents; Echinocandins; Fungi; Global Health; Hospitals; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles

2014
Synthesis of antifungal evaluation of 2H-[1,2,3]Triazolo[4,5-g]isoquinoline-4,9-diones.
    Chemical & pharmaceutical bulletin, 2014, Volume: 62, Issue:11

    Topics: Antifungal Agents; Drug Design; Fungi; Humans; Isoquinolines; Microbial Sensitivity Tests; Mycoses; Structure-Activity Relationship; Triazoles

2014
Switching from posaconazole suspension to tablets increases serum drug levels in leukemia patients without clinically relevant hepatotoxicity.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11

    Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Female; Food-Drug Interactions; Gastrointestinal Absorption; Humans; Leukemia; Liver; Male; Middle Aged; Mycoses; Suspensions; Tablets; Triazoles

2014
Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Child; Child, Preschool; Drug Resistance, Fungal; Female; Fluconazole; Fungemia; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Romania; Saccharomyces cerevisiae; Triazoles; Voriconazole; Yeasts; Young Adult

2015
Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2015, Volume: 36, Issue:2

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Child, Preschool; China; Female; Fungi; Hematologic Neoplasms; Humans; Infant; Infant, Newborn; Male; Middle Aged; Mycoses; Risk Factors; Triazoles

2015
Keratitis by Fusarium temperatum, a novel opportunist.
    BMC infectious diseases, 2014, Nov-12, Volume: 14

    Topics: Amphotericin B; Antifungal Agents; Base Sequence; DNA, Fungal; Echinocandins; Fungal Proteins; Fusarium; Humans; Keratitis; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Multilocus Sequence Typing; Mycoses; Phylogeny; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Tubulin; Zea mays

2014
Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in Taiwan.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2016, Volume: 49, Issue:4

    Topics: Adolescent; Adult; Antibiotic Prophylaxis; Antifungal Agents; Child; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Opportunistic Infections; Retrospective Studies; Taiwan; Treatment Outcome; Triazoles; Young Adult

2016
An update to the cost-effectiveness of posaconazole vs fluconazole or itraconazole in the prevention of invasive fungal disease among neutropenic patients in the United States.
    Journal of medical economics, 2015, Volume: 18, Issue:5

    Topics: Antifungal Agents; Cost-Benefit Analysis; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid; Mycoses; Triazoles; United States

2015
Synthesis, spectroscopic, thermal and antimicrobial studies of neodymium(III) and samarium(III) complexes derived from tetradentate ligands containing N and S donor atoms.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2015, Apr-05, Volume: 140

    Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bacterial Infections; Coordination Complexes; Fungi; Humans; Ligands; Microbial Sensitivity Tests; Mycoses; Neodymium; Samarium; Schiff Bases; Spectrum Analysis; Temperature; Triazoles

2015
Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:6

    Topics: Adolescent; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Cohort Studies; Drug-Related Side Effects and Adverse Reactions; Female; Fluconazole; Humans; Incidence; Infant; Itraconazole; Male; Mycoses; Neoplasms; Neutropenia; Retrospective Studies; Treatment Outcome; Triazoles

2015
Efficacy of antifungal prophylaxis with oral suspension posaconazole during induction chemotherapy of acute myeloid leukemia.
    Journal of cancer research and clinical oncology, 2015, Volume: 141, Issue:9

    Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Cohort Studies; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Randomized Controlled Trials as Topic; Retrospective Studies; Suspensions; Triazoles; Young Adult

2015
Isavuconazonium sulfate approved for invasive fungal infections.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2015, Apr-15, Volume: 72, Issue:8

    Topics: Administration, Oral; Antifungal Agents; Drug Approval; Humans; Infusions, Intravenous; Mycoses; Nitriles; Prodrugs; Pyridines; Triazoles

2015
Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015, Volume: 21, Issue:6

    Topics: Adolescent; Adult; Antifungal Agents; China; Chronic Disease; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Mycoses; Myeloablative Agonists; Neutropenia; Prognosis; Prospective Studies; Risk Factors; Siblings; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Triazoles; Unrelated Donors

2015
Posaconazole liquid suspension in solid organ transplant recipients previously treated with voriconazole.
    Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:3

    Topics: Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Mucormycosis; Mycoses; Transplant Recipients; Transplants; Triazoles; Voriconazole

2015
Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes.
    European journal of haematology, 2016, Volume: 96, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Fluconazole; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Pre-Exposure Prophylaxis; Remission Induction; Retrospective Studies; Survival Analysis; Triazoles

2016
Suspected posaconazole toxicity in a pediatric oncology patient.
    Pediatric blood & cancer, 2015, Volume: 62, Issue:9

    Topics: Adolescent; Anorexia; Antifungal Agents; Combined Modality Therapy; Delayed-Action Preparations; Drug Therapy, Combination; Fatigue; Female; Humans; Hypokalemia; Maxillary Sinus Neoplasms; Medication Errors; Musculoskeletal Pain; Mycoses; Osteosarcoma; Postoperative Complications; Sinusitis; Triazoles

2015
Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and prop
    Diagnostic microbiology and infectious disease, 2015, Volume: 82, Issue:4

    Topics: Antifungal Agents; Drug Resistance, Fungal; Echinocandins; Fungi; Global Health; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Nitriles; Opportunistic Infections; Pyridines; Triazoles

2015
Superior Serum Concentrations with Posaconazole Delayed-Release Tablets Compared to Suspension Formulation in Hematological Malignancies.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Suspensions; Tablets; Triazoles; Young Adult

2015
Isavuconazole: a new extended spectrum triazole for invasive mold diseases.
    Future microbiology, 2015, Volume: 10, Issue:5

    Topics: Antifungal Agents; Double-Blind Method; Fungi; Humans; Mycoses; Nitriles; Pyridines; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles

2015
In Vitro Triple Combination of Antifungal Drugs against Clinical Scopulariopsis and Microascus Species.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:8

    Topics: Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Scopulariopsis; Terbinafine; Triazoles

2015
Serum posaconazole levels among haematological cancer patients taking extended release tablets is affected by body weight and diarrhoea: single centre retrospective analysis.
    Mycoses, 2015, Volume: 58, Issue:7

    Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Biological Availability; Body Mass Index; Body Weight; Delayed-Action Preparations; Diarrhea; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Tablets; Triazoles; Young Adult

2015
Paradoxical response preceding control of Scedosporium apiospermum mycetoma with posaconazole treatment.
    Infectious diseases (London, England), 2015, Volume: 47, Issue:11

    Topics: Adult; Antifungal Agents; Contraindications; Humans; Immunocompromised Host; Male; Mycetoma; Mycoses; Scedosporium; Triazoles

2015
Antifungal Prophylaxis With Posaconazole Is Effective in Preventing Invasive Fungal Infections in Acute Myeloid Leukemia Patients During Induction and Salvage Chemotherapy.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Oct-15, Volume: 61, Issue:8

    Topics: Antifungal Agents; Female; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Mycoses; Triazoles

2015
Reply to Wong et al.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Oct-15, Volume: 61, Issue:8

    Topics: Antifungal Agents; Female; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Mycoses; Triazoles

2015
Cost-benefit Analysis of Posaconazole Versus Fluconazole or Itraconazole as a Primary Antifungal Prophylaxis in High-risk Hematologic Patients: A Propensity Score-matched Analysis.
    Clinical therapeutics, 2015, Volume: 37, Issue:9

    Topics: Adult; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Cost Savings; Cost-Benefit Analysis; Drug Costs; Female; Fluconazole; Hospital Costs; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Primary Prevention; Propensity Score; Remission Induction; Republic of Korea; Retrospective Studies; Triazoles

2015
Posaconazole for primary antifungal prophylaxis in patients with acute myeloid leukaemia or myelodysplastic syndrome during remission induction chemotherapy: a single-centre retrospective study in Korea and clinical considerations.
    Mycoses, 2015, Volume: 58, Issue:9

    Topics: Adult; Antifungal Agents; Female; Fluconazole; Humans; Incidence; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Remission Induction; Republic of Korea; Retrospective Studies; Time Factors; Triazoles

2015
Treatment trial of clinically ill corroboree frogs with chytridiomycosis with two triazole antifungals and electrolyte therapy.
    Veterinary research communications, 2015, Volume: 39, Issue:3

    Topics: Animals; Antifungal Agents; Anura; Chytridiomycota; Electrolytes; Mycoses; Random Allocation; Survival Analysis; Treatment Outcome; Triazoles

2015
Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis.
    Bone marrow transplantation, 2015, Volume: 50, Issue:11

    Topics: Administration, Oral; Adult; Aged; Allografts; Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Cause of Death; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Incidence; Lipopeptides; Male; Medication Adherence; Middle Aged; Mycoses; Neutropenia; Patient Compliance; Premedication; Retrospective Studies; Risk Assessment; Risk Factors; Survival Analysis; Transplantation Conditioning; Treatment Failure; Triazoles; Young Adult

2015
Posaconazole vs fluconazole or itraconazole for prevention of invasive fungal diseases in patients with acute myeloid leukemia or myelodysplastic syndrome: a cost-effectiveness analysis in an Asian teaching hospital.
    Journal of medical economics, 2016, Volume: 19, Issue:1

    Topics: Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Hong Kong; Hospitals, Teaching; Humans; Itraconazole; Leukemia, Myeloid, Acute; Models, Econometric; Mycoses; Myelodysplastic Syndromes; Socioeconomic Factors; Triazoles

2016
In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole

2015
Efficacy of Posaconazole in a Murine Model of Systemic Infection by Saprochaete capitata.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12

    Topics: Animals; Antifungal Agents; Basidiomycota; beta-Glucans; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Immunocompromised Host; Kidney; Male; Mice, Inbred Strains; Microbial Sensitivity Tests; Mycoses; Neutropenia; Proteoglycans; Triazoles

2015
Synthesis and Antimicrobial Evaluation of Thieno[2,3-d]-pyrimidine, Thieno[2',3':4,5]pyrimido[1,2-a][1,3,5]triazine, Thieno[2,3-d]-1,3-thiazine and 1,2,4-Triazole Systems.
    Chemical & pharmaceutical bulletin, 2015, Volume: 63, Issue:10

    Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Fungi; Humans; Isothiocyanates; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Thiazines; Triazines; Triazoles

2015
Posaconazole plasma concentration in pediatric patients receiving antifungal prophylaxis after allogeneic hematopoietic stem cell transplantation.
    Medical mycology, 2016, Volume: 54, Issue:2

    Topics: Adolescent; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Diet; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Plasma; Transplantation, Homologous; Triazoles

2016
Pharmacokinetics of Posaconazole Oral Suspension in Children Dosed According to Body Surface Area.
    The Pediatric infectious disease journal, 2016, Volume: 35, Issue:2

    Topics: Administration, Oral; Adolescent; Antifungal Agents; Body Surface Area; Child; Child, Preschool; Chromatography, High Pressure Liquid; Female; Hematologic Neoplasms; Humans; Male; Mycoses; Plasma; Prospective Studies; Suspensions; Triazoles

2016
Subtherapeutic Posaconazole Exposure and Treatment Outcome in Patients With Invasive Fungal Disease.
    Therapeutic drug monitoring, 2015, Volume: 37, Issue:6

    Topics: Adult; Antifungal Agents; Drug Administration Schedule; Drug Monitoring; Female; Humans; Linear Models; Male; Middle Aged; Multivariate Analysis; Mycoses; Retrospective Studies; Risk Factors; Treatment Outcome; Triazoles

2015
Isavuconazole: a role for the newest broad-spectrum triazole.
    Lancet (London, England), 2016, Feb-20, Volume: 387, Issue:10020

    Topics: Antifungal Agents; Female; Humans; Male; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole

2016
Posaconazole in lung transplant recipients: use, tolerability, and efficacy.
    Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:2

    Topics: Administration, Oral; Adult; Antifungal Agents; Drug Interactions; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Mycoses; Tacrolimus; Triazoles; Young Adult

2016
Virulence and Resistance to Antifungal Therapies of Scopulariopsis Species.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Cyclophosphamide; Disease Models, Animal; Drug Resistance, Fungal; Humans; Immunocompromised Host; Male; Mice; Mycoses; Neutropenia; Scopulariopsis; Species Specificity; Survival Analysis; Triazoles; Virulence; Voriconazole

2016
Posaconazole oral suspension primary prophylaxis in acute leukemia and allogeneic stem cell transplant patients: can it be used without measurement of plasma concentration?
    Medical mycology, 2016, Jul-01, Volume: 54, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Child; Child, Preschool; Female; Humans; Immunocompromised Host; Leukemia; Male; Middle Aged; Mycoses; Plasma; Prospective Studies; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Young Adult

2016
Azide-enolate 1,3-dipolar cycloaddition in the synthesis of novel triazole-based miconazole analogues as promising antifungal agents.
    European journal of medicinal chemistry, 2016, Apr-13, Volume: 112

    Topics: Antifungal Agents; Aspergillus fumigatus; Azides; Candida; Cycloaddition Reaction; Fungi; Humans; Miconazole; Microbial Sensitivity Tests; Mycoses; Rhizopus; Triazoles

2016
Posaconazole/hydroxypropyl-β-cyclodextrin host-guest system: Improving dissolution while maintaining antifungal activity.
    Carbohydrate polymers, 2016, May-20, Volume: 142

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Antifungal Agents; beta-Cyclodextrins; Drug Carriers; Fungi; Humans; Models, Molecular; Mycoses; Solubility; Triazoles; Water

2016
[NEW ANTIFUNGAL DRUGS FOR PREVENTION AND TREATMENT OF VISCERAL MYCOSES].
    La Revue du praticien, 2015, Volume: 65, Issue:10

    Topics: Antifungal Agents; Caspofungin; Drug Therapy; Echinocandins; Humans; Lipopeptides; Micafungin; Mycoses; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole

2015
1-R-2-([1,2,4]Triazolo[1,5-c]quinazoline-2-ylthio)etanon(ol)s: Synthesis, Bioluminescence Inhibition, Molecular Docking Studies, Antibacterial and Antifungal Activities.
    Current computer-aided drug design, 2016, Volume: 12, Issue:1

    Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bacterial Infections; Fungi; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycoses; Quinazolines; Tetrahydrofolate Dehydrogenase; Triazoles

2016
Posaconazole plasma exposure correlated to intestinal mucositis in allogeneic stem cell transplant patients.
    European journal of clinical pharmacology, 2016, Volume: 72, Issue:8

    Topics: Administration, Oral; Adult; Antifungal Agents; Citrulline; Female; Hematopoietic Stem Cell Transplantation; Humans; Intestinal Mucosa; Male; Middle Aged; Mucositis; Mycoses; Suspensions; Tablets; Triazoles

2016
Triazole antifungals used for prophylaxis and treatment of invasive fungal disease in adult haematology patients: Trough serum concentrations in relation to outcome.
    Medical mycology, 2016, Oct-01, Volume: 54, Issue:7

    Topics: Adult; Aged; Chemoprevention; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Serum; Treatment Outcome; Triazoles; Young Adult

2016
Effectiveness of increasing the frequency of posaconazole syrup administration to achieve optimal plasma concentrations in patients with haematological malignancy.
    International journal of antimicrobial agents, 2016, Volume: 48, Issue:1

    Topics: Administration, Oral; Adult; Antifungal Agents; Chemoprevention; Chromatography, Liquid; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Plasma; Prospective Studies; Tandem Mass Spectrometry; Triazoles

2016
Fungal infection of cystic fibrosis patients - single center experience.
    Pneumonologia i alergologia polska, 2016, Volume: 84, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Candida albicans; Candida tropicalis; Cystic Fibrosis; Drug Resistance, Multiple, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Scedosporium; Triazoles; Voriconazole; Yeasts

2016
Posaconazole Plasma Concentrations on Days Three to Five Predict Steady-State Levels.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:9

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Area Under Curve; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; ROC Curve; Triazoles

2016
Safety, clinical effectiveness and trough plasma concentrations of intravenous posaconazole in patients with haematological malignancies and/or undergoing allogeneic haematopoietic stem cell transplantation: off-trial experience.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:12

    Topics: Administration, Intravenous; Adult; Antifungal Agents; Australia; Chemoprevention; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Plasma; Retrospective Studies; Transplantation, Homologous; Treatment Outcome; Triazoles

2016
Posaconazole Therapeutic Drug Monitoring in a Regional Hospital Setting.
    Therapeutic drug monitoring, 2016, Volume: 38, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Australia; Drug Monitoring; Female; Hospitals; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Serum; Triazoles; Young Adult

2016
Posaconazole plasma concentrations in pediatric patients receiving antifungal prophylaxis during neutropenia.
    Medical mycology, 2017, Jun-01, Volume: 55, Issue:4

    Topics: Adolescent; Age Factors; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant; Infant, Newborn; Male; Mycoses; Neutropenia; Plasma; Retrospective Studies; Sex Factors; Triazoles

2017
Serum galactomannan surveillance may be safely withdrawn from antifungal management of hematology patients on effective antimold prophylaxis: a pilot single-center study.
    Bone marrow transplantation, 2017, Volume: 52, Issue:2

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Female; Fungi; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Mannans; Middle Aged; Mycoses; Prospective Studies; Triazoles

2017
Acute reversible pancreatitis induced by posaconazole.
    The Journal of antimicrobial chemotherapy, 2017, Volume: 72, Issue:2

    Topics: Acute Disease; Antifungal Agents; Female; Humans; Leukemia, Myeloid, Acute; Lipase; Mycoses; Pancreatitis; Triazoles

2017
Therapeutic drug monitoring of posaconazole oral suspension in paediatric patients younger than 13 years of age: a retrospective analysis and literature review.
    Journal of clinical pharmacy and therapeutics, 2017, Volume: 42, Issue:1

    Topics: Administration, Oral; Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Humans; Male; Mycoses; Retrospective Studies; Suspensions; Triazoles

2017
Hypokalemia and Hypertension Associated with Supratherapeutic Posaconazole Levels.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:4

    Topics: Adult; Antifungal Agents; Histoplasmosis; Humans; Hypertension; Hypokalemia; Lymphoma, Large B-Cell, Diffuse; Male; Mycoses; Triazoles

2017
Diaporthe soft tissue infection in a heart transplant patient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2017, Volume: 19, Issue:3

    Topics: Aged; Antifungal Agents; Ascomycota; DNA, Fungal; Glycopeptides; Heart Transplantation; Humans; Immunosuppression Therapy; Male; Mycoses; Myocardial Ischemia; Polymerase Chain Reaction; Soft Tissue Infections; Thigh; Tomography, X-Ray Computed; Triazoles

2017
Pharmacokinetic-pharmacodynamic analysis of voriconazole in Japanese patients with hematological malignancies.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2008, Volume: 27, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Asian People; Female; Hematologic Neoplasms; Humans; Male; Metabolic Clearance Rate; Middle Aged; Monte Carlo Method; Mycoses; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole

2008
[Use of topical voriconazole in Alternaria keratitis].
    Archivos de la Sociedad Espanola de Oftalmologia, 2008, Volume: 83, Issue:8

    Topics: Administration, Oral; Adult; Alternaria; Antifungal Agents; Eye Infections, Fungal; Eye Injuries; Humans; Keratitis; Keratoplasty, Penetrating; Male; Mycoses; Ophthalmic Solutions; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2008
Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Europe; Fungi; Guidelines as Topic; Humans; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Triazoles; Yeasts

2008
Breakpoints for posaconazole susceptibility testing: background and discussion about the need of establishing values.
    Mycoses, 2008, Volume: 51 Suppl 2

    Topics: Antifungal Agents; Drug Resistance, Fungal; Endpoint Determination; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles

2008
Posaconazole in intensive care patients I: invasive fungal infections in surgical intensive care and case presentation.
    Mycoses, 2008, Volume: 51 Suppl 2

    Topics: Aged; Antifungal Agents; Aspergillosis; Candidiasis; Critical Care; Cross Infection; Humans; Middle Aged; Mycoses; Postoperative Complications; Triazoles

2008
Five-year retrospective review of guideline-based management of fungal endophthalmitis.
    Acta ophthalmologica, 2008, Volume: 86, Issue:5

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Costs; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Flucytosine; Guideline Adherence; Health Care Costs; Humans; Male; Medical Audit; Middle Aged; Mycoses; Practice Guidelines as Topic; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole

2008
Economic evaluation of posaconazole vs. standard azole prophylaxis in high risk neutropenic patients in the Netherlands.
    European journal of haematology, 2008, Volume: 81, Issue:6

    Topics: Adult; Aged; Antifungal Agents; Costs and Cost Analysis; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Econometric; Mycoses; Myelodysplastic Syndromes; Netherlands; Neutropenia; Randomized Controlled Trials as Topic; Triazoles

2008
Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    International journal of antimicrobial agents, 2008, Volume: 32, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Clinical Trials, Phase III as Topic; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts

2008
Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant.
    Transplantation, 2008, Sep-27, Volume: 86, Issue:6

    Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Female; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Mycoses; Organ Transplantation; Postoperative Complications; Retrospective Studies; Safety; Treatment Outcome; Triazoles

2008
Alternaria infectoria brain abscess in a child with chronic granulomatous disease.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2009, Volume: 28, Issue:4

    Topics: Alternaria; Antifungal Agents; Brain; Brain Abscess; Caspofungin; Child, Preschool; Echinocandins; Fatal Outcome; Granulomatous Disease, Chronic; Humans; Lipopeptides; Male; Mycoses; Pyrimidines; Radiography; RNA, Fungal; RNA, Ribosomal, 5.8S; Seizures; Triazoles; Voriconazole

2009
Comparison of disk diffusion test and Etest for voriconazole and fluconazole susceptibility testing.
    Folia microbiologica, 2008, Volume: 53, Issue:2

    Topics: Antifungal Agents; Culture Media; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2008
Quantitative PCR assay used to monitor serum Trichosporon asahii DNA concentrations in disseminated trichosporonosis.
    The Pediatric infectious disease journal, 2008, Volume: 27, Issue:11

    Topics: Adolescent; Antifungal Agents; Antigens, Fungal; Bone Marrow Transplantation; DNA, Fungal; Graft vs Host Disease; Humans; Immunocompromised Host; Latex Fixation Tests; Male; Microbial Sensitivity Tests; Mycoses; Polymerase Chain Reaction; Polysaccharides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2008
Studies with new fungistatic agents for the treatment of superficial mycoses.
    The Journal of investigative dermatology, 1948, Volume: 10, Issue:2

    Topics: Dermatomycoses; Mycoses; Triazoles

1948
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
    Journal of clinical microbiology, 2009, Volume: 47, Issue:1

    Topics: Africa; Antifungal Agents; Asia, Southeastern; Drug Resistance, Fungal; Europe; Fluconazole; Humans; Latin America; Microbial Sensitivity Tests; Middle East; Mycoses; North America; Pyrimidines; Triazoles; Voriconazole; Yeasts

2009
Disseminated fusariosis caused by Fusarium verticillioides in an acute lymphoblastic leukemia patient after allogeneic hematopoietic stem cell transplantation.
    Journal of clinical microbiology, 2009, Volume: 47, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Child; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole

2009
Paecilomyces lilacinus peritonitis complicating peritoneal dialysis cured by oral voriconazole and terbinafine combination therapy.
    Journal of medical microbiology, 2008, Volume: 57, Issue:Pt 12

    Topics: Administration, Oral; Adolescent; Antifungal Agents; Drug Therapy, Combination; Humans; Male; Mycoses; Naphthalenes; Paecilomyces; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Pyrimidines; Terbinafine; Treatment Outcome; Triazoles; Voriconazole

2008
Comparative cost-effectiveness of posaconazole versus fluconazole or itraconazole prophylaxis in patients with prolonged neutropenia.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, Dec-01, Volume: 65, Issue:23

    Topics: Antifungal Agents; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Monte Carlo Method; Multicenter Studies as Topic; Mycoses; Neutropenia; Triazoles

2008
Posaconazole efficacy in a murine disseminated infection caused by Paecilomyces lilacinus.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Kidney; Liver; Male; Mice; Mycoses; Paecilomyces; Spleen; Triazoles

2009
Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.
    Revista iberoamericana de micologia, 2008, Dec-31, Volume: 25, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Brazil; Cross Infection; Dermatomycoses; Drug Resistance, Fungal; Echinocandins; Female; Flucytosine; Fungemia; Hospitals, University; Humans; Mycological Typing Techniques; Mycoses; Onychomycosis; Opportunistic Infections; Organ Specificity; Triazoles; Trichosporon; Urine; Vaginitis

2008
Combined antifungal therapy in a murine model of disseminated infection by Cladophialophora bantiana.
    Medical mycology, 2009, Volume: 47, Issue:1

    Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Flucytosine; Humans; Lipopeptides; Male; Micafungin; Mice; Mycoses; Treatment Outcome; Triazoles

2009
In vitro activities of isavuconazole against opportunistic filamentous and dimorphic fungi.
    Medical mycology, 2009, Volume: 47, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Nitriles; Opportunistic Infections; Pyridines; Triazoles

2009
Antifungal susceptibility testing of Exophiala spp.: a head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole.
    Medical mycology, 2009, Volume: 47, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Exophiala; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2009
Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Feb-01, Volume: 48, Issue:3

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Candida; Deoxycholic Acid; Drug Combinations; Female; Fungi; Hematopoietic Stem Cell Transplantation; Humans; Logistic Models; Male; Middle Aged; Mucorales; Mycoses; North America; Prevalence; Prospective Studies; Pyrimidines; Risk Factors; Treatment Outcome; Triazoles; Voriconazole

2009
Early detection of breakthrough trichosporonosis by serum PCR in a cord blood transplant recipient being prophylactically treated with voriconazole.
    Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:12

    Topics: Adolescent; Antifungal Agents; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; DNA, Fungal; Fungemia; Humans; Male; Mycoses; Myelodysplastic Syndromes; Polymerase Chain Reaction; Prognosis; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2008
The use of voriconazole in the treatment of cylindrocarpon keratomycosis.
    Cornea, 2009, Volume: 28, Issue:2

    Topics: Antifungal Agents; Ascomycota; Cornea; Corneal Ulcer; Drug Resistance, Fungal; Female; Humans; Keratitis; Microscopy, Confocal; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole

2009
Interactions between triazoles and amphotericin B in treatment of disseminated murine infection by Fusarium oxysporum.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy, Combination; Fusarium; Male; Mice; Mycoses; Pyrimidines; Triazoles; Voriconazole

2009
Scedosporium apiospermum skeletal infection in an immunocompetent child.
    Medical mycology, 2009, Volume: 47, Issue:4

    Topics: Antifungal Agents; Child; Female; Humans; Knee; Mycoses; Osteomyelitis; Pyrimidines; Radiography; Scedosporium; Triazoles; Voriconazole

2009
Voriconazole-induced phototoxicity masquerading as chronic graft-versus-host disease of the skin in allogeneic hematopoietic cell transplant recipients.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2009, Volume: 15, Issue:3

    Topics: Adolescent; Adult; Antifungal Agents; Child; Dermatitis, Phototoxic; Diagnosis, Differential; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2009
Successful treatment of disseminated fusariosis in a child with acute myelogenous leukaemia with medical and surgical approach.
    Mycoses, 2010, Mar-01, Volume: 53, Issue:2

    Topics: Antifungal Agents; Child; Debridement; Dermatomycoses; Fusarium; Humans; Leukemia, Myeloid; Leukocyte Transfusion; Lung Diseases, Fungal; Male; Mycoses; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole

2010
Treatment of invasive fungal infections: stability of voriconazole infusion solutions in PVC bags.
    The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2008, Volume: 12, Issue:5

    Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Drug Packaging; Drug Stability; Drug Storage; Hydrogen-Ion Concentration; Infusions, Parenteral; Mycoses; Polyenes; Polyvinyl Chloride; Pyrimidines; Time Factors; Triazoles; Voriconazole

2008
Serial plasma voriconazole concentrations after allogeneic hematopoietic stem cell transplantation.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Adult; Antifungal Agents; Chemoprevention; Dose-Response Relationship, Drug; Drug Monitoring; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole

2009
Posaconazole therapeutic drug monitoring: a reference laboratory experience.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Antifungal Agents; Chemoprevention; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Laboratories; Mycoses; Reference Standards; Texas; Triazoles

2009
Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
    Transplant infectious disease : an official journal of the Transplantation Society, 2009, Volume: 11, Issue:3

    Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Cystic Fibrosis; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Female; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Mycoses; Pyrimidines; Scedosporium; Tacrolimus; Triazoles; Voriconazole; Young Adult

2009
Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, May-01, Volume: 48, Issue:9

    Topics: Antifungal Agents; Child; Drug Therapy, Combination; Female; Fractures, Bone; Humans; Mycoses; Naphthalenes; Osteomyelitis; Phosphorylcholine; Pyrimidines; Scedosporium; Terbinafine; Treatment Outcome; Triazoles; Voriconazole; Wounds and Injuries

2009
Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders.
    International journal of hematology, 2009, Volume: 89, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Dose-Response Relationship, Drug; Drug Monitoring; Hematologic Neoplasms; Humans; Liver Diseases; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole; Young Adult

2009
Posaconazole-increased vincristine neurotoxicity in a child: a case report.
    Journal of pediatric hematology/oncology, 2009, Volume: 31, Issue:4

    Topics: Antifungal Agents; Antineoplastic Agents, Phytogenic; Child; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Humans; Mycoses; Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Triazoles; Vincristine

2009
Safe management of tacrolimus together with posaconazole in lung transplant patients with cystic fibrosis.
    Therapeutic drug monitoring, 2009, Volume: 31, Issue:3

    Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Cystic Fibrosis; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Female; Graft Rejection; Humans; Immunosuppressive Agents; Itraconazole; Lung Transplantation; Male; Microbial Sensitivity Tests; Mycoses; Prescriptions; Pyrimidines; Tacrolimus; Triazoles; Voriconazole

2009
Evaluating the resistance to posaconazole by E-test and CLSI broth microdilution methodologies of Candida spp. and pathogenic moulds.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2009, Volume: 28, Issue:9

    Topics: Antifungal Agents; Candida; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles

2009
Peritonitis due to Neosartorya pseudofischeri in an elderly patient undergoing peritoneal dialysis successfully treated with voriconazole.
    Journal of medical microbiology, 2009, Volume: 58, Issue:Pt 5

    Topics: Antifungal Agents; Female; Humans; Kidney Failure, Chronic; Middle Aged; Mycoses; Neosartorya; Peritoneal Dialysis; Peritonitis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2009
In vitro activity of isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces and Pichia species.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:1

    Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Triazoles

2009
Posaconazole: new indications. Prevention of invasive mycosis and treatment of oropharyngeal candidiasis: no therapeutic advantage.
    Prescrire international, 2008, Volume: 17, Issue:98

    Topics: Antifungal Agents; Candidiasis, Oral; Drug Approval; Europe; Humans; Mycoses; Randomized Controlled Trials as Topic; Triazoles

2008
Compassionate use study of caspofungin in children with proven or suspected invasive mycosis or persistent febrile neutropenia.
    Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:2

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Infant; Infant, Newborn; Lipopeptides; Male; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Salvage Therapy; Triazoles; Voriconazole

2009
Antifungal activity of itraconazole and voriconazole against clinical isolates obtained from animals with mycoses.
    Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology, 2009, Volume: 50, Issue:2

    Topics: Animals; Antifungal Agents; Cat Diseases; Cats; Dog Diseases; Dogs; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole

2009
Systemic phaeohyphomycosis resembling primary sclerosing cholangitis caused by Exophiala dermatitidis.
    Journal of medical microbiology, 2009, Volume: 58, Issue:Pt 9

    Topics: Amphotericin B; Antifungal Agents; Cholangitis, Sclerosing; Diagnosis, Differential; Exophiala; Female; Humans; Lymph Nodes; Mycoses; Pyrimidines; Triazoles; Voriconazole; Young Adult

2009
Genotyping and antifungal drug susceptibility of the pathogenic yeast Trichosporon asahii isolated from Thai patients.
    Mycopathologia, 2010, Volume: 169, Issue:1

    Topics: Antifungal Agents; DNA, Fungal; DNA, Ribosomal Spacer; Drug Resistance, Multiple, Fungal; Genetic Variation; Genome, Fungal; Geography; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Sequence Analysis, DNA; Thailand; Triazoles; Trichosporon; Voriconazole

2010
What should be the first-choice strategy to maximize posaconazole exposure in daily clinical practice?
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8

    Topics: Administration, Oral; Antifungal Agents; Area Under Curve; Drug Administration Schedule; Food-Drug Interactions; Gastric Mucosa; Humans; Mycoses; Triazoles

2009
Fusarium endophthalmitis following refractive lens exchange for correction of high myopia.
    Journal of cataract and refractive surgery, 2009, Volume: 35, Issue:8

    Topics: Anterior Chamber; Antifungal Agents; Endophthalmitis; Eye Infections, Fungal; Female; Fusarium; Humans; Lens Implantation, Intraocular; Middle Aged; Mycoses; Myopia, Degenerative; Pyrimidines; Reoperation; Triazoles; Visual Acuity; Voriconazole

2009
Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: hepatotoxicity and effectiveness.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2009, Volume: 9, Issue:9

    Topics: Aged; Antifungal Agents; Cohort Studies; Female; Humans; Itraconazole; Lung Diseases, Fungal; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2009
Practice patterns in the management of fungal corneal ulcers.
    Cornea, 2009, Volume: 28, Issue:8

    Topics: Administration, Topical; Amphotericin B; Antifungal Agents; Corneal Ulcer; Debridement; Drug Costs; Drug Therapy, Combination; Humans; Mycoses; Natamycin; Ophthalmology; Patients; Practice Patterns, Physicians'; Pyrimidines; Surveys and Questionnaires; Treatment Outcome; Triazoles; Voriconazole

2009
Trichosporon mycotoxinivorans, a novel respiratory pathogen in patients with cystic fibrosis.
    Journal of clinical microbiology, 2009, Volume: 47, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Cystic Fibrosis; Echinocandins; Fatal Outcome; Humans; Lung; Lung Diseases, Fungal; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Mycoses; Radiography, Thoracic; Retrospective Studies; Triazoles; Trichosporon

2009
Intraocular penetration of voriconazole and caspofungin in a patient with fungal endophthalmitis.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:4

    Topics: Antifungal Agents; Caspofungin; Echinocandins; Endophthalmitis; Fusarium; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole

2009
Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD.
    Bone marrow transplantation, 2010, Volume: 45, Issue:4

    Topics: Adult; Antifungal Agents; Chemoprevention; Female; Fluconazole; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2010
Keratitis resulting from Thielavia subthermophila Mouchacca.
    Cornea, 2009, Volume: 28, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Child; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Mycoses; Pyrimidines; Retrospective Studies; Sordariales; Triazoles; Voriconazole

2009
Therapeutic drug monitoring of posaconazole: a monocentric study with 54 adults.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Adult; Antifungal Agents; Diarrhea; Drug Monitoring; Female; Humans; Male; Middle Aged; Mucositis; Mycoses; Retrospective Studies; Triazoles

2009
Susceptibility of Mexican isolates of yeasts and moulds to amphotericin B and triazole antifungals.
    Journal of infection in developing countries, 2009, Jun-01, Volume: 3, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Cities; Drug Resistance, Fungal; Fungi; Humans; Mexico; Microbial Sensitivity Tests; Mycoses; Triazoles; Urban Population

2009
Hyalohyphomycosis caused by Paecilomyces lilacinus after kidney transplantation.
    Transplantation proceedings, 2009, Volume: 41, Issue:7

    Topics: Antifungal Agents; Diabetes Mellitus; Female; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Interferons; Kidney Transplantation; Middle Aged; Mycoses; Paecilomyces; Polycystic Kidney Diseases; Postoperative Complications; Pyrimidines; Renal Replacement Therapy; Ribavirin; Treatment Outcome; Triazoles; Voriconazole

2009
Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2010, Volume: 12, Issue:1

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Chemoprevention; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Mycoses; Pyrimidines; Time Factors; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult

2010
Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens.
    Journal of clinical microbiology, 2009, Volume: 47, Issue:12

    Topics: Antifungal Agents; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Fungi; Histone Deacetylase Inhibitors; Humans; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Triazoles

2009
Economic evaluation of posaconazole vs fluconazole in the prevention of invasive fungal infections in patients with GVHD following haematopoietic SCT.
    Bone marrow transplantation, 2010, Volume: 45, Issue:5

    Topics: Antifungal Agents; Cost-Benefit Analysis; Fluconazole; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Multivariate Analysis; Mycoses; Sensitivity and Specificity; Treatment Outcome; Triazoles

2010
Voriconazole concentrations and outcome of invasive fungal infections.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2010, Volume: 16, Issue:7

    Topics: Adult; Aged; Antifungal Agents; Australia; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Monitoring; Female; Humans; Immunosuppression Therapy; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2010
Factors influencing pharmacokinetics of prophylactic posaconazole in patients undergoing allogeneic stem cell transplantation.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Adolescent; Adult; Aged; Algorithms; Antifungal Agents; Chromatography, High Pressure Liquid; Cohort Studies; Drug Interactions; Drug Monitoring; Female; Humans; Male; Middle Aged; Models, Statistical; Mycoses; Population; Stem Cell Transplantation; Triazoles; Young Adult

2010
[Prophylaxis use of posaconazole (P) in an hemato-oncology unit: a retrospective study].
    Pathologie-biologie, 2010, Volume: 58, Issue:2

    Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Therapy, Combination; Esomeprazole; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Oncology Service, Hospital; Postoperative Complications; Premedication; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous; Treatment Failure; Triazoles

2010
Voriconazole serum concentrations in prophylactically treated acute myelogenous leukaemia patients.
    Mycoses, 2011, Volume: 54, Issue:3

    Topics: Adolescent; Aged; Antifungal Agents; Chemoprevention; Drug Monitoring; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Mycoses; Pyrimidines; Serum; Triazoles; Voriconazole

2011
A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections.
    Mycoses, 2011, Volume: 54, Issue:3

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Female; Fungi; Hematologic Neoplasms; Humans; Infant; Lipopeptides; Male; Mycoses; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole

2011
Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:1

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Blood Chemical Analysis; Cyclosporine; Female; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Mycoses; Pyrimidines; Transplantation; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult

2010
How many steps along the path is too far?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Jan-01, Volume: 50, Issue:1

    Topics: Antifungal Agents; Child; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2010
Voriconazole pharmacokinetics and pharmacodynamics in children.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Jan-01, Volume: 50, Issue:1

    Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Computer Simulation; Female; Humans; Infant; Linear Models; Male; Models, Biological; Mycoses; Proportional Hazards Models; Pyrimidines; Retrospective Studies; Statistics, Nonparametric; Triazoles; Voriconazole; Young Adult

2010
An outbreak of early-onset endophthalmitis caused by Fusarium species following cataract surgery.
    Current eye research, 2009, Volume: 34, Issue:11

    Topics: Aged; Amphotericin B; Antifungal Agents; Combined Modality Therapy; Disease Outbreaks; Drug Therapy, Combination; Endophthalmitis; Eye Evisceration; Eye Infections, Fungal; Female; Fusarium; Humans; Lens Implantation, Intraocular; Male; Middle Aged; Mycoses; Phacoemulsification; Postoperative Complications; Pyrimidines; Retrospective Studies; Triazoles; Turkey; Visual Acuity; Vitrectomy; Voriconazole

2009
Alternaria sinusitis in children with acute myeloid leukemia: case reports from the Childhood Acute Myeloid Leukemia Infection Research Group.
    Leukemia & lymphoma, 2010, Volume: 51, Issue:2

    Topics: Adolescent; Alternaria; Amphotericin B; Antifungal Agents; Child, Preschool; Female; Humans; Leukemia, Myeloid, Acute; Male; Mycoses; Pyrimidines; Sinusitis; Triazoles; Voriconazole

2010
Evaluation of antifungal therapy in a neutropenic murine model of Neoscytalidium dimidiatum infection.
    International journal of antimicrobial agents, 2010, Volume: 35, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Colony Count, Microbial; Disease Models, Animal; Kidney; Male; Mice; Mycoses; Neutropenia; Pyrimidines; Sepsis; Spleen; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole

2010
Murine model of a disseminated infection by the novel fungus Fonsecaea monophora and successful treatment with posaconazole.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:2

    Topics: Animals; Antifungal Agents; Ascomycota; Brain; Disease Models, Animal; Kidney; Liver; Lung; Male; Mice; Mycoses; Triazoles

2010
Beauveria keratitis and biopesticides: case histories and a random amplification of polymorphic DNA comparison.
    Cornea, 2010, Volume: 29, Issue:2

    Topics: Adult; Antifungal Agents; Beauveria; Contact Lenses, Hydrophilic; Corneal Ulcer; DNA, Fungal; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Middle Aged; Mycoses; Pest Control; Pyrimidines; Random Amplified Polymorphic DNA Technique; Triazoles; Voriconazole

2010
Efficacy of posaconazole as treatment and prophylaxis against Fusarium solani.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3

    Topics: Animals; Antifungal Agents; Chemoprevention; Disease Models, Animal; Drug Resistance, Fungal; Fusarium; Humans; Kidney; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mycoses; Neutropenia; Treatment Outcome; Triazoles

2010
Impact of mold infections in explanted lungs on outcomes of lung transplantation.
    Transplantation, 2010, Jan-27, Volume: 89, Issue:2

    Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antifungal Agents; Female; Heart-Lung Transplantation; Humans; Incidence; Lung; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Pyrimidines; Retrospective Studies; Survival Rate; Survivors; Triazoles; Voriconazole

2010
The successful medical treatment of a case of Paecilomyces lilacinus keratitis.
    Cornea, 2010, Volume: 29, Issue:3

    Topics: Administration, Topical; Aged; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Male; Mycoses; Paecilomyces; Pyrimidines; Triazoles; Voriconazole

2010
Efficacy of voriconazole in a murine model of invasive paecilomycosis.
    International journal of antimicrobial agents, 2010, Volume: 35, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Citrus paradisi; Colony Count, Microbial; Diet; Immunocompromised Host; Kidney; Liver; Male; Mice; Mycoses; Paecilomyces; Pyrimidines; Spleen; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole

2010
Drug costs and utilization after implementation of a posaconazole prophylaxis protocol in adults with acute myelogenous leukemia.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010, Feb-15, Volume: 67, Issue:4

    Topics: Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Drug Costs; Drug Utilization; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pharmacy Service, Hospital; Retrospective Studies; Triazoles

2010
Differences in voriconazole trough plasma concentrations per oral dosages between children younger and older than 3 years of age.
    Pediatric blood & cancer, 2010, Jul-01, Volume: 54, Issue:7

    Topics: Administration, Oral; Adolescent; Age Factors; Antifungal Agents; Child; Child, Preschool; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infant; Infant, Newborn; Male; Mycoses; Neoplasms; Pyrimidines; Triazoles; Voriconazole

2010
In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii.
    International journal of antimicrobial agents, 2010, Volume: 35, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Synergism; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2010
Determination of saliva trough levels for monitoring voriconazole therapy in immunocompromised children and adults.
    Therapeutic drug monitoring, 2010, Volume: 32, Issue:2

    Topics: Adult; Age Factors; Child; Child, Preschool; Drug Monitoring; Female; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses; Pyrimidines; Saliva; Triazoles; Voriconazole

2010
[Near-drowning and cerebral infections caused by fungi belonging to the Pseudallescheria / Scedosporium-complex].
    Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 2010, Volume: 45, Issue:3

    Topics: Adolescent; Adult; Antifungal Agents; Brain; Central Nervous System Infections; Child, Preschool; Female; Germany; Humans; Male; Middle Aged; Mycoses; Near Drowning; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Young Adult

2010
Pharmacoeconomic evaluation of voriconazole versus posaconazole for antifungal prophylaxis in acute myeloid leukaemia.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Australia; Chemoprevention; Cost-Benefit Analysis; Female; Hospitals; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2010
Fungistatic agents for treatment of dermatophytosis.
    The Journal of investigative dermatology, 1946, Volume: 7, Issue:5

    Topics: Antifungal Agents; Dermatomycoses; Humans; Mycoses; Tinea; Triazoles

1946
Cellulitis and nodular skin lesions due to Fusarium spp in liver transplant: case report.
    Transplantation proceedings, 2010, Volume: 42, Issue:2

    Topics: Amphotericin B; Biopsy; Cellulitis; Fusarium; Graft Rejection; Hepatitis C; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Skin; Treatment Outcome; Triazoles; Voriconazole

2010
Alternaria and paecilomyces keratitis associated with soft contact lens wear.
    Cornea, 2010, Volume: 29, Issue:5

    Topics: Adult; Alternaria; Antifungal Agents; Contact Lens Solutions; Contact Lenses, Hydrophilic; Corneal Ulcer; Eye Infections, Fungal; Female; Humans; Male; Middle Aged; Mycoses; Paecilomyces; Pyrimidines; Triazoles; Voriconazole; Young Adult

2010
Posaconazole prophylaxis during induction therapy of patients with acute lymphoblastic leukaemia.
    Mycoses, 2011, Volume: 54, Issue:4

    Topics: Adult; Alanine Transaminase; Antifungal Agents; Aspartate Aminotransferases; Aspergillus; Bilirubin; Candida; Chemical and Drug Induced Liver Injury; Chemoprevention; Female; Humans; Liver Function Tests; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Triazoles; Young Adult

2011
Voriconazole, a safe alternative for treating infections caused by the Chrysosporium anamorph of Nannizziopsis vriesii in bearded dragons (Pogona vitticeps).
    Medical mycology, 2010, Volume: 48, Issue:6

    Topics: Animals; Antifungal Agents; Chordata; Chrysosporium; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Reptiles; Triazoles; Voriconazole

2010
Sulphobutylether-beta-cyclodextrin accumulation in critically ill patients with acute kidney injury treated with intravenous voriconazole under extended daily dialysis.
    International journal of antimicrobial agents, 2010, Volume: 36, Issue:1

    Topics: Aged; Animals; Antifungal Agents; beta-Cyclodextrins; Critical Illness; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Renal Dialysis; Renal Insufficiency; Triazoles; Voriconazole

2010
Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:7

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Female; Germany; Humans; Incidence; Length of Stay; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Polyenes; Retrospective Studies; Treatment Outcome; Triazoles; Young Adult

2010
Cost-effectiveness of posaconazole compared with standard azole therapy for prevention of invasive fungal infections in patients at high risk in Switzerland.
    Oncology, 2010, Volume: 78, Issue:3-4

    Topics: Cost-Benefit Analysis; Decision Support Techniques; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Markov Chains; Models, Theoretical; Mycoses; Myelodysplastic Syndromes; Neutropenia; Risk; Switzerland; Treatment Outcome; Triazoles

2010
Isolation of Exophiala dermatitidis from pigmented sputum in a cystic fibrosis patient.
    Pediatric pulmonology, 2010, Volume: 45, Issue:5

    Topics: Adolescent; Adrenal Cortex Hormones; Antifungal Agents; Cystic Fibrosis; Exophiala; Female; Humans; Lung Diseases, Fungal; Mycoses; Pyrimidines; Recurrence; Sputum; Triazoles; Voriconazole

2010
Photosensitivity in immunocompromised patients receiving long-term therapy with oral voriconazole.
    The Pediatric infectious disease journal, 2010, Volume: 29, Issue:5

    Topics: Administration, Oral; Adolescent; Antifungal Agents; Child, Preschool; Female; Humans; Immunocompromised Host; Infant; Male; Mycoses; Photosensitivity Disorders; Pyrimidines; Triazoles; Voriconazole

2010
Voriconazole for both successful treatment of disseminated Trichosporon asahii infection and subsequent cord blood transplantation in an infant with acute myelogenous leukemia.
    Bone marrow transplantation, 2011, Volume: 46, Issue:2

    Topics: Antifungal Agents; Cord Blood Stem Cell Transplantation; Female; Humans; Infant; Leukemia, Myeloid, Acute; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2011
Fusarium sepsis, voriconazole, and the skin.
    Cutis, 2010, Volume: 85, Issue:4

    Topics: Antifungal Agents; Fusarium; Humans; Mycoses; Pyrimidines; Sepsis; Skin; Triazoles; Voriconazole

2010
Antifungal therapies in murine disseminated phaeohyphomycoses caused by Exophiala species.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:7

    Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Exophiala; Injections, Intraperitoneal; Itraconazole; Male; Mice; Mycoses; Treatment Outcome; Triazoles

2010
Posaconazole salvage treatment in paediatric patients: a multicentre survey.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:8

    Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Humans; Male; Mycoses; Salvage Therapy; Time Factors; Treatment Outcome; Triazoles

2010
Identification of Paecilomyces variotii in clinical samples and settings.
    Journal of clinical microbiology, 2010, Volume: 48, Issue:8

    Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Flucytosine; Fungal Proteins; Genes, rRNA; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Paecilomyces; Pyrimidines; RNA, Fungal; RNA, Ribosomal, 5.8S; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole

2010
Design, synthesis and antifungal activity of the novel water-soluble prodrug of antifungal triazole CS-758.
    Chemical & pharmaceutical bulletin, 2010, Volume: 58, Issue:6

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Humans; Mice; Microsomes, Liver; Mycoses; Prodrugs; Rats; Solubility; Triazoles

2010
Catastrophic squamous cell carcinoma in lung transplant patients treated with voriconazole.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2010, Volume: 36, Issue:11

    Topics: Antifungal Agents; Carcinoma, Squamous Cell; Fatal Outcome; Female; Heart Transplantation; Humans; Lung Transplantation; Middle Aged; Mycoses; Neoplasm Invasiveness; Neoplasm Metastasis; Pyrimidines; Skin Neoplasms; Triazoles; Voriconazole

2010
Therapeutic drug monitoring of posaconazole in hematology patients: experience with a new high-performance liquid chromatography-based method.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9

    Topics: Adult; Aged; Antifungal Agents; Chromatography, High Pressure Liquid; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Prospective Studies; Triazoles

2010
In vitro susceptibility of filamentous fungi to itraconazole, voriconazole and posaconazole by Clinical and Laboratory Standards Institute reference method and E-test.
    Mycoses, 2011, Volume: 54, Issue:5

    Topics: Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2011
Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2010, Volume: 29, Issue:11

    Topics: Adult; Aged; Antifungal Agents; Carcinoma, Squamous Cell; Case-Control Studies; Female; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Multivariate Analysis; Mycoses; Opportunistic Infections; Pyrimidines; Retrospective Studies; Risk Factors; Skin Neoplasms; Sunlight; Triazoles; Voriconazole

2010
[Rhodotorula glutinis sepsis. A case report].
    Le infezioni in medicina, 2010, Volume: 18, Issue:2

    Topics: Aged; Antifungal Agents; Catheter-Related Infections; Catheterization, Central Venous; Communicable Diseases, Emerging; Comorbidity; Diabetes Complications; Fungemia; Humans; Immunocompromised Host; Liver Cirrhosis; Male; Mycoses; Pyrimidines; Rhodotorula; Sepsis; Triazoles; Voriconazole

2010
Clinical characteristics and therapeutic analysis of invasive fungal infection in chronic severe hepatitis patients.
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2010, Volume: 35, Issue:6

    Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Hepatitis, Chronic; Humans; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2010
International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:10

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Child, Preschool; Female; Fusarium; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2010
Comparative evaluation of the Vitek 2 yeast susceptibility test and CLSI broth microdilution reference method for testing antifungal susceptibility of invasive fungal isolates in Italy: the GISIA3 study.
    Journal of clinical microbiology, 2010, Volume: 48, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Fluconazole; Geotrichum; Humans; Italy; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2010
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.
    Bone marrow transplantation, 2011, Volume: 46, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Lipopeptides; Micafungin; Mycoses; Neutropenia; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2011
In vitro activity of isavuconazole against 140 reference fungal strains and 165 clinically isolated yeasts from Japan.
    International journal of antimicrobial agents, 2010, Volume: 36, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Azoles; Fungi; Humans; Japan; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Reference Standards; Triazoles; Yeasts

2010
Synthesis and antifungal evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:10

    Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Fungi; Humans; Models, Molecular; Mycoses; Sterol 14-Demethylase; Triazoles

2010
Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole vs itraconazole in allogeneic blood and marrow transplantation.
    Bone marrow transplantation, 2011, Volume: 46, Issue:5

    Topics: Adult; Aged; Antifungal Agents; Bone Marrow Transplantation; Disease-Free Survival; Female; Humans; Itraconazole; Male; Middle Aged; Mycoses; Triazoles

2011
Synthesis of novel sulfanilamide-derived 1,2,3-triazoles and their evaluation for antibacterial and antifungal activities.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:10

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacteria; Bacterial Infections; Fungi; Humans; Magnetic Resonance Spectroscopy; Mycoses; Spectrophotometry, Infrared; Sulfanilamide; Sulfanilamides; Triazoles

2010
Developing a safe antifungal treatment protocol to eliminate Batrachochytrium dendrobatidis from amphibians.
    Medical mycology, 2011, Volume: 49, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Anura; Chytridiomycota; Clinical Protocols; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2011
Fungal spinal cord compression in metastatic synovial sarcoma.
    Acta oncologica (Stockholm, Sweden), 2011, Volume: 50, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Diagnosis, Differential; Disease Progression; Fatal Outcome; Female; Fractures, Spontaneous; Humans; Lung Neoplasms; Mycoses; Neoplasm Recurrence, Local; Neoplasm Staging; Osteomyelitis; Pneumonectomy; Pyrimidines; Radiotherapy, Adjuvant; Sarcoma, Synovial; Spinal Cord Compression; Spinal Cord Neoplasms; Triazoles; Voriconazole

2011
Fusarium keratitis 3 weeks after healed corneal cross-linking.
    Journal of refractive surgery (Thorofare, N.J. : 1995), 2010, Volume: 26, Issue:12

    Topics: Collagen; Corneal Stroma; Corneal Ulcer; Cross-Linking Reagents; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fusarium; Humans; Keratoconus; Mycoses; Photosensitizing Agents; Pyrimidines; Riboflavin; Surgical Wound Infection; Tobramycin; Triazoles; Ultraviolet Rays; Voriconazole; Wound Healing; Young Adult

2010
Oral voriconazole dose in children: one size does not fit all.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Oct-01, Volume: 51, Issue:7

    Topics: Administration, Oral; Adolescent; Antifungal Agents; Child; Child, Preschool; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2010
Trichosporon surgical wound infection in a renal allograft recipient successfully treated with voriconazole.
    Transplantation, 2010, Sep-15, Volume: 90, Issue:5

    Topics: Adult; Antifungal Agents; Biopsy; Humans; Immunosuppressive Agents; Kidney Transplantation; Kidney Tubules; Male; Mycoses; Necrosis; Pyrimidines; Treatment Outcome; Triazoles; Trichosporon; Voriconazole

2010
Antifungal activity of posaconazole against Candida spp. and non-Candida clinical yeasts isolates.
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2010, Volume: 23, Issue:3

    Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles; Yeasts

2010
Combined therapy against murine-disseminated infection by Fusarium verticillioides.
    Mycopathologia, 2011, Volume: 171, Issue:3

    Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy, Combination; Fusarium; Mice; Mycoses; Pyrimidines; Survival Rate; Triazoles; Voriconazole

2011
Fatal invasive trichosporonosis due to Trichosporon loubieri in a patient with T-lymphoblastic lymphoma.
    Medical mycology, 2011, Volume: 49, Issue:3

    Topics: Antifungal Agents; DNA, Fungal; DNA, Ribosomal Spacer; Fatal Outcome; Female; Fungemia; Humans; Immunocompromised Host; Molecular Sequence Data; Mycoses; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sequence Analysis, DNA; Triazoles; Trichosporon; Voriconazole; Young Adult

2011
Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2011, Volume: 19, Issue:11

    Topics: Antifungal Agents; Antineoplastic Agents; Canada; Cost Savings; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Models, Economic; Mycoses; Myelodysplastic Syndromes; Neoplasms; Randomized Controlled Trials as Topic; Triazoles

2011
Evaluation of hepatotoxicity with off-label oral-treatment doses of voriconazole for invasive fungal infections.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:1

    Topics: Aged; Antifungal Agents; Female; Humans; Liver; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2011
Severe Arthrographis kalrae keratomycosis in an immunocompetent patient.
    Cornea, 2011, Volume: 30, Issue:3

    Topics: Adult; Antifungal Agents; Candida albicans; Contact Lenses, Hydrophilic; Corneal Perforation; Corneal Ulcer; Eye Infections, Fungal; Female; Humans; Keratoplasty, Penetrating; Mitosporic Fungi; Mycoses; Pyrimidines; Reoperation; Triazoles; Voriconazole

2011
Studies of the fungistatic and irritative qualities of agents suggested for the treatment of dermatophytosis.
    Research report. Naval Medical Research Institute (U.S.), 1945, Issue:2

    Topics: Antifungal Agents; Dermatomycoses; Humans; Mycoses; Tinea; Triazoles

1945
In vivo confocal microscopy and anterior segment optical coherence tomography in a case of alternaria keratitis.
    Cornea, 2011, Volume: 30, Issue:4

    Topics: Administration, Topical; Aged; Alternaria; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Male; Microscopy, Confocal; Mycoses; Pyrimidines; Tomography, Optical Coherence; Triazoles; Voriconazole

2011
A case of bovine valve endocarditis caused by Engyodontium album.
    Medical mycology, 2011, Volume: 49, Issue:4

    Topics: Adult; Antifungal Agents; Arthritis, Juvenile; Ascomycota; Beauveria; DNA, Fungal; Endocarditis; Heart Valve Prosthesis; Humans; Male; Mitral Valve; Mycoses; Prosthesis-Related Infections; Pyrimidines; Reoperation; Sequence Analysis, DNA; Triazoles; Voriconazole

2011
Retrospective survey on the off-label use of posaconazole in pediatric hematology patients.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2011, Volume: 30, Issue:4

    Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Hematologic Diseases; Humans; Mycoses; Off-Label Use; Retrospective Studies; Treatment Outcome; Triazoles

2011
Posaconazole prophylaxis in patients with acute myelogenous leukaemia--results from an observational study.
    Mycoses, 2011, Volume: 54 Suppl 1

    Topics: Adult; Aged; Antifungal Agents; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Neutropenia; Retrospective Studies; Triazoles

2011
Clinical experience with posaconazole prophylaxis--a retrospective analysis in a haematological unit.
    Mycoses, 2011, Volume: 54 Suppl 1

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Graft vs Host Disease; Hematology; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Retrospective Studies; Stem Cell Transplantation; Triazoles; Young Adult

2011
Posaconazole: clinical pharmacokinetics and drug interactions.
    Mycoses, 2011, Volume: 54 Suppl 1

    Topics: Antifungal Agents; Biological Availability; Drug Interactions; Fungi; Humans; Mycoses; Tissue Distribution; Triazoles

2011
Posaconazole as part of the antifungal armamentarium in the intensive care unit--case reports from a surgical ICU.
    Mycoses, 2011, Volume: 54 Suppl 1

    Topics: Aged; Antifungal Agents; Female; Humans; Intensive Care Units; Male; Middle Aged; Mycoses; Postoperative Complications; Triazoles

2011
Impact of therapeutic drug monitoring of voriconazole in a pediatric population.
    The Pediatric infectious disease journal, 2011, Volume: 30, Issue:6

    Topics: Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Female; Humans; Infant; Male; Mycoses; Plasma; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2011
Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimi
    Diagnostic microbiology and infectious disease, 2011, Volume: 69, Issue:1

    Topics: Antifungal Agents; Aspergillus fumigatus; Candida; Cryptococcus neoformans; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles

2011
Managing invasive fungal disease in immunocompromised patients.
    Future microbiology, 2010, Volume: 5, Issue:12

    Topics: Antibiotic Prophylaxis; Antibodies, Monoclonal; Antifungal Agents; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunotherapy; Infectious Disease Medicine; Mycoses; Risk Factors; Salvage Therapy; Travel; Triazoles

2010
Resolution of recurrent fusarium arthritis after prolonged antifungal therapy.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2011, Volume: 17, Issue:1

    Topics: Ankle Joint; Antifungal Agents; Arthritis, Infectious; Drug Therapy, Combination; Fusarium; Humans; Immunocompromised Host; Mycoses; Pyrimidines; Recurrence; Toe Joint; Triazoles; Voriconazole

2011
Invasive fungal rhinitis caused by Paecilomyces lilacinus infection: Report of a case and a novel treatment.
    Ear, nose, & throat journal, 2010, Volume: 89, Issue:12

    Topics: Aged; Antifungal Agents; Combined Modality Therapy; Debridement; Female; Follow-Up Studies; Fungemia; Humans; Immunocompromised Host; Lung Transplantation; Mycoses; Paecilomyces; Pulmonary Fibrosis; Pyrimidines; Rhinitis; Severity of Illness Index; Treatment Outcome; Triazoles; Voriconazole

2010
Cost effectiveness of posaconazole in the prophylaxis of invasive fungal infections in acute leukaemia patients for the French healthcare system.
    Journal of medical economics, 2011, Volume: 14, Issue:1

    Topics: Acute Disease; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Cost-Benefit Analysis; Decision Trees; Female; France; Fungi; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; National Health Programs; Triazoles

2011
Case collection study of the safety of AmBisome in association with voriconazole in the treatment of patients with invasive fungal infection.
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2010, Volume: 23, Issue:4

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Combinations; Female; Humans; Kidney Function Tests; Liver Function Tests; Male; Middle Aged; Mycoses; Pyrimidines; Survival Analysis; Triazoles; Voriconazole; Young Adult

2010
Recurrent Lecythophora mutabilis keratitis and endophthalmitis after deep anterior lamellar keratoplasty.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2011, Volume: 129, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Combined Modality Therapy; Corneal Transplantation; Corneal Ulcer; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Microscopy, Acoustic; Middle Aged; Mycoses; Phialophora; Pyrimidines; Recurrence; Triazoles; Voriconazole

2011
Effects of voriconazole co-administration on oxycodone-induced adverse events: a case in the retrospective survey.
    European journal of clinical pharmacology, 2011, Volume: 67, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Antifungal Agents; Aspergillosis; Burkitt Lymphoma; Chronic Pain; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Mycoses; Oxycodone; Pyrimidines; Receptors, Opioid, mu; Retrospective Studies; Triazoles; Voriconazole

2011
A post-marketing evaluation of posaconazole plasma concentrations in neutropenic patients with haematological malignancy receiving posaconazole prophylaxis.
    International journal of antimicrobial agents, 2011, Volume: 37, Issue:3

    Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Drug Monitoring; Female; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Retrospective Studies; Triazoles

2011
Emergence of disseminated infections due to Geosmithia argillacea in patients with chronic granulomatous disease receiving long-term azole antifungal prophylaxis.
    Journal of clinical microbiology, 2011, Volume: 49, Issue:4

    Topics: Abscess; Adolescent; Adult; Antifungal Agents; Azoles; Caspofungin; Chemoprevention; DNA, Fungal; DNA, Ribosomal Spacer; Echinocandins; Eurotiales; Fatal Outcome; Female; Granulomatous Disease, Chronic; Histocytochemistry; Humans; Interferon-gamma; Lipopeptides; Male; Microscopy; Molecular Sequence Data; Mycoses; Naphthalenes; Sequence Analysis, DNA; Terbinafine; Triazoles

2011
Disseminated fusariosis occurring in two patients despite posaconazole prophylaxis.
    Journal of clinical microbiology, 2011, Volume: 49, Issue:4

    Topics: Adult; Chemoprevention; Female; Fusarium; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses; Triazoles

2011
Lack of evidence for exposure-response relationship in the use of posaconazole as prophylaxis against invasive fungal infections.
    Clinical pharmacology and therapeutics, 2011, Volume: 89, Issue:3

    Topics: Antifungal Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Mycoses; Treatment Outcome; Triazoles

2011
Voriconazole as secondary antifungal prophylaxis in stem cell transplant recipients.
    Haematologica, 2011, Volume: 96, Issue:2

    Topics: Antifungal Agents; Humans; Leukemia; Mycoses; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole

2011
Cerebral phaeohyphomycosis caused by Bipolaris spicifera after heart transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2011, Volume: 13, Issue:4

    Topics: Antifungal Agents; Ascomycota; Brain Abscess; Cerebral Phaeohyphomycosis; Heart Transplantation; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Middle Aged; Mycoses; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole

2011
A retrospective analysis of the effect of patient-specific factors on voriconazole concentrations in oncology patients.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2012, Volume: 18, Issue:1

    Topics: Adult; Age Factors; Aged; Alkaline Phosphatase; Antifungal Agents; Female; Humans; International Normalized Ratio; Linear Models; Male; Middle Aged; Multivariate Analysis; Mycoses; Neoplasms; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2012
Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Female; Hematology; Hospital Costs; Humans; Length of Stay; Lipopeptides; Male; Middle Aged; Models, Economic; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2011
Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus successfully treated by oral voriconazole and nystatin packing.
    Mycopathologia, 2011, Volume: 172, Issue:2

    Topics: Administration, Oral; Administration, Topical; Aged; Antifungal Agents; Dermatomycoses; Female; Humans; Liver Cirrhosis; Mycoses; Nystatin; Paecilomyces; Pyrimidines; Skin Ulcer; Treatment Outcome; Triazoles; Voriconazole

2011
The effects of intrastromal voriconazole injection and topical voriconazole in the treatment of recalcitrant Fusarium keratitis.
    Cornea, 2011, Volume: 30, Issue:8

    Topics: Administration, Topical; Adult; Antifungal Agents; Corneal Stroma; Corneal Ulcer; Eye Infections, Fungal; Fusarium; Humans; Injections, Intraocular; Male; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2011
Successful treatment of intra-abdominal Exophiala dermatitidis infection in a dog.
    The Veterinary record, 2011, Feb-26, Volume: 168, Issue:8

    Topics: Abdomen; Abdominal Abscess; Animals; Antifungal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Exophiala; Female; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Treatment Outcome; Triazoles; Voriconazole

2011
Diagnosis and treatment of fungal infection after liver transplantation.
    Chinese medical journal, 2011, Volume: 124, Issue:7

    Topics: Adult; Amphotericin B; Antifungal Agents; Female; Fluconazole; Humans; Liver Transplantation; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2011
Fatal invasive infection with fungemia due to Microascus cirrosus after heart and lung transplantation in a patient with cystic fibrosis.
    Journal of clinical microbiology, 2011, Volume: 49, Issue:7

    Topics: Adult; Antifungal Agents; Ascomycota; Caspofungin; Cystic Fibrosis; DNA, Fungal; Echinocandins; Fatal Outcome; Fungemia; Heart Transplantation; Histocytochemistry; Humans; Immunocompromised Host; Lipopeptides; Lung Transplantation; Male; Microscopy; Molecular Sequence Data; Mycoses; Pleura; Pyrimidines; Radiography, Thoracic; Sequence Analysis, DNA; Tomography, X-Ray Computed; Triazoles; Voriconazole

2011
Therapeutic drug monitoring of posaconazole in hematology adults under posaconazole prophylaxis: influence of food intake.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2012, Volume: 31, Issue:2

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Antineoplastic Agents; Chemoprevention; Drug Monitoring; Eating; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Triazoles; Young Adult

2012
Optimising absorption of posaconazole.
    Mycoses, 2011, Volume: 54, Issue:6

    Topics: Absorption; Administration, Oral; Adult; Aged; Antifungal Agents; Female; Humans; Male; Middle Aged; Mycoses; Serum; Triazoles

2011
Invasive Myceliophthora thermophila infection mimicking invasive aspergillosis in a neutropenic patient: a new cause of cross-reactivity with the Aspergillus galactomannan serum antigen assay.
    Medical mycology, 2011, Volume: 49, Issue:8

    Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus; Base Sequence; Cross Reactions; Diagnosis, Differential; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Middle Aged; Molecular Sequence Data; Mycoses; Neutropenia; Pyrimidines; Sensitivity and Specificity; Sordariales; Spores, Fungal; Triazoles; Voriconazole

2011
Fatal disseminated infection due to Scedosporium prolificans in a patient with acute myeloid leukemia and posaconazole prophylaxis.
    Leukemia & lymphoma, 2011, Volume: 52, Issue:8

    Topics: Acute Disease; Aged; Antifungal Agents; Fatal Outcome; Humans; Leukemia, Myeloid; Male; Mycoses; Scedosporium; Triazoles

2011
Delayed recalcitrant fungal endophthalmitis secondary to Curvularia.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2011, Volume: 46, Issue:2

    Topics: Abscess; Aged; Amphotericin B; Ascomycota; Cataract Extraction; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Eye Enucleation; Eye Infections, Fungal; Female; Humans; Mycoses; Pyrimidines; Recurrence; Triazoles; Vitrectomy; Vitreous Body; Voriconazole

2011
The effect of enteral nutrition supplements on serum voriconazole levels.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2012, Volume: 18, Issue:1

    Topics: Adolescent; Antifungal Agents; Enteral Nutrition; Food-Drug Interactions; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Pyrimidines; Suspensions; Triazoles; Voriconazole

2012
Synthesis and biological activity of novel 1-substituted phenyl-4-[N-[(2'-morpholinothoxy)phenyl]aminomethyl]-1H-1,2,3-triazoles.
    Chemical biology & drug design, 2011, Volume: 78, Issue:4

    Topics: Antifungal Agents; Drug Design; Fungi; Humans; Mycoses; Structure-Activity Relationship; Triazoles

2011
Therapeutic drug monitoring of voriconazole after intravenous administration in infants and children with primary immunodeficiency.
    Therapeutic drug monitoring, 2011, Volume: 33, Issue:4

    Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Female; Humans; Immunologic Deficiency Syndromes; Infant; Injections, Intravenous; Male; Mycoses; Pyrimidines; Treatment Failure; Triazoles; Voriconazole

2011
Selection of resistant fungi in liver transplant recipients during use of newer antifungal agents -- a report of two cases.
    Annals of the Academy of Medicine, Singapore, 2011, Volume: 40, Issue:6

    Topics: Adult; Antifungal Agents; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fatal Outcome; Female; Fluconazole; Humans; Lipopeptides; Liver Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Trichosporonosis; Voriconazole; Young Adult

2011
Fatal post-operative Trichoderma longibrachiatum mediastinitis and peritonitis in a paediatric patient with complex congenital cardiac disease on peritoneal dialysis.
    Journal of medical microbiology, 2011, Volume: 60, Issue:Pt 12

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child, Preschool; Echinocandins; Fatal Outcome; Female; Heart Defects, Congenital; Humans; Immunocompromised Host; Lipopeptides; Mediastinitis; Mycoses; Peritoneal Dialysis; Peritonitis; Postoperative Complications; Pyrimidines; Spleen; Triazoles; Trichoderma; Voriconazole

2011
Dosing voriconazole in an obese patient.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Volume: 53, Issue:7

    Topics: Adult; Antifungal Agents; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Mycoses; Obesity; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole

2011
Synthesis and electrophilic substitutions of novel pyrazolo[1,5-c]-1,2,4-triazolo[4,3-a]pyrimidines.
    Molecules (Basel, Switzerland), 2011, Aug-18, Volume: 16, Issue:8

    Topics: Acetic Acid; Antifungal Agents; Chemistry, Pharmaceutical; Fungi; Halogens; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mycoses; Pyrazoles; Pyrimidines; Triazoles

2011
Synthesis and biological evaluation of dihydroindeno and indeno [1,2-e] [1,2,4]triazolo [3,4-b] [1,3,4]thiadiazines as antimicrobial agents.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:10

    Topics: Anti-Infective Agents; Antifungal Agents; Bacteria; Bacterial Infections; Fungi; Humans; Indans; Microbial Sensitivity Tests; Mycoses; Thiadiazines; Triazoles

2011
Concentration of antifungal agents within host cell membranes: a new paradigm governing the efficacy of prophylaxis.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:12

    Topics: Antifungal Agents; Aspergillus fumigatus; Cell Line; Cell Membrane; Chemoprevention; Epithelial Cells; Humans; Itraconazole; Lung; Macrophages; Mycoses; Triazoles

2011
Tenosynovitis caused by a pseudallescheria boydii infection and symptoms of reflex sympathetic dystrophy after a dog bite.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2011, Volume: 17, Issue:7

    Topics: Animals; Antifungal Agents; Bites and Stings; Diagnosis, Differential; Dogs; Humans; Male; Middle Aged; Mycoses; Pseudallescheria; Pyrimidines; Reflex Sympathetic Dystrophy; Tenosynovitis; Triazoles; Voriconazole

2011
Post-traumatic Pseudallescheria apiosperma osteomyelitis: positive outcome of a young immunocompetent male patient due to surgical intervention and voriconazole therapy.
    Mycoses, 2011, Volume: 54 Suppl 3

    Topics: Adolescent; Antifungal Agents; Bone Transplantation; Fractures, Open; Humans; Immunocompetence; Male; Microbial Sensitivity Tests; Mycoses; Osteomyelitis; Pseudallescheria; Pyrimidines; Tibial Fractures; Transplantation, Autologous; Treatment Outcome; Triazoles; Voriconazole

2011
Penicillium marneffei infection presenting as vulv-ulcer in an HIV-infected woman.
    European journal of medical research, 2011, Sep-12, Volume: 16, Issue:9

    Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Diagnosis, Differential; Female; HIV; HIV Infections; Humans; Mycoses; Penicillium; Pyrimidines; Triazoles; Ulcer; Voriconazole; Vulvar Diseases; Young Adult

2011
Synthesis, spectral characterization and biological activity of zinc(II) complexes with 3-substituted phenyl-4-amino-5-hydrazino-1, 2, 4-triazole Schiff bases.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2012, Volume: 85, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacteria; Bacterial Infections; Coordination Complexes; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Schiff Bases; Triazoles; Zinc

2012
Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period.
    Haematologica, 2012, Volume: 97, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Medication Adherence; Middle Aged; Mycoses; Myelodysplastic Syndromes; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2012
Voriconazole serum levels measured by high-performance liquid chromatography: a monocentric study in treated patients.
    Medical mycology, 2012, Volume: 50, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Serum; Time Factors; Triazoles; Voriconazole; Young Adult

2012
Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, real-life experience.
    Haematologica, 2012, Volume: 97, Issue:4

    Topics: Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Hospitalization; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Survival Analysis; Treatment Outcome; Triazoles; Young Adult

2012
Synthesis and antimicrobial activity of pyrrolyl/pyrazolyl arylaminosulfonylmethyl 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazoles.
    Chemical & pharmaceutical bulletin, 2011, Volume: 59, Issue:12

    Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Oxazoles; Thiadiazoles; Triazoles

2011
Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:3

    Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Immunocompromised Host; Incidence; Infant; Male; Mycoses; Plasma; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2012
[Efficacy of voriconazole for treatment of invasive fungal infections in 87 cases with hematologic malignancies].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2011, Volume: 32, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2011
Posaconazole serum level on day 2 predicts steady state posaconazole serum level.
    Therapeutic drug monitoring, 2012, Volume: 34, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Mycoses; Triazoles; Young Adult

2012
Administration of voriconazole in patients with renal dysfunction.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 54, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Creatinine; Female; Humans; Infusions, Intravenous; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Mycoses; Pyrimidines; Renal Insufficiency; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2012
Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndrome.
    European journal of clinical pharmacology, 2012, Volume: 68, Issue:6

    Topics: Adult; Aged; Antifungal Agents; Antineoplastic Agents; Cohort Studies; Humans; Leukemia, Myeloid, Acute; Middle Aged; Models, Biological; Mycoses; Myelodysplastic Syndromes; Suspensions; Triazoles; Young Adult

2012
New heterocyclic compounds from 1,2,4-triazole and 1,3,4-thiadiazole class bearing diphenylsulfone moieties. Synthesis, characterization and antimicrobial activity evaluation.
    European journal of medicinal chemistry, 2012, Volume: 49

    Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Thiadiazoles; Triazoles

2012
Purpureocillium lilacinum as a cause of cavitary pulmonary disease: a new clinical presentation and observations on atypical morphologic characteristics of the isolate.
    Journal of clinical microbiology, 2012, Volume: 50, Issue:5

    Topics: Aged, 80 and over; Antifungal Agents; DNA, Fungal; Female; Humans; Hypocreales; Lung Diseases, Fungal; Microscopy; Molecular Sequence Data; Mycoses; Pyrimidines; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole

2012
Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicity.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5

    Topics: Adult; Aged; Antifungal Agents; Central Nervous System; Chromatography, High Pressure Liquid; Cystic Fibrosis; Drug Monitoring; Female; Fungi; Humans; Liver; Lung; Lung Transplantation; Male; Middle Aged; Mycoses; Prospective Studies; Pulmonary Fibrosis; Pyrimidines; Treatment Outcome; Triazoles; United States; Voriconazole

2012
[Outcome analysis of caspofungin in combination with voriconazole for treatment of 12 hematologic malignancies cases with invasive fungal infection].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2011, Volume: 32, Issue:8

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2011
Posaconazole is not superior to itraconazole for fungal prophylaxis in allogeneic blood and marrow transplantation.
    Bone marrow transplantation, 2012, Volume: 47, Issue:10

    Topics: Antifungal Agents; Bone Marrow Transplantation; Female; Humans; Itraconazole; Male; Mycoses; Triazoles

2012
Scedosporium apiospermum keratomycosis in a dog.
    Veterinary ophthalmology, 2012, Volume: 15, Issue:6

    Topics: Animals; Antifungal Agents; Ascomycota; Dog Diseases; Dogs; Keratitis; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2012
Systemic mycosis in a California sea lion (Zalophus californianus) with detection of cystofilobasidiales DNA.
    Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2012, Volume: 43, Issue:1

    Topics: Animals; Antifungal Agents; Basidiomycota; DNA, Fungal; Fatal Outcome; Itraconazole; Male; Mycoses; Pyrimidines; Sea Lions; Triazoles; Voriconazole

2012
Idiosyncratic nature of voriconazole photosensitivity in children undergoing cancer therapy.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:7

    Topics: Antifungal Agents; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Mycoses; Neoplasms; Photosensitivity Disorders; Pyrimidines; Triazoles; Voriconazole

2012
Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain.
    BMC infectious diseases, 2012, Apr-03, Volume: 12

    Topics: Antifungal Agents; Chemoprevention; Cost-Benefit Analysis; Hematologic Neoplasms; Humans; Immunocompromised Host; Itraconazole; Mycoses; Neutropenia; Prospective Studies; Spain; Triazoles

2012
Posaconazole plasma concentrations and invasive mould infections in patients with haematological malignancies.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:6

    Topics: Adult; Antifungal Agents; Aspergillosis; Chemoprevention; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Risk Factors; Triazoles; Young Adult

2012
High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2012, Volume: 31, Issue:7

    Topics: Adult; Antifungal Agents; Carcinoma, Squamous Cell; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Immunocompromised Host; Immunosuppression Therapy; Lung Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Risk Factors; Skin Neoplasms; Triazoles; Voriconazole

2012
Paecilomyces lilacinus endophthalmitis following cataract surgery: a therapeutic challenge.
    Klinische Monatsblatter fur Augenheilkunde, 2012, Volume: 229, Issue:4

    Topics: Aged; Antifungal Agents; Cataract Extraction; Endophthalmitis; Humans; Male; Mycoses; Paecilomyces; Pyrimidines; Surgical Wound Infection; Treatment Outcome; Triazoles; Voriconazole

2012
Voriconazole-induced phototoxicity in children.
    The Pediatric infectious disease journal, 2012, Volume: 31, Issue:7

    Topics: Chemoprevention; Child; Child, Preschool; Dermatitis, Phototoxic; Female; Humans; Immunocompromised Host; Incidence; Infant; Male; Mycoses; Neoplasms; Pyrimidines; Retrospective Studies; Risk Assessment; Triazoles; Voriconazole

2012
Synthesis and biological evaluation of triazole derivatives as potential antifungal agent.
    Chemical biology & drug design, 2012, Volume: 80, Issue:3

    Topics: Antifungal Agents; Catalytic Domain; Fungi; Humans; Microbial Sensitivity Tests; Models, Molecular; Mycoses; Piperidines; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles

2012
In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:8

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Drug Synergism; Echinocandins; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles

2012
Duration of voriconazole exposure: an independent risk factor for skin cancer after lung transplantation.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2012, Volume: 38, Issue:8

    Topics: Antifungal Agents; Female; Humans; Immunocompromised Host; Lung Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Risk Factors; Skin Neoplasms; Triazoles; Voriconazole

2012
Posaconazole treatment in hematology patients: a pilot study of therapeutic drug monitoring.
    Therapeutic drug monitoring, 2012, Volume: 34, Issue:3

    Topics: Adult; Antifungal Agents; Drug Monitoring; Female; Follow-Up Studies; Hematologic Diseases; Humans; Male; Middle Aged; Mycoses; Pilot Projects; Retrospective Studies; Treatment Outcome; Triazoles

2012
Safety of posaconazole and sirolimus coadministration in allogeneic hematopoietic stem cell transplants.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2012, Volume: 18, Issue:9

    Topics: Adult; Antifungal Agents; Drug Administration Schedule; Drug Dosage Calculations; Drug Synergism; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycoses; Sirolimus; Transplantation, Homologous; Triazoles

2012
Simultaneous determination of triazole antifungal drugs in human plasma by sweeping-micellar electrokinetic chromatography.
    Analytical and bioanalytical chemistry, 2012, Volume: 404, Issue:1

    Topics: Antifungal Agents; Chromatography, Micellar Electrokinetic Capillary; Humans; Mycoses; Triazoles

2012
Editorial commentary: Antifungal therapeutic drug monitoring progress: getting it right the first time.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55, Issue:3

    Topics: Antifungal Agents; Female; Humans; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2012
Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55, Issue:3

    Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Drug Monitoring; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Plasma; Pyrimidines; Triazoles; Voriconazole

2012
The impact of prior invasive mold infections in leukemia patients who undergo allo-SCT in the era of triazole-based secondary prophylaxis.
    Bone marrow transplantation, 2013, Volume: 48, Issue:1

    Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Child; Cohort Studies; Drug Therapy, Combination; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Middle Aged; Mycoses; Retrospective Studies; Secondary Prevention; Transplantation, Homologous; Triazoles; Young Adult

2013
Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:9

    Topics: Antifungal Agents; Chemoprevention; Drug Resistance, Fungal; Fungi; Humans; Immunocompromised Host; Incidence; Mycoses; Retrospective Studies; Triazoles

2012
Fungal malignant otitis externa: pitfalls, diagnosis, and treatment.
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2012, Volume: 33, Issue:5

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Female; Humans; Male; Mycoses; Otitis Externa; Pseudomonas aeruginosa; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2012
A retrospective analysis of voriconazole pharmacokinetics in Japanese pediatric and adolescent patients.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013, Volume: 19, Issue:1

    Topics: Administration, Intravenous; Administration, Oral; Adolescent; Antifungal Agents; Aspergillosis; Candidemia; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Japan; Male; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2013
Multicenter study of voriconazole pharmacokinetics and therapeutic drug monitoring.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:9

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antifungal Agents; Australia; Drug Interactions; Drug Monitoring; Female; Glucocorticoids; Humans; Male; Middle Aged; Mitosporic Fungi; Mycoses; Nucleic Acid Synthesis Inhibitors; Phenytoin; Pyrimidines; Retrospective Studies; Rifampin; Treatment Outcome; Triazoles; Voltage-Gated Sodium Channel Blockers; Voriconazole

2012
Frequency of fungal isolation and antifungal susceptibility pattern of the fungal isolates from nasal polyps of chronic rhinosinusitis patients at a tertiary care centre in north India.
    Medical mycology, 2013, Volume: 51, Issue:2

    Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Female; Fungi; Humans; Immunoglobulin E; Incidence; India; Itraconazole; Male; Middle Aged; Mucins; Mycoses; Nasal Polyps; Pyrimidines; Retrospective Studies; Rhinitis, Allergic, Perennial; Sinusitis; Tertiary Healthcare; Tomography, X-Ray Computed; Triazoles; Voriconazole

2013
A targeted peritransplant antifungal strategy for the prevention of invasive fungal disease after lung transplantation: a sequential cohort analysis.
    Transplantation, 2012, Aug-15, Volume: 94, Issue:3

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cohort Studies; Echinocandins; Female; Humans; Lipopeptides; Lung Transplantation; Male; Micafungin; Middle Aged; Mycoses; Risk; Time Factors; Triazoles

2012
The management of febrile neutropenia in the posaconazole era: a new challenge?
    Haematologica, 2012, Volume: 97, Issue:7

    Topics: Antifungal Agents; Antineoplastic Agents; Fever; Fungi; Galactose; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Mannans; Mycoses; Neutropenia; Polymerase Chain Reaction; Randomized Controlled Trials as Topic; Retrospective Studies; Triazoles

2012
Poor absorption of high-dose posaconazole in pediatric bone marrow transplant patients.
    The Annals of pharmacotherapy, 2012, Volume: 46, Issue:9

    Topics: Absorption; Antifungal Agents; Bone Marrow Transplantation; Child; Humans; Infant; Male; Mycoses; Triazoles

2012
Design, synthesis and evaluation of clinafloxacin triazole hybrids as a new type of antibacterial and antifungal agents.
    Bioorganic & medicinal chemistry letters, 2012, Sep-01, Volume: 22, Issue:17

    Topics: Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Drug Design; Fluoroquinolones; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycoses; Staphylococcal Infections; Triazoles

2012
Sinus fungal balls: characteristics and management in patients with host factors for invasive infection.
    Rhinology, 2012, Volume: 50, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Endoscopy; Female; Humans; Male; Middle Aged; Mycoses; Osteolysis; Paranasal Sinus Diseases; Retrospective Studies; Risk Factors; Triazoles

2012
Multicenter study of posaconazole therapeutic drug monitoring: exposure-response relationship and factors affecting concentration.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Australia; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Female; Fungi; Humans; Logistic Models; Male; Metoclopramide; Middle Aged; Mycoses; Phenytoin; Ranitidine; Retrospective Studies; Rifampin; Triazoles

2012
Management of recurrent Paecilomyces lilacinus keratitis.
    Clinical & experimental optometry, 2013, Volume: 96, Issue:3

    Topics: Aged; Humans; Keratitis; Male; Mycoses; Paecilomyces; Pyrimidines; Recurrence; Triazoles; Voriconazole

2013
[Early onset of paralytic ileus caused by simultaneous administration of bortezomib and azole antifungals in multiple myeloma patients].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2012, Volume: 53, Issue:8

    Topics: Aged; Antifungal Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Interactions; Drug Therapy, Combination; Humans; Intestinal Pseudo-Obstruction; Itraconazole; Middle Aged; Multiple Myeloma; Mycoses; Pyrazines; Pyrimidines; Triazoles; Voriconazole

2012
Metal based new triazoles: their synthesis, characterization and antibacterial/antifungal activities.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2012, Volume: 98

    Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Artemia; Bacteria; Bacterial Infections; Fungi; Humans; Mycoses; Spectrum Analysis; Toxicity Tests; Triazoles; Vanadates

2012
Effect of posaconazole on cyclosporine blood levels and dose adjustment in allogeneic blood and marrow transplant recipients.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:12

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Blood Transfusion; Bone Marrow Transplantation; Cyclosporine; Drug Interactions; Drug Monitoring; Female; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Lymphoproliferative Disorders; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Triazoles; Young Adult

2012
In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study.
    Journal of clinical microbiology, 2012, Volume: 50, Issue:12

    Topics: Antifungal Agents; China; Cross Infection; Drug Resistance, Fungal; Epidemiological Monitoring; Fluconazole; Humans; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole; Yeasts

2012
A hematology consensus agreement on antifungal strategies for neutropenic patients with hematological malignancies and stem cell transplant recipients. Gruppo Italiano Malattie Ematologiche dell'Adulto, Gruppo Italiano Trapianto di Midollo Osseo, Associaz
    Hematological oncology, 2013, Volume: 31, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Chemotherapy-Induced Febrile Neutropenia; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance, Fungal; Drug Therapy, Combination; Febrile Neutropenia; Fungi; Hematologic Neoplasms; Humans; Immunocompromised Host; Multicenter Studies as Topic; Mycoses; Premedication; Prospective Studies; Randomized Controlled Trials as Topic; Transplantation Conditioning; Triazoles

2013
Penicillium marneffei chylous ascites in acquired immune deficiency syndrome: a case report.
    World journal of gastroenterology, 2012, Oct-07, Volume: 18, Issue:37

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Alkynes; Amphotericin B; Anti-Retroviral Agents; Antifungal Agents; Benzoxazines; Chylous Ascites; Cyclopropanes; Diagnosis, Differential; Humans; Male; Middle Aged; Mycoses; Penicillium; Pyrimidines; Sepsis; Triazoles; Voriconazole

2012
Evaluation of an alternative posaconazole prophylaxis regimen in haematological malignancy patients receiving concomitant stress ulcer prophylaxis.
    International journal of antimicrobial agents, 2012, Volume: 40, Issue:6

    Topics: Adult; Aged; Antifungal Agents; Chemoprevention; Drug Interactions; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Plasma; Proton Pump Inhibitors; Stress, Physiological; Triazoles; Ulcer

2012
Successful treatment of a severe case of fusariomycosis in a beluga whale (Delphinapterus leucas leucas).
    Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2012, Volume: 43, Issue:3

    Topics: Animals; Animals, Zoo; Antifungal Agents; Drug Administration Schedule; Extremities; Fusarium; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole; Whales

2012
Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation.
    BMC infectious diseases, 2012, Oct-19, Volume: 12

    Topics: Antifungal Agents; Chemoprevention; Child; Child, Preschool; Female; Humans; Immunocompromised Host; Infant; Male; Mycoses; Retrospective Studies; Stem Cell Transplantation; Treatment Outcome; Triazoles

2012
In vitro antifungal drug susceptibilities of Penicillium marneffei from China.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013, Volume: 19, Issue:4

    Topics: Animals; Antifungal Agents; China; Humans; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Penicillium; Pyrimidines; Rats; Terbinafine; Triazoles; Voriconazole

2013
In vitro activity of colistin as single agent and in combination with antifungals against filamentous fungi occurring in patients with cystic fibrosis.
    Mycoses, 2013, Volume: 56, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Colistin; Cystic Fibrosis; Drug Evaluation, Preclinical; Drug Synergism; Echinocandins; Exophiala; Humans; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2013
Real-world experience with posaconazole prophylaxis in high-risk hematological patients in Singapore: a prospective audit.
    The Journal of infection, 2013, Volume: 66, Issue:3

    Topics: Administration, Oral; Adult; Antifungal Agents; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Medical Audit; Middle Aged; Mycoses; Prospective Studies; Singapore; Treatment Outcome; Triazoles

2013
Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:3

    Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fluconazole; Hematologic Neoplasms; Humans; Hypokalemia; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Mycoses; Ofloxacin; Pyrimidines; Risk Factors; Torsades de Pointes; Triazoles; Ventricular Dysfunction, Left; Voriconazole

2013
Adapting a global cost-effectiveness model to local country requirements: posaconazole case study.
    Journal of medical economics, 2013, Volume: 16, Issue:3

    Topics: Antifungal Agents; Cost-Benefit Analysis; Developed Countries; Drug Therapy, Combination; Fluconazole; Fungi; Humans; Itraconazole; Models, Economic; Mycoses; Triazoles

2013
Antifungal prophylaxis in the haematological patient: a practical approach.
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2012, Volume: 25, Issue:4

    Topics: Algorithms; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Biological Availability; Decision Trees; Drug Interactions; Echinocandins; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Liver Diseases; Mycoses; Myelodysplastic Syndromes; Postoperative Complications; Practice Guidelines as Topic; Premedication; Triazoles

2012
Scedosporium apiospermum soft tissue infection as the initial presentation of acute myeloid leukemia: a case report.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Mar-01, Volume: 31, Issue:7

    Topics: Aged, 80 and over; Amputation, Surgical; Antifungal Agents; Antimetabolites, Antineoplastic; Azacitidine; Bone Marrow; Decitabine; Diagnosis, Differential; Disease Progression; Fatal Outcome; Female; Humans; Leg Ulcer; Leukemia, Myeloid, Acute; Mycoses; Pancytopenia; Pyrimidines; Scedosporium; Soft Tissue Infections; Triazoles; Voriconazole

2013
Evaluation of intravenous voriconazole in patients with compromised renal function.
    BMC infectious diseases, 2013, Jan-16, Volume: 13

    Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Creatinine; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; Mycoses; Pyrimidines; Renal Insufficiency; Triazoles; Voriconazole; Young Adult

2013
[Infectious diseases: progress in diagnosis and treatment. Topics: IV. Towards containing infectious diseases: 3. Development of new antifungal drugs].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2012, Nov-10, Volume: 101, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole

2012
Invasive sino-orbital mycosis in an aplastic anemia patient caused by Neosartorya laciniosa.
    Journal of clinical microbiology, 2013, Volume: 51, Issue:4

    Topics: Aged; Anemia, Aplastic; Antifungal Agents; Debridement; DNA, Fungal; Echinocandins; Eye Enucleation; Fungal Proteins; Humans; Lipopeptides; Male; Micafungin; Molecular Sequence Data; Mycoses; Neosartorya; Orbital Diseases; Phylogeny; Pyrimidines; Sequence Analysis, DNA; Sequence Homology; Sinusitis; Triazoles; Voriconazole

2013
Synthesis, experimental, theoretical characterization and biological activities of 4-ethyl-5-(2-hydroxyphenyl)-2H-1,2,4-triazole-3(4H)-thione.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2013, Mar-15, Volume: 105

    Topics: Anti-Infective Agents; Antioxidants; Bacteria; Bacterial Infections; Crystallography, X-Ray; Fungi; Humans; Magnetic Resonance Spectroscopy; Models, Molecular; Mycoses; Spectroscopy, Fourier Transform Infrared; Thiones; Triazoles

2013
Reflections on the approach to treatment of a mycologic disaster.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Cladosporium; Humans; Mucormycosis; Mycoses; Pyrimidines; Rhizopus; Rhodotorula; Triazoles; Voriconazole

2013
Schizophyllum commune: a new organism in eye infection.
    Mycopathologia, 2013, Volume: 175, Issue:3-4

    Topics: Administration, Topical; Adult; Amphotericin B; Antifungal Agents; Cornea; Corneal Transplantation; DNA, Fungal; DNA, Ribosomal Spacer; Humans; Keratitis; Male; Molecular Sequence Data; Mycoses; Polymerase Chain Reaction; Pyrimidines; Schizophyllum; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole

2013
Voriconazole.
    The Medical letter on drugs and therapeutics, 2002, Jul-22, Volume: 44, Issue:1135

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Fusarium; Humans; Injections, Intravenous; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2002
Voriconazole treatment of disseminated paecilomyces infection in a patient with acquired immunodeficiency syndrome.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Oct-01, Volume: 35, Issue:7

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Humans; Male; Mycoses; Paecilomyces; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2002
New drugs, old drugs - dear drugs, cheap drugs.
    Swiss medical weekly, 2002, Jun-15, Volume: 132, Issue:23-24

    Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bone Marrow Transplantation; Caspofungin; Cyclosporine; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Renal Insufficiency; Triazoles; Voriconazole

2002
Multidrug-resistant Trichosporon asahii isolates are susceptible to voriconazole.
    Journal of clinical microbiology, 2003, Volume: 41, Issue:2

    Topics: Antifungal Agents; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2003
Paecilomyces variotii central nervous system infection in a patient with cancer.
    Mycoses, 2003, Volume: 46, Issue:1-2

    Topics: Antifungal Agents; Breast Neoplasms; Central Nervous System Infections; Cerebrospinal Fluid; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Mycoses; Opportunistic Infections; Paecilomyces; Triazoles

2003
Successful treatment of disseminated fusariosis.
    Bone marrow transplantation, 2003, Volume: 31, Issue:5

    Topics: Amphotericin B; Child, Preschool; Female; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2003
Comment: caspofungin acetate for treatment of invasive fungal infections.
    The Annals of pharmacotherapy, 2003, Volume: 37, Issue:4

    Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Drug Synergism; Echinocandins; Guinea Pigs; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2003
Improving the mouse model for studying the efficacy of voriconazole.
    The Journal of antimicrobial chemotherapy, 2003, Volume: 51, Issue:6

    Topics: Animals; Beverages; Citrus paradisi; Disease Models, Animal; Fusarium; Kidney; Mice; Mice, Inbred ICR; Mycoses; Pyrimidines; Spleen; Triazoles; Voriconazole

2003
Voriconazole in the treatment of invasive mold infections in transplant recipients.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2003, Volume: 22, Issue:7

    Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Fungi; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Organ Transplantation; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2003
Posaconazole: SCH 56592.
    Drugs in R&D, 2003, Volume: 4, Issue:4

    Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Cytochrome P-450 Enzyme Inhibitors; Humans; Mycoses; Opportunistic Infections; Oxidoreductases; Sterol 14-Demethylase; Treatment Outcome; Triazoles

2003
Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Jul-15, Volume: 37, Issue:2

    Topics: Aged; Amphotericin B; Antifungal Agents; Fusarium; Humans; Immunocompromised Host; Male; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2003
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi.
    Journal of clinical microbiology, 2003, Volume: 41, Issue:8

    Topics: Amphotericin B; Anti-Bacterial Agents; Aspergillus; Caspofungin; Echinocandins; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Penicillium; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole

2003
Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Sep-01, Volume: 37, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Animals; Antifungal Agents; Brain; Brain Chemistry; Child; Child, Preschool; Drug Administration Schedule; Female; Guinea Pigs; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole

2003
Cerebral phaeohyphomycosis in an immunodeficient child treated medically with combination antifungal therapy.
    Medical mycology, 2003, Volume: 41, Issue:4

    Topics: Anti-Bacterial Agents; Antifungal Agents; Ascomycota; Brain Abscess; Brain Diseases; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Immunologic Deficiency Syndromes; Lipopeptides; Male; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2003
[Update on voriconazole].
    Deutsche medizinische Wochenschrift (1946), 2003, Aug-15, Volume: 128, Issue:33

    Topics: Adult; Age Factors; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Candidiasis; Child; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2003
[Finger nail polish with fungistatic effects].
    Medizinische Klinik, 1955, Aug-19, Volume: 50, Issue:33

    Topics: Cosmetics; Humans; Mycoses; Nails; Triazoles

1955
[Value in the Army of a fungistatic antibiotic active by buccal route: griseofulvin].
    Bulletin mensuel - Societe de medecine militaire francaise, 1961, Apr-13, Volume: 55

    Topics: Anti-Bacterial Agents; Griseofulvin; Military Medicine; Military Personnel; Mycoses; Triazoles

1961
Some investigative problems of the new oral fungistatic agent, griseofulvin.
    Connecticut medicine, 1959, Volume: 23

    Topics: Griseofulvin; Mycoses; Triazoles

1959
Voriconazole serum concentrations in an infant treated for Trichosporon beigelii infection.
    The Pediatric infectious disease journal, 2003, Volume: 22, Issue:11

    Topics: Antifungal Agents; Fatal Outcome; Humans; Infant; Mycoses; Neutropenia; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2003
Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:12

    Topics: Animals; Antifungal Agents; Brain; Colony Count, Microbial; Kidney; Male; Mice; Mycoses; Neutropenia; Pyrimidines; Scedosporium; Spleen; Survival Analysis; Triazoles; Voriconazole

2003
Pharmacokinetic interaction between voriconazole and ciclosporin A following allogeneic bone marrow transplantation.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:1

    Topics: Adolescent; Antifungal Agents; Bone Marrow Transplantation; Cyclosporine; Drug Interactions; Female; Humans; Leukemia, Myeloid, Acute; Mycoses; Pyrimidines; Triazoles; Voriconazole

2004
Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy.
    Transplantation, 2003, Dec-15, Volume: 76, Issue:11

    Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Child; Drug Resistance, Fungal; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Middle Aged; Mycoses; Neoplasms; Pyrimidines; Salvage Therapy; Transplantation; Treatment Failure; Triazoles; Voriconazole

2003
Case study: posaconazole treatment of disseminated phaeohyphomycosis due to Exophiala spinifera.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Feb-01, Volume: 38, Issue:3

    Topics: Adult; Antifungal Agents; Drug Therapy, Combination; Exophiala; Female; Flucytosine; Humans; Itraconazole; Mycoses; Pregnancy; Pregnancy Complications, Infectious; Triazoles

2004
[symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
    Drug and therapeutics bulletin, 2004, Volume: 42, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2004
[Fungicidal and fungistatic effect of p-chlorophenoxethol and propylene phenoxethol on African dermatophytes].
    Annales de la Societe belge de medecine tropicale (1920), 1950, Volume: 30, Issue:3

    Topics: Alkenes; Arthrodermataceae; Ethylene Glycols; Fungi; Humans; Mycoses; Triazoles

1950
Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants.
    The New England journal of medicine, 2004, Feb-26, Volume: 350, Issue:9

    Topics: Adult; Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole; Zygomycosis

2004
Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
    Prescrire international, 2004, Volume: 13, Issue:69

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Drug Interactions; Fusarium; Humans; Immunocompromised Host; Mycetoma; Mycoses; Pyrimidines; Scedosporium; Treatment Outcome; Triazoles

2004
In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.
    American journal of ophthalmology, 2004, Volume: 137, Issue:5

    Topics: Antifungal Agents; Cornea; Databases, Factual; Drug Resistance, Fungal; Endophthalmitis; Eye Infections, Fungal; Fungi; Humans; In Vitro Techniques; Keratitis; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2004
Posaconazole therapy of disseminated phaeohyphomycosis in a murine model.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:6

    Topics: Animals; Antifungal Agents; Brain; Colony Count, Microbial; Exophiala; Immunocompromised Host; Mice; Mice, Inbred BALB C; Mice, Nude; Mycoses; Survival Analysis; Triazoles

2004
Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis.
    European journal of haematology, 2004, Volume: 73, Issue:1

    Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Child; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Geotrichosis; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Liposomes; Male; Mycoses; Myelodysplastic Syndromes; Peptides; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Survival Rate; Treatment Outcome; Triazoles; Voriconazole

2004
Fungal keratitis caused by Paecilomyces lilacinus associated with a retained intracorneal hair.
    Cornea, 2004, Volume: 23, Issue:5

    Topics: Anti-Bacterial Agents; Antifungal Agents; Corneal Stroma; Corneal Ulcer; Drug Therapy, Combination; Eye Foreign Bodies; Eye Infections, Fungal; Foreign-Body Migration; Hair; Humans; Male; Middle Aged; Mycoses; Naphthalenes; Paecilomyces; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2004
Use of fatty acid RPMI 1640 media for testing susceptibilities of eight Malassezia species to the new triazole posaconazole and to six established antifungal agents by a modified NCCLS M27-A2 microdilution method and Etest.
    Journal of clinical microbiology, 2004, Volume: 42, Issue:8

    Topics: Antifungal Agents; Culture Media; Fatty Acids; Humans; Malassezia; Microbial Sensitivity Tests; Mycoses; Triazoles

2004
Fusarium dimerum infection in a stem cell transplant recipient treated successfully with voriconazole.
    Bone marrow transplantation, 2004, Volume: 34, Issue:9

    Topics: Adult; Anemia, Aplastic; Antifungal Agents; Female; Fusarium; Humans; Mycoses; Pyrimidines; Radiography, Thoracic; Stem Cell Transplantation; Tomography, X-Ray Computed; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole

2004
Antifungal therapy in patients with fever and neutropenia--more rational and less empirical?
    The New England journal of medicine, 2004, Sep-30, Volume: 351, Issue:14

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Lipopeptides; Liposomes; Mycoses; Neoplasms; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2004
Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Sep-15, Volume: 39, Issue:6

    Topics: Adolescent; Antifungal Agents; Bradycardia; Female; Fusarium; Humans; Mycoses; Opportunistic Infections; Pyrimidines; Tachycardia, Ventricular; Torsades de Pointes; Triazoles; Voriconazole

2004
Design issues in a prospective randomized double-blinded trial of prophylaxis with fluconazole versus voriconazole after allogeneic hematopoietic cell transplantation.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Oct-15, Volume: 39 Suppl 4

    Topics: Antifungal Agents; Double-Blind Method; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Research Design; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole

2004
Effect of voriconazole on a corneal abscess caused by fusarium.
    Acta ophthalmologica Scandinavica, 2004, Volume: 82, Issue:6

    Topics: Abscess; Antifungal Agents; Corneal Diseases; Eye Infections, Fungal; Fusarium; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole

2004
Voriconazole-induced musical hallucinations.
    Infection, 2004, Volume: 32, Issue:5

    Topics: Aged; Antifungal Agents; Hallucinations; Humans; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2004
Caspofungin versus liposomal amphotericin B for empirical therapy.
    The New England journal of medicine, 2005, Jan-27, Volume: 352, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Lipopeptides; Mycoses; Neutropenia; Peptides, Cyclic; Triazoles

2005
Caspofungin versus liposomal amphotericin B for empirical therapy.
    The New England journal of medicine, 2005, Jan-27, Volume: 352, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Infusions, Intravenous; Lipopeptides; Liposomes; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2005
Caspofungin versus liposomal amphotericin B for empirical therapy.
    The New England journal of medicine, 2005, Jan-27, Volume: 352, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Lipopeptides; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Survival Rate; Triazoles; Voriconazole

2005
[Drugs used in prophylaxis and treatment of fungal infections in immunosuppressed children].
    Przeglad lekarski, 2004, Volume: 61 Suppl 2

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Drug Resistance, Fungal; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Mycoses; Neoplasms; Peptides, Cyclic; Pyrimidines; Risk Factors; Triazoles; Voriconazole

2004
Surveillance of triazole susceptibility of colonizing yeasts in patients with haematological malignancies.
    Scandinavian journal of infectious diseases, 2004, Volume: 36, Issue:11-12

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Female; Fungi; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Neutropenia; Triazoles

2004
Synthesis and in vitro and in vivo structure-activity relationships of novel antifungal triazoles for dermatology.
    Journal of medicinal chemistry, 2005, Mar-24, Volume: 48, Issue:6

    Topics: Animals; Antifungal Agents; Dermatologic Agents; Guinea Pigs; Imidazoles; Itraconazole; Mice; Mitosporic Fungi; Mycoses; Naphthalenes; Stereoisomerism; Structure-Activity Relationship; Terbinafine; Triazoles

2005
Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Apr-15, Volume: 40, Issue:8

    Topics: Adult; Antifungal Agents; Fusarium; Humans; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Failure; Triazoles; Voriconazole

2005
In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
    Medical mycology, 2005, Volume: 43, Issue:2

    Topics: Antifungal Agents; Arthrodermataceae; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Terbinafine; Thiazoles; Triazoles; Yeasts

2005
Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole.
    Journal of pediatric hematology/oncology, 2005, Volume: 27, Issue:5

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Fungemia; Humans; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Outcome; Triazoles; Trichosporon; Voriconazole

2005
Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jun-15, Volume: 40, Issue:12

    Topics: Adult; Amphotericin B; Antifungal Agents; Cornea; Corneal Transplantation; Fusarium; Humans; Itraconazole; Keratitis; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2005
[Disseminated cutaneous and visceral fusariosis in an aplastic patient: an unusual digestive entry].
    Annales de dermatologie et de venereologie, 2005, Volume: 132, Issue:3

    Topics: Adult; Amsacrine; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Diet; Fusarium; Humans; Immunocompromised Host; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole

2005
[Subcutaneous phaeohyphomycosis due to Exophiala spinifera in a renal transplant recipient].
    Annales de dermatologie et de venereologie, 2005, Volume: 132, Issue:3

    Topics: Antifungal Agents; Cyclosporine; Exophiala; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Leg; Middle Aged; Mycoses; Prednisone; Pyrimidines; Triazoles; Voriconazole

2005
[Disseminated fusarium infection in two neutropenic children].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2005, Volume: 12, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Child; Drug Combinations; Fatal Outcome; Female; Fusarium; Humans; Immunocompromised Host; Leukemia, Lymphoid; Leukemia, Myeloid; Male; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2005
Voriconazole in the treatment of invasive fungal infections.
    Intensive & critical care nursing, 2005, Volume: 21, Issue:6

    Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Critical Care; Drug Interactions; Drug Monitoring; Humans; Immunocompromised Host; Infusions, Intravenous; Mycoses; Patient Selection; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2005
In vitro activities of new and established triazoles against opportunistic filamentous and dimorphic fungi.
    Medical mycology, 2005, Volume: 43, Issue:3

    Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Species Specificity; Thiazoles; Triazoles; Voriconazole

2005
Voriconazole activity against clinical yeast isolates: a multicentre Italian study.
    International journal of antimicrobial agents, 2005, Volume: 26, Issue:3

    Topics: Antifungal Agents; Candida; Cryptococcus neoformans; Drug Resistance, Fungal; Fungi; Geotrichum; Humans; Inpatients; Italy; Microbial Sensitivity Tests; Mycoses; Outpatients; Pyrimidines; Saccharomyces cerevisiae; Triazoles; Trichosporon; Voriconazole

2005
[In vitro susceptibility of fungal and yeast clinical isolates to itraconazole and voriconazole].
    Revista iberoamericana de micologia, 2005, Volume: 22, Issue:2

    Topics: Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Scedosporium; Sporothrix; Triazoles; Voriconazole; Yeasts

2005
[Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2005, Volume: 18, Issue:2

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Child, Preschool; Drug Resistance, Fungal; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Spain; Treatment Outcome; Triazoles; Voriconazole

2005
Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin.
    American journal of ophthalmology, 2005, Volume: 140, Issue:3

    Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Cataract Extraction; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Fusarium; Humans; Lens Implantation, Intraocular; Lipopeptides; Male; Middle Aged; Mycoses; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Triazoles; Vitrectomy; Voriconazole

2005
Voriconazole susceptibility of yeasts isolated from the mouths of patients with advanced cancer.
    Journal of medical microbiology, 2005, Volume: 54, Issue:Pt 10

    Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mouth Diseases; Mycoses; Neoplasms; Palliative Care; Pyrimidines; Triazoles; Voriconazole; Yeasts

2005
Fatal Trichosporon asahii septicemia in a Guatemalan farmer with acute lymphoblastic leukemia.
    Southern medical journal, 2005, Volume: 98, Issue:9

    Topics: Adult; Agriculture; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Catheterization, Peripheral; Emigration and Immigration; Fatal Outcome; Fever; Guatemala; Humans; Male; Mycoses; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sepsis; Triazoles; Trichosporon; United States; Urease; Voriconazole; Yeasts

2005
Advances in antifungal therapy.
    The Pediatric infectious disease journal, 2005, Volume: 24, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Animals; Antifungal Agents; Caspofungin; Child; Child, Preschool; Clinical Trials as Topic; Echinocandins; Fungal Proteins; Humans; Infant; Infant, Newborn; Lipopeptides; Lipoproteins; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Thiazoles; Treatment Outcome; Triazoles; Voriconazole

2005
Endogenous Phialemonium curvatum endophthalmitis.
    American journal of ophthalmology, 2005, Volume: 140, Issue:4

    Topics: Aged; Antifungal Agents; Ascomycota; Cataract Extraction; Drug Contamination; Endocarditis; Endophthalmitis; Erectile Dysfunction; Eye Infections, Fungal; Fungemia; Humans; Male; Muscle, Smooth; Mycoses; Parasympatholytics; Pyrimidines; Triazoles; Ultrasonography; Vitrectomy; Vitreous Body; Voriconazole

2005
[Economic evaluation of the treatment of systemic fungal infections in immunocompromised patients: the role of itraconazole].
    Recenti progressi in medicina, 2005, Volume: 96, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Mycoses; Neutropenia; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2005
Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis.
    Infection, 2005, Volume: 33, Issue:5-6

    Topics: Aged; Amphotericin B; Anemia, Aplastic; Ascomycota; Aspergillosis; Body Fluids; Caspofungin; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Mycoses; Peptides, Cyclic; Pyrimidines; Saccharomycetales; Shock, Septic; Triazoles; Voriconazole

2005
Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis.
    The Journal of infection, 2005, Volume: 51, Issue:4

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Fungemia; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Mycoses; Neutropenia; Paecilomyces; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole

2005
Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:1

    Topics: Animals; Antifungal Agents; Drug Synergism; Fungi; Lovastatin; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2006
Cyclomyces tabacinus as a cause of deep tissue infection: the first case report.
    Mycoses, 2006, Volume: 49, Issue:2

    Topics: Aged; Antifungal Agents; Arthritis, Infectious; Basidiomycota; Humans; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2006
Chronic endophthalmitis due to verticillium species after cataract surgery treated (or managed) with pars plana vitrectomy and oral and intravitreal voriconazole.
    Retina (Philadelphia, Pa.), 2006, Volume: 26, Issue:2

    Topics: Administration, Oral; Antifungal Agents; Chronic Disease; Combined Modality Therapy; Endophthalmitis; Eye Infections, Fungal; Humans; Injections; Lens Implantation, Intraocular; Male; Middle Aged; Mitosporic Fungi; Mycoses; Phacoemulsification; Postoperative Complications; Pyrimidines; Triazoles; Vitrectomy; Vitreous Body; Voriconazole

2006
Successful voriconazole therapy of disseminated Fusarium verticillioides infection in an immunocompromised patient receiving chemotherapy.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 57, Issue:4

    Topics: Antifungal Agents; Female; Fusarium; Humans; Immunocompromised Host; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2006
[Voriconazole at Saint Louis Hospital (Paris): Analysis of two-years of compassionate use].
    Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:2 Pt 1

    Topics: Acute Disease; Antifungal Agents; Aspergillosis; Candidiasis; Cohort Studies; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Mycoses; Pyrimidines; Retrospective Studies; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2006
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Spain; Triazoles; Voriconazole; Yeasts

2006
Rare lower extremity invasive fungal infection in an immunosuppressed patient: Exserohilum longirostratum.
    Plastic and reconstructive surgery, 2006, Volume: 117, Issue:3

    Topics: Aged; Antifungal Agents; Cellulitis; Comorbidity; Debridement; Disease Progression; Hepatitis C, Chronic; Humans; Immunocompromised Host; Leg Ulcer; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2006
Incidence of voriconazole hepatotoxicity during intravenous and oral treatment for invasive fungal infections.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 57, Issue:6

    Topics: Administration, Oral; Antifungal Agents; Hematologic Diseases; Humans; Injections, Intravenous; Liver; Liver Function Tests; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2006
Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B.
    The Journal of infection, 2006, Volume: 53, Issue:6

    Topics: Adult; Amphotericin B; Antifungal Agents; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2006
Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2006, Volume: 12, Issue:5

    Topics: Adult; Antifungal Agents; Cord Blood Stem Cell Transplantation; Creatinine; Dose-Response Relationship, Drug; Drug Evaluation; Drug Interactions; Female; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Leukemia; Lipids; Male; Middle Aged; Mycoses; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Pyrimidines; Retrospective Studies; Sirolimus; Transplantation, Homologous; Triazoles; Voriconazole

2006
Black fluid from a traumatic wound.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Jun-01, Volume: 42, Issue:11

    Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Fractures, Open; Humans; Male; Meropenem; Mycoses; Pyrimidines; Soft Tissue Infections; Thienamycins; Triazoles; Voriconazole; Wound Infection

2006
[Effect of new antifungals on the etiology of invasive fungal infections: emergence, resistance and breakthrough infection].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2006, Volume: 19, Issue:1

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Communicable Diseases, Emerging; Drug Resistance, Multiple, Fungal; Humans; Immunocompromised Host; Mycoses; Organ Transplantation; Postoperative Complications; Prosthesis-Related Infections; Pyrimidines; Recurrence; Triazoles; Voriconazole; Zygomycosis

2006
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Cryptococcosis; Cryptococcus; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2006
Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6

    Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Guinea Pigs; Humans; Kidney; Liver; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Spleen; Survival Analysis; Triazoles; Trichosporon; Voriconazole

2006
Fusarium oxysporum pneumonia in an immunocompetent host.
    Southern medical journal, 2006, Volume: 99, Issue:6

    Topics: Aged; Antifungal Agents; Bronchoscopy; Female; Fusarium; Humans; Immunocompetence; Mycoses; Pneumonia; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2006
Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Aug-15, Volume: 43, Issue:4

    Topics: Acute Disease; Antifungal Agents; Aspergillosis; Echinocandins; Fungemia; Humans; Leukemia, Myeloid; Lipopeptides; Lipoproteins; Male; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2006
[Clinical cases in medical mycology. Case no. 21].
    Revista iberoamericana de micologia, 2006, Volume: 23, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Endophthalmitis; Exophiala; Female; Fungemia; Humans; Itraconazole; Middle Aged; Mycoses; Opportunistic Infections; Osteolysis; Pregnancy; Pregnancy Complications, Infectious; Pyrimidines; Recurrence; Th2 Cells; Triazoles; Voriconazole

2006
Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment?
    European journal of haematology, 2006, Volume: 77, Issue:4

    Topics: Adult; Aged; Antifungal Agents; Caspofungin; Echinocandins; Female; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Peptides, Cyclic; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2006
Successful use of posaconazole in a pediatric case of fungal necrotizing fasciitis.
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2006, Volume: 7, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Child; Drug Therapy, Combination; Fasciitis, Necrotizing; Female; Humans; Mucormycosis; Mycoses; Triazoles; Trichosporon

2006
AmBisome treatment of fungal sinusitis in severe immunocompromised patient with acute lymphoblastic leukemia relapsed after autologous peripheral blood transplantation.
    Acta bio-medica : Atenei Parmensis, 2006, Volume: 77 Suppl 2

    Topics: Adult; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Combined Modality Therapy; Cytarabine; Cytomegalovirus Infections; Enterococcus faecalis; Fatal Outcome; Humans; Idarubicin; Immunocompromised Host; Immunoglobulins, Intravenous; Liposomes; Male; Mycoses; Peripheral Blood Stem Cell Transplantation; Pneumonia; Postoperative Complications; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pseudomonas putida; Pulmonary Edema; Pyrimidines; Sinusitis; Staphylococcus epidermidis; Transplantation, Autologous; Triazoles; Voriconazole

2006
HPLC analysis of the antifungal agent posaconazole in patients with haematological diseases.
    Mycoses, 2006, Volume: 49 Suppl 1

    Topics: Antifungal Agents; Biological Availability; Chromatography, High Pressure Liquid; Drug Monitoring; Hematologic Diseases; Humans; Mycoses; Triazoles

2006
Salvage therapy of refractory chronic disseminated candidiasis in a patient with acute myeloid leukaemia and secondary prophylaxis during allogeneic stem cell transplantation.
    Mycoses, 2006, Volume: 49 Suppl 1

    Topics: Adult; Antifungal Agents; Candidiasis; Chemoprevention; Drug Resistance, Fungal; Esophagitis; Humans; Leukemia, Myeloid, Acute; Male; Mycoses; Salvage Therapy; Stem Cell Transplantation; Transplantation, Homologous; Triazoles

2006
Severe osteomyelitis caused by Myceliophthora thermophila after a pitchfork injury.
    Annals of clinical microbiology and antimicrobials, 2006, Sep-08, Volume: 5

    Topics: Child, Preschool; Humans; Knee Injuries; Male; Mitosporic Fungi; Mycoses; Osteomyelitis; Pyrimidines; Triazoles; Voriconazole

2006
[Successful treatment with voriconazole for disseminated cutaneous and visceral infection by Fusarium solani in a patient with acute myeloid leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2006, Volume: 47, Issue:8

    Topics: Antifungal Agents; Dermatomycoses; Fusarium; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Opportunistic Infections; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2006
In vitro activity and synergism of amphotericin B, azoles and cationic antimicrobials against the emerging pathogen Trichoderma spp.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Antimicrobial Cationic Peptides; Azoles; Chlorhexidine; Communicable Diseases, Emerging; Drug Synergism; Fluconazole; Guanidines; Humans; Microbial Sensitivity Tests; Mycoses; Polymers; Pyrimidines; Triazoles; Trichoderma; Voriconazole

2006
[Keratomycosis due to Cylindrocarpon lichenicola].
    Mycoses, 2006, Volume: 49 Suppl 2

    Topics: Aged; Amphotericin B; Antifungal Agents; Clematis; Eye Infections, Fungal; Fusarium; Humans; Hypocreales; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole

2006
Chronic refractory phaeohyphomycosis: successful treatment with posaconazole.
    Mycoses, 2006, Volume: 49, Issue:6

    Topics: Adolescent; Adult; Alternaria; Amphotericin B; Antifungal Agents; Chronic Disease; Deoxycholic Acid; Drug Combinations; Female; Humans; Mouth Diseases; Mycoses; Treatment Outcome; Triazoles

2006
Intravitreal voriconazole for drug-resistant fungal endophthalmitis: case series.
    Retina (Philadelphia, Pa.), 2006, Volume: 26, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Humans; Injections; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Visual Acuity; Vitreous Body; Voriconazole

2006
Voriconazole prophylaxis in lung transplant recipients.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2006, Volume: 6, Issue:12

    Topics: Antifungal Agents; Aspergillosis; Chemoprevention; Female; Humans; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Probability; Pyrimidines; Retrospective Studies; Survival Analysis; Time Factors; Triazoles; Voriconazole

2006
Treatment of cutaneous infection by Alternaria alternata with voriconazole in a liver transplant patient.
    Transplantation proceedings, 2006, Volume: 38, Issue:8

    Topics: Alternaria; Antifungal Agents; Dermatomycoses; Fatal Outcome; Humans; Liver Transplantation; Middle Aged; Mycoses; Postoperative Complications; Pyrimidines; Skin; Triazoles; Voriconazole

2006
Posaconazole (Noxafil) for invasive fungal infections.
    The Medical letter on drugs and therapeutics, 2006, Nov-20, Volume: 48, Issue:1248

    Topics: Antifungal Agents; Candidiasis, Oral; Drug Interactions; Humans; Mycoses; Triazoles

2006
Penicillium piceum infection: diagnosis and successful treatment in chronic granulomatous disease.
    Medical mycology, 2006, Volume: 44, Issue:8

    Topics: Antifungal Agents; Biopsy, Fine-Needle; Blood Sedimentation; Child; DNA, Fungal; Genetic Diseases, X-Linked; Granulomatous Disease, Chronic; Humans; Male; Microscopy; Molecular Sequence Data; Mycoses; Osteomyelitis; Penicillium; Pyrimidines; Radiography, Thoracic; Sequence Analysis, DNA; Triazoles; Voriconazole

2006
Topical and oral voriconazole in the treatment of fungal keratitis.
    American journal of ophthalmology, 2007, Volume: 143, Issue:1

    Topics: Administration, Oral; Administration, Topical; Adult; Aged; Aged, 80 and over; Antifungal Agents; Eye Infections, Fungal; Female; Fungi; Humans; Keratitis; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2007
Unexplained increase in Paecilomyces variotii blood culture isolates in the UK.
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2006, Nov-16, Volume: 11, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Blood; Caspofungin; Diagnosis, Differential; Echinocandins; Equipment Contamination; False Positive Reactions; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Mycoses; Paecilomyces; Peptides, Cyclic; Pyrimidines; Species Specificity; Triazoles; United Kingdom; Voriconazole

2006
Voriconazole and fungal keratitis: a report of two treatment failures.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2006, Volume: 22, Issue:6

    Topics: Administration, Topical; Aged, 80 and over; Antifungal Agents; Colletotrichum; Fusarium; Humans; Keratitis; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Pyrimidines; Treatment Failure; Triazoles; Voriconazole

2006
Prophylaxis and aspergillosis--has the principle been proven?
    The New England journal of medicine, 2007, Jan-25, Volume: 356, Issue:4

    Topics: Antifungal Agents; Aspergillosis; Fluconazole; Graft vs Host Disease; Humans; Itraconazole; Mycoses; Neutropenia; Opportunistic Infections; Triazoles

2007
Successful treatment of resistant ocular fusariosis with posaconazole (SCH-56592).
    American journal of ophthalmology, 2007, Volume: 143, Issue:2

    Topics: Administration, Oral; Adult; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Female; Fusarium; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Triazoles

2007
Evaluation of disk diffusion and Etest compared to broth microdilution for antifungal susceptibility testing of posaconazole against clinical isolates of filamentous fungi.
    Journal of clinical microbiology, 2007, Volume: 45, Issue:4

    Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles

2007
Posaconazole.
    Prescrire international, 2007, Volume: 16, Issue:87

    Topics: Antifungal Agents; Aspergillosis; Europe; Humans; Mycoses; Triazoles

2007
Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients.
    Cancer, 2007, Apr-15, Volume: 109, Issue:8

    Topics: Antifungal Agents; Graft Rejection; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2007
Combined therapies in a murine model of blastoschizomycosis.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Flucytosine; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Trichosporon; Voriconazole

2007
Posaconazole salvage therapy allows successful allogeneic hematopoietic stem cell transplantation in patients with refractory invasive mold infections.
    Transplant infectious disease : an official journal of the Transplantation Society, 2007, Volume: 9, Issue:2

    Topics: Adult; Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Multiple Myeloma; Mycoses; Prospective Studies; Salvage Therapy; Transplantation, Homologous; Triazoles

2007
Successful treatment of disseminated fusariosis with posaconazole during neutropenia and subsequent allogeneic hematopoietic stem cell transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2007, Volume: 9, Issue:2

    Topics: Adolescent; Antifungal Agents; Female; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Mycoses; Neutropenia; Triazoles

2007
Management of tunnel fungal infection with voriconazole.
    Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:5

    Topics: Administration, Oral; Administration, Topical; Aged; Antifungal Agents; Cataract Extraction; Corneal Ulcer; Eye Infections, Fungal; Female; Fusarium; Humans; Microsurgery; Mycoses; Pyrimidines; Surgical Wound Infection; Triazoles; Visual Acuity; Voriconazole

2007
Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report.
    BMC infectious diseases, 2007, May-10, Volume: 7

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Female; Fusarium; Humans; Lipopeptides; Mycoses; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
Posaconazole prophylaxis in hematologic cancer.
    The New England journal of medicine, 2007, May-24, Volume: 356, Issue:21

    Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Opportunistic Infections; Triazoles

2007
Posaconazole prophylaxis in hematologic cancer.
    The New England journal of medicine, 2007, May-24, Volume: 356, Issue:21

    Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Myelodysplastic Syndromes; Opportunistic Infections; Research Design; Triazoles

2007
Posaconazole prophylaxis in hematologic cancer.
    The New England journal of medicine, 2007, May-24, Volume: 356, Issue:21

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Humans; Mucositis; Mycoses; Opportunistic Infections; Oxidoreductases; Point Mutation; Pyrimidines; Sterol 14-Demethylase; Triazoles; Voriconazole

2007
Posaconazole prophylaxis in hematologic cancer.
    The New England journal of medicine, 2007, May-24, Volume: 356, Issue:21

    Topics: Antifungal Agents; Bilirubin; Chemical and Drug Induced Liver Injury; Fluconazole; Graft vs Host Disease; Humans; Liver Diseases; Mycoses; Transaminases; Triazoles

2007
[Treatment with voriconazole for invasive fungal infection during chemotherapy for leukemia: doses and plasma concentration of voriconazole in children].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2007, Volume: 48, Issue:5

    Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Drug Monitoring; Female; Humans; Immunocompromised Host; Infant; Leukemia; Male; Metabolic Clearance Rate; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2007
In vitro susceptibility to posaconazole of 1,903 yeast isolates recovered in France from 2003 to 2006 and tested by the method of the European committee on antimicrobial susceptibility testing.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9

    Topics: Antifungal Agents; Fluconazole; France; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts

2007
Quantitative Fusarium spp. and Microdochium spp. PCR assays to evaluate seed treatments for the control of Fusarium seedling blight of wheat.
    Journal of applied microbiology, 2007, Volume: 102, Issue:6

    Topics: Antifungal Agents; Ascomycota; Benzimidazoles; Biphenyl Compounds; Crops, Agricultural; Dioxoles; DNA, Fungal; Fusarium; Mycoses; Plant Diseases; Polymerase Chain Reaction; Pyrroles; Seedlings; Seeds; Triazoles; Triticum

2007
Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole.
    Bone marrow transplantation, 2007, Volume: 40, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Data Collection; Drug Evaluation; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Premedication; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole; Zygomycosis

2007
Basidiomycetous fungal Inonotus tropicalis sacral osteomyelitis in X-linked chronic granulomatous disease.
    The Pediatric infectious disease journal, 2007, Volume: 26, Issue:7

    Topics: Adult; Antifungal Agents; Basidiomycota; Caspofungin; Echinocandins; Granulomatous Disease, Chronic; HMGB1 Protein; Humans; Lipopeptides; Male; Mycoses; Osteomyelitis; Peptides, Cyclic; Pyrimidines; Sacrum; Triazoles; Voriconazole

2007
Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study.
    BMC infectious diseases, 2007, Jul-02, Volume: 7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2007
The fusarium keratitis outbreak: not done yet?
    Archives of ophthalmology (Chicago, Ill. : 1960), 2007, Volume: 125, Issue:7

    Topics: Adult; Amphotericin B; Antifungal Agents; Child; Combined Modality Therapy; Corneal Ulcer; Disease Outbreaks; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fusarium; Humans; Keratoplasty, Penetrating; Microbial Sensitivity Tests; Mycoses; Natamycin; Pyrimidines; Triazoles; Voriconazole

2007
Third-time lung transplant using extended criteria lungs.
    The Annals of thoracic surgery, 2007, Volume: 84, Issue:2

    Topics: Adult; Antifungal Agents; Brain Death; Humans; Lung Transplantation; Male; Mycoses; Patient Selection; Postoperative Complications; Pyrimidines; Reoperation; Tissue Donors; Treatment Outcome; Triazoles; Voriconazole

2007
Lecythophora mutabilis prosthetic valve endocarditis in a diabetic patient.
    Medical mycology, 2007, Volume: 45, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Aortic Valve; Ascomycota; Diabetes Complications; Drug Combinations; Endocarditis; Heart Valve Prosthesis; Humans; Male; Middle Aged; Molecular Sequence Data; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Prosthesis-Related Infections; Pyrimidines; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole

2007
Posaconazole: a next-generation triazole antifungal.
    Future microbiology, 2007, Volume: 2, Issue:3

    Topics: Animals; Antifungal Agents; Aspergillus; Candida; Clinical Trials, Phase III as Topic; Drug Evaluation, Preclinical; Humans; Models, Animal; Molecular Structure; Mycoses; Triazoles

2007
Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients.
    The American journal of tropical medicine and hygiene, 2007, Volume: 77, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Female; Humans; Male; Mycoses; Penicillium; Pyrimidines; Triazoles; Voriconazole

2007
Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2007, Volume: 26, Issue:11

    Topics: Aged; Amphotericin B; Antifungal Agents; Cross Infection; Drug Therapy, Combination; Humans; Leukemia, Myeloid, Acute; Male; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2007
Recalcitrant Beauveria bassiana keratitis: confocal microscopy findings and treatment with posaconazole (Noxafil).
    Cornea, 2007, Volume: 26, Issue:8

    Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Beauveria; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Microscopy, Confocal; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole

2007
Candida krusei arthritis in a patient with hematologic malignancy: successful treatment with voriconazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Oct-01, Volume: 45, Issue:7

    Topics: Antifungal Agents; Arthritis, Infectious; Candida; Humans; Knee Joint; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mycoses; Pyrimidines; Synovial Fluid; Triazoles; Voriconazole

2007
Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:5

    Topics: Acute Kidney Injury; Adult; Aged; Antifungal Agents; Area Under Curve; Critical Illness; Female; Half-Life; Hemodiafiltration; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole

2007
[Present and future of voriconazole in the treatment of invasive mycoses: the inseparable binomial diagnosis-treatment].
    Revista iberoamericana de micologia, 2007, Sep-30, Volume: 24, Issue:3

    Topics: Antifungal Agents; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2007
Efficacy of caspofungin and posaconazole in a murine model of disseminated Exophiala infection.
    Medical mycology, 2007, Volume: 45, Issue:8

    Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Caspofungin; Disease Models, Animal; Echinocandins; Exophiala; Female; Immunocompromised Host; Kidney; Lipopeptides; Mice; Mice, Inbred ICR; Mycoses; Survival Analysis; Triazoles

2007
Antifungal efficacy of voriconazole, itraconazole and amphotericin b in experimental fusarium solani keratitis.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2008, Volume: 246, Issue:2

    Topics: Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Corneal Ulcer; Disease Models, Animal; Eye Infections, Fungal; Fusarium; Itraconazole; Mycoses; Pyrimidines; Rabbits; Treatment Outcome; Triazoles; Voriconazole

2008
Images in haematology. Cerebral fungal abscess in a patient with acute promyelocytic leukaemia.
    British journal of haematology, 2008, Volume: 140, Issue:3

    Topics: Antifungal Agents; Brain Abscess; Combined Modality Therapy; Female; Fusarium; Humans; Leukemia, Promyelocytic, Acute; Magnetic Resonance Imaging; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2008
In vitro efficacy of voriconazole against clinical isolates of Scytalidium spp. from clinical lesions.
    International journal of antimicrobial agents, 2008, Volume: 31, Issue:2

    Topics: Antifungal Agents; Humans; Mitosporic Fungi; Mycoses; Pyrimidines; Triazoles; Voriconazole

2008
In vitro activity (MIC and MFC) of voriconazole, amphotericin B, and itraconazole against 192 filamentous fungi: the GISIA-2 study.
    Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2007
Case report: allergic bronchopulmonary aspergillosis and allergic fungal sinusitis successfully treated with voriconazole.
    The Journal of asthma : official journal of the Association for the Care of Asthma, 2007, Volume: 44, Issue:10

    Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Humans; Hypersensitivity; Male; Middle Aged; Mycoses; Pyrimidines; Remission Induction; Sinusitis; Triazoles; Voriconazole

2007
Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia.
    Pharmacotherapy, 2008, Volume: 28, Issue:1

    Topics: Administration, Oral; Adult; Aged; Alanine Transaminase; Antifungal Agents; Aspartate Aminotransferases; Bilirubin; Creatinine; Exanthema; Female; Fever; Humans; Injections, Intravenous; Male; Middle Aged; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2008
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Jan-15, Volume: 46, Issue:2

    Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2008
Virulence studies of Scedosporium and Fusarium species in Drosophila melanogaster.
    The Journal of infectious diseases, 2007, Dec-15, Volume: 196, Issue:12

    Topics: Animals; Drosophila melanogaster; Drosophila Proteins; Female; Fusarium; Humans; Mycetoma; Mycoses; Pyrimidines; Scedosporium; Spores, Fungal; Toll-Like Receptors; Triazoles; Virulence; Voriconazole

2007
Breakthrough cutaneous alternariosis in a patient with acute lymphoblastic leukemia: clinical features and diagnostic issues.
    Leukemia & lymphoma, 2008, Volume: 49, Issue:1

    Topics: Adult; Alternaria; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Skin Diseases; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole

2008
Progressive fusariosis: unpredictable posaconazole bioavailability, and feasibility of recombinant interferon-gamma plus granulocyte macrophage-colony stimulating factor for refractory disseminated infection.
    Leukemia & lymphoma, 2008, Volume: 49, Issue:1

    Topics: Adult; Biological Availability; Fusarium; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunocompromised Host; Interferon-gamma; Leukemia; Male; Mycoses; Neutropenia; Recombinant Proteins; Salvage Therapy; Treatment Outcome; Triazoles

2008
In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Antifungal Agents; Aspergillus; Candida; Fluconazole; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Mycoses; Nitriles; Opportunistic Infections; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2008
Cervical spondylodiscitis caused by Blastoschizomyces capitatus.
    Infection, 2009, Volume: 37, Issue:2

    Topics: Adult; Amphotericin B; Antifungal Agents; Cervical Vertebrae; Dipodascus; Discitis; Female; Humans; Leukemia, Myeloid, Acute; Mycoses; Neck; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Ultrasonography; Voriconazole

2009
Voriconazole-induced blistering in the setting of graft versus host disease: A report of 2 patients.
    Journal of the American Academy of Dermatology, 2008, Volume: 58, Issue:3

    Topics: Adult; Antifungal Agents; Blister; Bone Marrow Transplantation; Extremities; Female; Fusarium; Graft vs Host Disease; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole

2008
Treatment of invasive fungal infections in clinical practice: a multi-centre survey on customary dosing, treatment indications, efficacy and safety of voriconazole.
    International journal of hematology, 2008, Volume: 87, Issue:2

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2008
Primary prophylaxis with voriconazole in patients receiving induction chemotherapy on the MRC adult acute lymphoblastic leukaemia trial (UK-ALL XII) to avoid itraconazole-enhanced vinca neurotoxicity.
    International journal of laboratory hematology, 2008, Volume: 30, Issue:2

    Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Humans; Itraconazole; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole

2008
Recurrent Trichosporon asahii glossitis: a case report.
    The journal of contemporary dental practice, 2008, Mar-01, Volume: 9, Issue:3

    Topics: Administration, Inhalation; Adult; Antifungal Agents; Asthma; Bronchodilator Agents; Budesonide; Drug Resistance, Fungal; Glossitis; Humans; Immunocompromised Host; Male; Mycoses; Pyrimidines; Recurrence; Triazoles; Trichosporon; Voriconazole

2008
Successful treatment of subcutaneous Scytalidium hyalinum infection with voriconazole and topical terbinafine in a cardiac transplant patient.
    Transplantation, 2008, Mar-15, Volume: 85, Issue:5

    Topics: Administration, Topical; Antifungal Agents; Ascomycota; Erythema; Heart Transplantation; Humans; Male; Middle Aged; Mycoses; Naphthalenes; Postoperative Complications; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2008
[Antifungal activity of posaconazole and caspofungin in yeast causing invasive fungal infection (2002-2003). E-test system evaluation].
    Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26, Issue:2

    Topics: Antifungal Agents; Candida; Caspofungin; Cryptococcus; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Rhodotorula; Sensitivity and Specificity; Species Specificity; Triazoles

2008
In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6

    Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Fusarium; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Naphthalenes; Sequence Analysis, DNA; Terbinafine; Triazoles; Tubulin

2008
[Usefulness of voriconazole in treatment of Phoma glomerata after penetrating injury].
    Journal francais d'ophtalmologie, 2008, Volume: 31, Issue:1

    Topics: Aged; Antifungal Agents; Ascomycota; Eye Injuries, Penetrating; Humans; Male; Mycoses; Pyrimidines; Retinal Detachment; Triazoles; Voriconazole

2008
Disseminated infection by Bipolaris spicifera in an immunocompetent subject.
    Medical mycology, 2008, Volume: 46, Issue:4

    Topics: Adult; Amphotericin B; Ascomycota; DNA, Fungal; DNA, Ribosomal; Humans; Immunocompetence; Itraconazole; Lymph Nodes; Male; Mycoses; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole

2008
Invasive pulmonary infection due to Trichoderma longibrachiatum mimicking invasive Aspergillosis in a neutropenic patient successfully treated with voriconazole combined with caspofungin.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, May-15, Volume: 46, Issue:10

    Topics: Adolescent; Antifungal Agents; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Hematologic Neoplasms; Humans; Lipopeptides; Male; Mycoses; Neutropenia; Pneumonia; Pyrimidines; Radiography, Thoracic; Tomography, X-Ray Computed; Triazoles; Trichoderma; Voriconazole

2008
Numbers needed to treat with posaconazole prophylaxis to prevent invasive fungal infection and death.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, May-15, Volume: 46, Issue:10

    Topics: Antifungal Agents; Chemoprevention; Humans; Mycoses; Triazoles

2008
Combined therapy in treatment of murine infection by Fusarium solani.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:3

    Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Drug Therapy, Combination; Echinocandins; Fusarium; Immunocompromised Host; Kidney; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mycoses; Pyrimidines; Spleen; Survival Analysis; Triazoles; Voriconazole

2008
Antimycotic therapy of experimental infections caused by dematiaceous fungi.
    Sabouraudia, 1984, Volume: 22, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Flucytosine; Fluorouracil; Humans; Ketoconazole; Male; Mice; Mitosporic Fungi; Mycoses; Triazoles

1984
Antimycotic activity of BAY N 7133 in animal experiments.
    The Journal of antimicrobial chemotherapy, 1984, Volume: 13, Issue:5

    Topics: Administration, Oral; Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Female; Flucytosine; Guinea Pigs; Hair; Infusions, Parenteral; Ketoconazole; Male; Mice; Mycoses; Triazoles

1984
Activities of D0870, a novel triazole, against Candida lusitaniae and Trichosporon beigelii in experimental murine infections.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:2

    Topics: Animals; Antifungal Agents; Candida; Candidiasis; Male; Mice; Microbial Sensitivity Tests; Mycoses; Triazoles; Trichosporon

1995
Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:11

    Topics: Amphotericin B; Animals; Antifungal Agents; Dose-Response Relationship, Drug; Drug Carriers; Drug Therapy, Combination; Evaluation Studies as Topic; Liposomes; Male; Mice; Mycoses; Triazoles; Trichosporon

1994
In vitro and in vivo antifungal activities of D0870, a new triazole agent.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:11

    Topics: Animals; Antifungal Agents; Culture Media; Fungi; Hydrogen-Ion Concentration; Immunosuppression Therapy; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mycoses; Stereoisomerism; Triazoles

1993
In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:4

    Topics: Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

1997
In vitro antifungal activity of novel azole derivatives with a morpholine ring, UR-9746 and UR-9751, and comparison with fluconazole.
    Diagnostic microbiology and infectious disease, 1997, Volume: 29, Issue:2

    Topics: Antifungal Agents; Culture Media; Fluconazole; Fungi; Humans; Microbial Sensitivity Tests; Morpholines; Mycoses; Triazoles

1997
Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts.
    Journal of clinical microbiology, 1998, Volume: 36, Issue:10

    Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Culture Media; Echinocandins; Fungi; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Peptides; Peptides, Cyclic; Structure-Activity Relationship; Triazoles; Yeasts

1998
[Antifungal drugs: the new frontier].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 1998, Volume: 11, Issue:3

    Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Caspofungin; Drug Resistance, Microbial; Echinocandins; Female; Fungi; Humans; Lipopeptides; Male; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Research; Triazoles; Trypanocidal Agents; Voriconazole

1998
Treatment of murine fusariosis with SCH 56592.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:3

    Topics: Animals; Antifungal Agents; Colony Count, Microbial; Fusarium; Kidney; Male; Mice; Mycoses; Triazoles

1999
In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

1998
Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi.
    Medical mycology, 1998, Volume: 36, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

1998
Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species.
    Journal of clinical microbiology, 1999, Volume: 37, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

1999
ER 30346. BMS 207147.
    Drugs in R&D, 1999, Volume: 1, Issue:2

    Topics: Animals; Antifungal Agents; Dogs; Drug Interactions; Drugs, Investigational; Fungi; Humans; Mycoses; Rats; Thiazoles; Triazoles

1999
SCH 56592.
    Drugs in R&D, 1999, Volume: 1, Issue:2

    Topics: Animals; Antifungal Agents; Candidiasis; Chagas Disease; Drugs, Investigational; Fungi; Humans; Mice; Mycoses; Parasitic Diseases; Triazoles

1999
Voriconazole. UK 109496.
    Drugs in R&D, 1999, Volume: 1, Issue:2

    Topics: Animals; Antifungal Agents; Aspergillosis; Drug Interactions; Drugs, Investigational; Fungi; Guinea Pigs; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

1999
SCH 56592, amphotericin B, or itraconazole therapy of experimental murine cerebral phaeohyphomycosis due to Ramichloridium obovoideum ("Ramichloridium mackenziei").
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:5

    Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Central Nervous System Fungal Infections; Disease Models, Animal; Female; Itraconazole; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mycoses; Triazoles

2000
Cutaneous infection caused by Paecilomyces lilacinus in a renal transplant patient: treatment with voriconazole.
    Scandinavian journal of infectious diseases, 2000, Volume: 32, Issue:3

    Topics: Antifungal Agents; Dermatomycoses; Humans; Immunocompromised Host; Kidney Transplantation; Male; Middle Aged; Mycoses; Opportunistic Infections; Paecilomyces; Pyrimidines; Triazoles; Voriconazole

2000
[Therapy of deep seated mycoses--Timing of administration and selection of antifungal agents].
    The Japanese journal of antibiotics, 2000, Volume: 53, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Mycoses; Nystatin; Pyrimidines; Triazoles; Voriconazole

2000
Optimal use of the newer antifungal agents.
    Oncology (Williston Park, N.Y.), 2000, Volume: 14, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Drugs, Investigational; Humans; Immunocompromised Host; Mycoses; Opportunistic Infections; Randomized Controlled Trials as Topic; Triazoles

2000
Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading.
    Diagnostic microbiology and infectious disease, 2000, Volume: 38, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Reference Standards; Time Factors; Triazoles; Trichosporon; Turkey; Voriconazole

2000
In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
    Journal of clinical microbiology, 2001, Volume: 39, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2001
In vitro antifungal activity of posaconazole against various pathogenic fungi.
    International journal of antimicrobial agents, 2001, Volume: 18, Issue:2

    Topics: Antifungal Agents; Aspergillus fumigatus; Candida albicans; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles

2001
In vitro and in vivo activities of CS-758 (R-120758), a new triazole antifungal agent.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:2

    Topics: Animals; Antifungal Agents; Aspergillus; Candida; Cryptococcus neoformans; Disease Models, Animal; Mice; Microbial Sensitivity Tests; Mycoses; Treatment Outcome; Triazoles

2002
Empirical antifungal therapy--new options, new tradeoffs.
    The New England journal of medicine, 2002, Jan-24, Volume: 346, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2002
Voriconazole versus liposomal amphotericin B in patients with neutropenia and persistent fever.
    The New England journal of medicine, 2002, Jan-24, Volume: 346, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Data Interpretation, Statistical; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Research Design; Treatment Outcome; Triazoles; Voriconazole

2002
Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Canada; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Quality Control; Thiazoles; Triazoles; United States; Voriconazole

2002
In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles

2002
Decisions about voriconazole versus liposomal amphotericin B.
    The New England journal of medicine, 2002, May-09, Volume: 346, Issue:19

    Topics: Amphotericin B; Antifungal Agents; Clinical Protocols; Data Interpretation, Statistical; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Research Design; Triazoles; Voriconazole

2002
Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
    The New England journal of medicine, 2002, May-30, Volume: 346, Issue:22

    Topics: Amphotericin B; Antifungal Agents; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2002
Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
    The New England journal of medicine, 2002, May-30, Volume: 346, Issue:22

    Topics: Amphotericin B; Antifungal Agents; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2002
Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992, Volume: 15, Issue:5

    Topics: Adult; Aged; Amphotericin B; Animals; Antifungal Agents; Child, Preschool; Disease Models, Animal; Female; Fluconazole; Humans; Immunocompromised Host; Male; Mice; Miconazole; Middle Aged; Mycoses; Triazoles; Trichosporon

1992
[Clinical features of 32 cases of fungal pneumonia].
    Nihon Kyobu Shikkan Gakkai zasshi, 1991, Volume: 29, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Cross Infection; Female; Fungi; Humans; Imidazoles; Lung Diseases, Fungal; Male; Middle Aged; Mycoses; Pneumonia; Radiography; Triazoles

1991
New strategies developed to prevent serious infections in children.
    Journal of the National Cancer Institute, 1991, May-01, Volume: 83, Issue:9

    Topics: Agranulocytosis; Amphotericin B; Cell Wall; Child, Preschool; Humans; Mycoses; Peptides; Triazoles

1991
Preclinical antimycotic activity of SDZ 89-485: a new orally and topically effective triazole.
    Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 1990, Volume: 28, Issue:6

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Candidiasis, Vulvovaginal; Culture Media; Disease Models, Animal; Female; Guinea Pigs; Histoplasmosis; Humans; Mice; Mycoses; Nephritis; Rats; Sporotrichosis; Tinea; Triazoles

1990
Differential staining of fungi in clinical specimens using fluorescent whitening agent (Blankophor).
    Mykosen, 1987, Volume: 30, Issue:1

    Topics: Fluorescent Dyes; Fungi; Humans; Microscopy, Fluorescence; Mucous Membrane; Mycoses; Skin; Staining and Labeling; Triazoles

1987
Pharmacokinetics of oral fluconazole in autologous bone marrow transplantation recipients given TBI and high-dose melphalan.
    Transplantation proceedings, 1989, Volume: 21, Issue:1 Pt 3

    Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Bone Marrow Transplantation; Drug Administration Schedule; Female; Fluconazole; Humans; Male; Melphalan; Middle Aged; Mycoses; Transplantation, Autologous; Triazoles; Whole-Body Irradiation

1989
[A clinical evaluation of fluconazole in the treatment of deep mycosis].
    The Japanese journal of antibiotics, 1989, Volume: 42, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug Evaluation; Drug Tolerance; Female; Fluconazole; Fungi; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Triazoles

1989
[Clinical evaluation of fluconazole in patients with mycotic infection].
    The Japanese journal of antibiotics, 1989, Volume: 42, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus; Candidiasis; Candidiasis, Oral; Drug Evaluation; Female; Fluconazole; Humans; Lung; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Mycoses; Sepsis; Tissue Distribution; Triazoles

1989
[Experience of fluconazole in pediatric patients].
    The Japanese journal of antibiotics, 1989, Volume: 42, Issue:1

    Topics: Administration, Oral; Adolescent; Antifungal Agents; Candida; Candidiasis; Child; Child, Preschool; Drug Evaluation; Drug Tolerance; Female; Fluconazole; Humans; Infant; Male; Mycoses; Risk Factors; Triazoles

1989
[Clinical evaluation of fluconazole].
    The Japanese journal of antibiotics, 1989, Volume: 42, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Ambulatory Care; Antifungal Agents; Antigens, Fungal; Candidiasis; Child; Cryptococcosis; Cryptococcus neoformans; Drug Evaluation; Esophagitis; Female; Fluconazole; Humans; Male; Meningitis; Middle Aged; Mycoses; Renal Dialysis; Triazoles

1989
[A clinical evaluation of injectable fluconazole in the treatment of deep mycosis associated with hematological malignancy].
    The Japanese journal of antibiotics, 1989, Volume: 42, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Aged; Antifungal Agents; Candida; Candidiasis; Drug Evaluation; Drug Tolerance; Female; Fluconazole; Humans; Injections, Intravenous; Leukemia; Lymphoma; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Triazoles

1989
[Fluconazole treatment of systemic mycoses].
    The Japanese journal of antibiotics, 1989, Volume: 42, Issue:1

    Topics: Adolescent; Adult; Aged; Anorexia; Antifungal Agents; Candidiasis; Drug Evaluation; Drug Tolerance; Endophthalmitis; Female; Fluconazole; Humans; Leukopenia; Lung Diseases, Fungal; Male; Middle Aged; Mycoses; Triazoles

1989
[Recent antifungal agents].
    Pathologie-biologie, 1989, Volume: 37, Issue:2

    Topics: Allylamine; Animals; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Morpholines; Mycoses; Triazoles

1989
[International symposium: Fluconazole in fungal infections. 20-21 January 1989, Berlin. Abstracts].
    Der Gynakologe, 1989, Volume: 22, Issue:2 Suppl

    Topics: Antifungal Agents; Fluconazole; Humans; Mycoses; Triazoles

1989
Ocular toxicity after intravitreal injection of terconazole.
    Annals of ophthalmology, 1989, Volume: 21, Issue:9

    Topics: Animals; Antifungal Agents; Electroretinography; Endophthalmitis; Eye; Mycoses; Ophthalmoscopy; Rabbits; Triazoles

1989
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
    Chemotherapy, 1987, Volume: 33, Issue:5

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Exophiala; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mycoses; Triazoles

1987
Chemotherapy of the pulmonary mycoses. This Official Statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1987.
    The American review of respiratory disease, 1988, Volume: 138, Issue:4

    Topics: Amphotericin B; Flucytosine; Humans; Imidazoles; Lung Diseases; Mycoses; Triazoles

1988
[Antimycotic agents in generalized fungal infections].
    Nederlands tijdschrift voor geneeskunde, 1988, May-14, Volume: 132, Issue:20

    Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Imidazoles; Mycoses; Triazoles

1988
Serum fungistatic and fungicidal activity in volunteers receiving antifungal agents.
    European journal of clinical microbiology, 1986, Volume: 5, Issue:1

    Topics: Aspergillus fumigatus; Candida; Candida albicans; Chromatography, High Pressure Liquid; Cryptococcus neoformans; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Humans; Ketoconazole; Mucorales; Mycoses; Rifampin; Triazoles

1986
Antifungal agents used for deep-seated mycotic infections.
    Mayo Clinic proceedings, 1987, Volume: 62, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Mycoses; Triazoles

1987